5-Hydroxytryptamine, Phenylephrine and Endothelium-Dependent Relaxant Factor in the Rat Aorta: Effects and Interactions by Dainty, Ian Albert
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
January 1989
5-Hydroxytryptamine, phenylephrine and 
endothelium-dependent relaxant factor in 
the rat aorta: effects and interactions.
A thesis presented for the degree of 
Doctor of Philosophy
by
Ian Albert Dainty
Institute of Physiology, 
University of Glasgow, 
Glasgow, 
Scotland.
@ I. A. Dainty, 1989.
ProQuest Number: 10999240
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10999240
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
Dedication
I would like to dedicate this thesis to my mother who 
was always there and to my father who never knew.
“Only at the end is it known what should have been done at the beginning”
Dr V.G. Wilson, 1988
List of Contents
Page
N um ber
Contents i-iii
List of Figures iv-xii
List of Tables xiii
Acknowledgements xiv
Declaration and Publications xv-xvi
Summary xvii-xix
General Introduction 1-19
Ca2+ requirement for contraction of smooth muscle. 2-5
Source of Intracellular free Ca2+ 2-3
Influx of Ca2+0 3
Release of Ca2f  4-5
The V ascular Endothelium 6-18
Endothelium derived relaxant factor(s) 6-17
Historical Viewpoint 6-8
S dmulated release of EDRF 8-9
Basal release of EDRF 10-11
Mechanism of Action 11-12
Nature of EDRF 12-16
Endothelium-dependent contractile factor 17-18
Aims of the study 19
General Methods 20-28
General Methods 21-26
Statistical Analysis 26
Drugs 27-28
Chapter One 29-78
Contractions of the rat aorta to phenylephrine and 5-hydroxytryptamine: 
dependence on extracellular Ca2+ and effect of lithium pre-treatment
Introduction
Methods
Results
Discussion
Chapter Two
The influence of the initial stretch and the agonist-induced tone on the 
effect of basal and stimulated release of EDRF.
Introduction
Methods
Results
Discussion
Chapter Three
The influence of the endothelium on 5-HT-induced responses of the rat 
aorta.
Introduction
Methods
Results
Discussion
Chapter Four
Classification of the muscarinic receptor subtype mediating endothelium- 
dependent relaxations of the rat aorta.
Introduction
30-31
32-36
37-66
67-78
79-117
80
81-84
85-108
109-117
118-146
119-121
122-124
125-142
143-146
147-182
148-150
Methods 151-157
Results 158-173
Discussion 174-182
Chapter Five 183-216
The effect of palmitoyl carnitine on endothelium-dependent relaxations of 
the rat aorta.
Introduction 184-185
Methods 186-190
Results 191-208
Discussion 209-216
General Discussion 217-222
References R (i)-
R (xvii)
Appendix
Computerised system for acquisition and analysis of data.
A (i) -
A (xv i)
List of Figures
F ig u re
N um ber
1.1 Effect of disruption of the endothelium by rubbing or collagenase 
treatment on ACh-induced relaxations of the rabbit aorta. Figure 
taken from Furchgott and Zawadski, 1980.
G. 1 Representative trace showing decrease in size of contractile response 
to PhE following overzealous rubbing of the intimal layer of the 
aortic ring to disrupt the endothelium.
G.2 Scanning electron micrograph of rubbed and unrubbed aortic rings.
G.3 Method of attachment of rat aortic rings to the transducer for
isometric tension recordings.
Chapter One
1.1 Representative trace showing contractile response to Ca2+ re-addition 
in the presence of 5-HT or PhE.
1.2 Effect of re-addition of Ca2+0 in the presence of 0.1 fiM PhE or 3pM 5- 
HT in endothelium-denuded aortic ring preparations previously 
contracted in 2.5mM Ca2+0 with 10}iM PhE or 30pM 5-HT.
1.3 Representative trace showing contractile response to 0.1 pM PhE 
following re-addition of Ca2+ in the presence of 3pM 5-HT.
1.4 Contractions of endothelium-disrupted rat aortic rings to 0. lpM  PhE 
and 3pM 5-HT in PSS containing a fixed concentration of Ca2+.
1.5 Contractions of rat aortic rings to (a) PhE and (b) 5-HT. Data 
represents the contraction to re-addition of Ca2+ in the presence of the 
agonist and also addition of the agonist in a fixed concentration of 
Ca2+.
1.6 Effect of re-addition of Ca2+ in the presence of (a) 0. lpM  PhE or (b) 
3pM 5-HT in tissues previously contracted in PSS containing 2.5mM 
Ca2+ with 30pM 5-HT or lOpM PhE.
1.7 Contractile response of rat aortic rings to re-addition of Ca2+ in the 
presence of (a) PhE or (b) 5-HT in control preparations and 
preparations pre-incubated with lpM  BAY K 8644.
1.8 The effect of BAY K 8644 following re-addition of Ca2+ in the 
presence of (a) PhE or (b) 5-HT.
iv
Page
N um ber
7
22
23
24
38
39
40
41
42
44
45
46
1.9 Contractions of rat aortic rings to (a) PhE and (b) 5-HT in 2.5 mM 
Ca2+ PSS in the presence or absence of a subcontractile concentration 
(20mM) of KC1.
1.10 Effect of a subcontractile concentration (20mM) of KC1 on (a) the 
maximum contraction and (b) the sensitivity of rat aortic rings to PhE 
and 5-HT.
1.11 Difference in sensitivity (A pEC50) for PhE and 5-HT between 
responses in control PSS and PSS containing 20mM KC1.
1.12 Contractions of rat aortic rings to (a) PhE and (b) 5-HT in 2.5 mM 
Ca2+ PSS in the presence of BRL 34195.
1.13 Effect of increasing concentrations of BRL 34195 on the maximum 
contraction of rat aortic rings to PhE and 5-HT.
1.14 Effect of disruption of the endothelium on contractions of rat aortic 
rings to PhE and 5-HT.
1.15 Effect o f disruption of the endothelium on (a) the maximum 
contraction and (b) the sensitivity (pEC50) of rat aortic rings to PhE 
and 5-HT.
1.16 Difference in sensitivity (A pEC50) for PhE and 5-HT between 
responses in the absence and presence of an intact endothelium.
1.17 Effect of disruption of the endothelium on (a) the contractile response 
and (b) the sensitivity (pEC50) of rat aortic rings to U46619.
1.18 Contractions of aortic rings with a disrupted endothelium to (a) PhE 
and (b) 5-HT from control rats and rats chronically pre-treated with 
LiCl.
1.19 Sensitivity (pEC50) of PhE and 5-HT in endothelium-intact aortic 
rings from control rats and rats chronically pre-treated with LiCl.
1.20 Contractions of aortic rings with a functional endothelium to (a) PhE 
and (b) 5-HT from control rats and rats chronically pre-treated with 
LiCl.
1.21 Sensitivity (pEC50) of PhE and 5-HT in endothelium-disrupted aortic 
rings from control rats and rats chronically pre-treated with LiCl.
1.22 Contractions of aortic rings with a disrupted endothelium to (a) PhE 
and (b) 5-HT from rats chronically pre-treated with LiCl and rats 
chronically pre-treated with a combination of LiCl and myoinositol.
1.23 Contractions of aortic rings with a functional endothelium to (a) PhE 
and (b) 5-HT from rats chronically pre-treated with LiCl and rats 
chronically pre-treated with a combination of LiCl and myoinositol.
47
48
51
52
53
54
55
56
59
60
61
62
63
64
65
v
1.24 Diagram showing the proposed pathway for agonist-induced turnover 74 
of membrane inositol phospholipids.
C hap ter Two
2.1 Diagram representing a ‘side-on’ view of a rat aortic ring segment 82 
suspended between an upper and lower wire tissue holder for 
measurement of isometric tension at different degrees of ‘stretch’.
Values of ‘stretch’ indicate wire separation with ‘zero’ indicating the 
position where the upper and lower edge of the upper and lower wire 
holders theoretically meet.
2.2 Typical trace showing the response of the rat aorta to l|iM  PhE and 86
lpM  ACh in preparations with (a) an intact endothelium and (b) a 
disrupted endothelium.
2.3 Effect of increasing the degree of ‘stretch’ on the resting tension of 87
rat aortic rings in the presence and absence of a functional 
endothelium.
2.4 Effect of increasing the degree of ‘stretch’ on contractile response of 88
rat aortic rings to lp M  PhE in the presence and absence of a 
functional endothelium.
2.5 Effect of increasing the degree of ‘stretch’, on the difference in 89
contractile response of rat aortic rings to l|iM  PhE in the presence
and absence of a functional endothelium. The difference is expressed 
as (a) the ‘absolute’ effect (i.e. in terms of mg. wt.) and (b) the 
‘proportionate’ effect (i.e. as a percentage of the contraction in the 
intact vessel).
2.6 Effect of increasing the degree of ‘stretch’ on ACh-induced 91
relaxations of rat aortic rings precontracted with lp.M PhE. The 
response is expressed as (a) the ‘absolute’ effect (i.e. in terms of mg.
wt.) and (b) the ‘proportionate’ effect (i.e. as a percentage reduction 
of the induced tone).
2.7 Effect of increasing the resting tension, hence degree of ‘stretch’, on 92
sensitivity of rat aortic rings to PhE-induced contractions expressed
as the pD2 for PhE in (a) the absence and (b) the presence of a 
functional endothelium for time controls and with increasing initial 
resting tension.
2.8 Effect of increasing the resting tension, hence degree of ‘stretch’, on 93
sensitivity of rat aortic rings to PhE-induced contractions expressed
as the pD2 for PhE. Data shown represents the pD2 values for time 
controls in the absence and presence of a functional endothelium and 
the pD2 values, with increasing initial resting tension in the absence 
and presence of a functional endothelium.
vi
2.9 The increase in sensitivity to PhE-induced contractions due to 95
removal of the endothelium of rat aortic rings in preparations with 
increasing resting tension and in concomitant time controls set at a 
resting tension of 1000 mg. wt.
2.10 Relaxations of intact rat aortic rings by successive cumulative 96 
concentration-response curves for ACh in terms of the percentage 
maximum response. Effect of (a) time, and (b) increasing initial 
resting tension.
2.11 Effect of increasing the resting tension, hence degree of ‘stretch’, on 97
sensitivity of rat aortic rings to ACh-induced relaxations of lfiM PhE- 
induced tone for time controls and with increasing initial resting 
tension.
2.12 Effect of time on relaxations of intact rat aortic rings to successive 98
cumulative concentration-response curves for ACh. Tone was 
induced by addition of 0.3p.M NA.
2.13 Effect of time on contraction of intact rat aortic rings to successive 99
cumulative concentration-response curves for NA. Data shown 
represents (a) the absolute response (i.e., mg. wt.) and (b) the 
proportionate response (i.e. percentage maximum response).
2.14 Effect of increasing the degree of NA-induced tone on ACh-induced 100
relaxations of intact aortic rings. Relaxations are expressed as (a) the 
‘absolute’ effect (i.e. in terms of mg. wt.) and (b) the ‘proportionate’
effect (i.e. as a percentage reduction of the induced tone).
2.15 Effect of increasing the degree of NA-induced tone on ACh-induced 102
relaxations of rat aortic rings. Relaxations are expressed as a 
percentage of the maximum relaxation.
2.16 Correlation of pooled data for sensitivity of intact aortic rings to ACh- 103
induced relaxations of NA-induced tone expressed as the pIC50 for
ACh and the degree of induced tone expressed in terms of (a) a 
percentage of the initial control maximum response to NA and (b) the 
loglO molar concentration of NA used to induce the tone.
2.17 Correlation of sensitivity of individual intact aortic rings to ACh- 104
induced relaxations of NA-induced tone expressed as the pIC50 for
ACh and the degree of induced tone expressed in terms of (a) a 
percentage of the initial control maximum response to NA and (b) the 
log10 molar concentration of NA used to induce the tone.
2.18 Correlation of tissue sensitivity to the contractile response of NA 105
expressed as its pD2 and the subsequent responsiveness of the tissue
to ACh-induced relaxation of tone induced by NA expressed in terms 
of (a) the maximum relaxation of induced tone and (b) the sensitivity 
of the preparations to ACh (pIC50).
vii
2.19 Effect of increasing the degree of PhE-induced tone on ACh-induced 107
relaxations of intact aortic rings. Relaxations are expressed as (a) the 
‘absolute’ effect (i.e. in terms of mg. wt.) and (b) the ‘proportionate’
effect (i.e. as a percentage reduction of the induced tone).
2.20 Effect of increasing the degree of PhE-induced tone on sensitivity to 108
ACh-induced relaxations of intact aortic rings. Relaxations are 
expressed as a percentage of the maximum relaxation.
2.21 Summary of study examining the effect of varying the initial degree 112
of stretch, hence length, of rat aortic ring segments on the contractile 
response to PhE and the subsequent relaxant response to ACh in the 
presence of an intact endothelium.
Chapter Three
3.1 Typical trace showing disruption the vascular endothelium of rat 126
aortic rings abolishes the ability of the preparation to relax to ACh.
3.2 Effect of increasing concentrations of (a) 5-HT and (b) N-MeT on the 127 
rat aorta in preparations with an intact endothelium and after 
disruption of the endothelium by gentle rubbing.
3.3 Effect of increasing concentrations of (a) 5-MeT and (b) 5-CT on the 128
rat aorta in preparations with an intact endothelium and after 
disruption of the endothelium by gentle rubbing.
3.4 Effect of increasing concentrations of 5-HT, N-MeT, 5-MeT and 5- 129
CT on preparations of the rat aorta with an intact endothelium.
3.5 The effect of removal of the endothelium of rat aortic rings on the 131
potency (pEC50) of 5-CT, 5-MeT, N-MeT and 5-HT.
3.6 The difference in potency of 5-CT, 5-MeT, N-MeT, and 5-HT in 133
rubbed and unrubbed preparations expressed (A pEC50).
3.7 Correlation of difference in potency (A pEC50) between rubbed and 134
unrubbed preparations of rat aorta for 5-CT, 5-MeT, N-MeT and 5-
HT and the intrinsic activity of each agonist relative to 5-HT.
3.8 The effect of removal of the endothelium of rat aortic rings on the 135
potency (pEC50) of 5-CT, 5-MeT, N-MeT and 5-HT.
3.9 Effect of increasing concentrations of 5-HT, N-Me, 5-MeT and 5-CT 136
on preparations of the rat aorta following disruption of the 
endothelium by gentle rubbing.
viii
3.10 The difference between nibbed and unrubbed preparations of the 137 
maximum contractile response to 5-CT, 5-MeT, N-MeT, and 5-HT 
expressed as a percentage of the maximum contraction in the 
unrubbed preparation (A Max Response (%)).
3.11 Correlation of difference in maximum response (A Max Response 138
(%)) between rubbed and unrubbed preparations of rat aorta for 5-
CT, 5-MeT, N-MeT and 5-HT and the intrinsic activity of each 
agonist relative to 5-HT.
3.12 Correlation of percentage reduction of l|iM  PhE-induced tone by 140
lfiM ACh and subsequent potency (pEC50) for (a) 5-HT and (b) 5-
CT in the same preparation.
3.13 Relaxations of aortic rings to 5-HT and 5-CT in the presence and 141
absence of an intact endothelium.
3.14 Effect of methysergide, pindolol, indomethacin, and imiloxan on 142
relaxations of aortic rings to 5-HT and 5-CT in the presence and 
absence of an intact endothelium.
Chapter Four
4.1 Effect of time on relaxations of intact rat aortic rings to successive 152
cumulative concentration-response curves for ACh of 10|iM PhE- 
induced tone. Relaxations are expressed in terms of the percentage 
maximum response.
4.2 Schematic of experimental protocols used in determination of pA2 154
values for muscarinic receptor antagonists.
4.3 Depressed response to PhE in aortic rings from LiCl pre-treated rats. 156
4.4 Effect of atropine on ACh-induced relaxations of rat aortic rings pre- 159
contracted with PhE. ACh-induced relaxations are expressed as; a) a 
percentage of the maximum response in the absence and presence of 
atropine; b) the Arunlakshana-Schild analysis of the inhibition by 
atropine of these responses.
4.5 Effect of pirenzepine on ACh-induced relaxations of rat aortic rings 160
pre-contracted with PhE. ACh-induced relaxations are expressed as;
a) a percentage of the maximum response in the absence and presence 
of pirenzepine; b) the Arunlakshana-Schild analysis of the inhibition 
by pirenzepine of these responses.
4.6 Effect of 4DAMP on ACh-induced relaxations of rat ao tic rings. 161
ACh-induced relaxations are expressed as; a) a percentage of the 
maximum response in the absence and presence of 4DAMP; b) the 
Arunlakshana-Schild analysis of the effect of 4DAMP.
ix
4.7 Effect of himbacine on ACh-induced relaxations of rat aortic rings pre- 162
contracted with PhE. ACh-induced relaxations are expressed as; a) a 
percentage of the maximum response in the absence and presence of 
himbacine; b) the Arunlakshana-Schild analysis of the inhibition by 
himbacine of these responses.
4.8 Effect of methoctramine on ACh-induced relaxations of rat aortic 163
rings pre-contracted with U46619. ACh-induced relaxations are 
expressed as; a) a percentage of the maximum response in the 
absence and presence of methoctramine; b) the Arunlakshana-Schild 
analysis of the inhibition by methoctramine of these responses.
4.9 Effect of ACh, bethanecol and pilocarpine on tone induced by a) 165
0.03(iM U46619 in control preparations and b) 0.3|iM U46619 in 
preparations from rats pre-treated with LiCl.
4.10 The intrinsic activity for endothelial-dependent relaxations by ACh, 168
bethanecol and pilocarpine preparations from control and LiCl pre­
treated rats.
4.11 Relaxation (expressed as a percentage of the induced tone) of intact 169
rat aortic rings by a) ACh, b) bethanecol and c) pilocarpine. Tone
was induced by U46619 in preparations from control and LiCl pre­
treated rats.
4.12 Relaxation (expressed as mg. wt.) of intact rat aortic rings by a) 170
ACh, b) bethanecol and c) pilocarpine. Tone (represented by single 
symbols) was induced by U46619 in preparations from control and
LiCl pre-treated rats.
4.13 The maximum relaxation of induced tone in rat aortic rings 171
(expressed as a percentage of the induced tone) to ACh, bethanecol
and pilocarpine in preparations from control and LiCl pre-treated rats.
4.14 The effect of LiCl pre-treatment on the potency (pIC50) of ACh, 172
bethanecol and pilocarpine in rat aortic rings.
4.15 Relaxation (expressed as a percentage of the agonist maximum 173
response) of intact rat aortic rings by a) ACh, b) bethanecol and c) 
pilocarpine. Tone was induced by U46619 in preparations from 
control and LiCl pre-treated rats.
4.16 Summary and comparison of pA2 values obtained in this study and 176
from other studies
Chapter Five
5.1 Diagram of apparatus used for bioassay of EDRF.
x
5.2 Relaxations of PhE-induced tone in intact rat aortic rings to 192
cumulative addition of ACh, A23187, and ATP. Relaxations are 
expressed as (a) the percentage reduction of induced tone and (b) the 
percentage maximum relaxation to that agonist.
5.3 The effect of palmitoyl carnitine on SNP-induced relaxations of rat 193
aortic rings pre-contracted with PhE. SNP-induced relaxations are 
expressed as a percentage of the induced tone in the absence and 
presence of 30fiM palmitoyl carnitine.
5.4 Representative trace showing response of the rat aorta to repeated 194
administration of lfiM  PhE and lfiM  ACh in preparations with an
intact endothelium. Responses shown are (a) control and (b) the 
response before and after incubation with 100[iM palmitoyl carnitine 
10 minutes before addition of PhE.
5.5 The effect of palmitoyl carnitine on ACh-induced relaxations of rat 195
aortic rings pre-contracted with PhE.
5.6 The effect of palmitoyl carnitine on ATP-induced relaxations of rat 196
aortic rings pre-contracted with PhE.
5.7 The effect of palmitoyl carnitine on A23187-induced relaxations of rat 197
aortic rings pre-contracted with PhE.
5.8 The effect of various concentrations of palmitoyl carnitine on 198
relaxation of PhE-induced tone by a) 3p.M ACh, b) 100|iM ATP and
c) l|iM  A23187.
5.9 Representative trace showing response of the rat aorta to lfiM  PhE 200
and l|iM  ACh in preparations with an intact endothelium. Responses 
shown are (a) control and (b), (c), (d), (e) and (f) responses after 
incubation with 30}iM palmitoyl carnitine. The preparation was 
washed between repeated administration of PhE and ACh with 
palmitoyl carnitine-free PSS after the first exposure to palmitoyl 
carnitine.
5.10 Scanning electron micrograph of rat aortic rings with an intact 201
endothelium before (a) and after (b) incubation for 20 minutes with 
IOOjiM palmitoyl carnitine.
5.11 Representative trace showing the effect of cumulative addition of (a) 202
BAY K 8644 and (b) palmitoyl carnitine on endothelium-intact rat
aortic rings pre-contracted with PhE.
5.12 Representative trace showing potentiation of the contraction of 203
endothelium-intact rat aortic rings to ljiM  PhE by pre-incubation with
(a) BAY K 8644 (3|J.M) and (b) palmitoyl carnitine (30fiM). Also 
shown is the inhibition of ACh-induced relaxation by both palmitoyl 
carnitine and BAY K 8644.
xi
5.13 Representative trace showing reversal of the relaxation of to l(iM  204
ACh in rat aortic rings pre-contracted with ljiM  PhE-induced tone by 
addition of (a) BAY K 8644 and (b) palmitoyl carnitine. Dotted line 
represents the degree of PhE-induced tone expected before addition
of ACh and palmitoyl carnitine or BAY K 8644.
5.14 Representative trace showing reversal of the relaxation of to 0.1 \iM  206
SNP in rat aortic rings pre-contracted with 1|4M PhE-induced tone by 
addition of (a) BAY K 8644 and (b) palmitoyl carnitine.
5.15 Representative trace showing relaxation, in the presence of a ‘donor’ 207
tissue, by superfusion with 10|J.M carbachol, of a rat aortic strip with 
disrupted endothelium. Tone was induced by superfusion with
0.1 p.M phenylephrine. Removal of the ‘donor’ tissue rapidly 
reversed the carbachol-induced relaxation of the ‘recipient’ tissue.
5.16 Relaxation of PhE-induced tone (expressed as a percentage reduction 208
of the induced tone) in superfused ‘recipient’ aortic strips with a 
disrupted endothelium. Relaxations are due to carbachol-induced 
release of EDRF from a ‘donor’ preparation placed over the 
‘recipient’.
xii
List of Tables
Table
Number
1.1 Examples of stimuli inducing endothelium-dependent relaxations.
Chapter One
1.1 Effect of incubation in 20mM [K+]0 PSS of rat aortic ring segments 
on the maximum contractile response (expressed in mg.wt.) and 
sensitivity (expressed as the pEC50) to PhE and 5-HT.
1.2 Effect of removal of the endothelial cell layer of rat aortic ring 
segments on the maximum contractile response (expressed in 
mg.wt.) and sensitivity (expressed as its pEC50) to PhE and 5-HT.
Chapter Three
3.1 Effect of removal of the endothelial cell layer of rat aortic ring 
segments on the potency of 5HT receptor agonists (expressed as each 
agonist’s pEC50) and their maximum contractile response (expressed 
in m g.w t).
Chapter Four
4.1 Effect of atropine, pirenzepine, 4DAMP, methoctramine and 
himbacine on acetylcholine-induced relaxations of rat aortic ring 
segments pre-contracted with phenylephrine or U46619.
4.2 Effect of chronic pre-treatment of rats on endothelium-dependent 
relaxations to ACh, bethanecol and pilocarpine.
Page
Number
9
49
57
130
164
167
Acknowledgements
I would like to thank both Dr J.C. McGrath (who gave me the opportunity to 
undertake this research) and Dr M. Spedding for their stimulating discussion and 
encouragement throughout my past three years at Glasgow University. I would also 
like to thank Professor Sheila Jennett and the Institute of Physiology for allowing me 
to work in the department. Special thanks to Dr R.L. Whiting for initiating this CASE 
award and also Dr R.M. Eglen whose advice and friendship helped to get me off to a 
flying start in addition to making me laugh a lot.
Thanks also to Christine Brown, Janette Bulloch, Karen Crichton, Craig Daly, Billy 
Dunn, Steve MacLennan, Joyce MacMillan, Alison Templeton, Eddie Wilson, and 
Vince Wilson (despite the sarcasm) who, as past and present members of the 
Autonomic Physiology Unit under the direction of Ian McGrath, have provided a most 
stimulating environment for the discussion and carrying out of research work. Thanks 
for the fond memories folks!
Everyone at Syntex deserve a mention for putting up with me for my somewhat 
protracted ‘six weeks’ spent there especially Ruth who had to put up with me more 
than anyone else but made me feel at home.
Although never quite understanding what I was doing, without the support of my 
family, particularly my mother, throughout the whole of my studies (both under­
graduate and post-graduate) this thesis could never have been written.
Finally, but not least, my thanks to U  who made me smile and with whom I would 
not have come to Glasgow.
xiv
Declaration
The experimental work and other research contained within this thesis was 
undertaken wholly by myself except for the work contained in Figures 2.12, 2.13 , 
2.14, 2.15, 2.16, 2.17 and 2.18 which was carried out as part of a collaborative 
project with A.G.B. Templeton. The data shown in Figures 5.15 and 5.16 is 
presented here by the kind permission of Dr M. Spedding. None of the material has 
been previously presented for any other degree. Some of the results have been 
published during the period of this study, details of which are given below.
Publications
D A IN TY , I.A., EGLEN, R.M ., M CGRATH, J.C. & SPEDDING, M., (1986). 
Differences in the relaxant effects of 5-HT, 5-CT, and 8-OH-DPAT on the rat aorta 
and guinea-pig ileum. Br. J. Pharmacol., 88, 369P
D a in t y , I.A., M cGr a t h , J.C. & Sp e d d in g , M., (1986). A simple, inexpensive 
method of storage and analysis of data from Pharmacolacological concentration 
responses. Br. J. Pharmacol., 89, 884P
DAINTY, I.A., M cGr a t h , J.C., MILLER, D.J. & Sp e d d in g , M., (1987). Ca2+ Re­
addition distinguishes between phenylephrine and 5-HT in rat aortic rings: differences 
in a r  and 5-HT receptor coupling ? Br. J. Pharmacol., 91, 387P
DAINTY, I.A., DALY, C.J., MCGRATH, J.C., SINCLAIR, J. & SPEDDING, M., 
(1987). Measurement and analysis o f analogue signals from a Linseis chart recorder 
using a BBC microcomputer. Br. J. Pharmacol., 91, 506P
d a i n t y , I.A., M c G r a t h , J.C., Sp e d d in g , m . & Te m p l e t o n , a .g .b . (1987). 
Optimisation of conditions for the demonstration of the influence of endothelium 
derived relaxing factor on rings of blood vessels. J. Physiol., 392, 2 IP
D a i n t y , I.A., D a l y , C.J., M c G r a t h , J.C., Si n c l a ir , j . & Sp e d d i n g , M., 
(1987). A simple, inexpensive method of collection, storage and analysis of data for 
the BBC microcomputer. J. Physiol., 392, 22P
DAINTY, I.A., EGLEN, R.M., MCGRATH, J.C. & SPEDDING, M., (1987). Effect of 
endothelium on responses of rat aorta to 5-HT receptor agonists. Proceedings of the 
Xth international Congress of Pharmacolacology (September, 1987).
DAINTY, I.A., McGr a t h , J.C. & SPEDDING, M., (1987). The effect of palmitoyl- 
camitine on endothelial-dependent relaxations of rat aorta. Blood Vessels, 24, 203
DAINTY, I.A., M c G r a t h , J.C. & SPEDDING, M., (1987). The length-tension 
relationship critically affects the quantitative demonstration of the effects of 
endothelium on aortic smooth muscle. Blood Vessels, 24, 203-204
xv
D a i n t y , I.A., M c G r a t h , J.C., Sp e d d i n g , M. & Te m p l e t o n , A.G.B. (1987). 
Experimental conditions affect the quantitative demonstration of the effect of basal and 
stimulated release of EDRF. Br. J. Pharmacol., 92, 619P
DAINTY, I.A., EGLEN, R.M ., MCGRATH, J.C. & WHITING, R .L., (1988). Analysis 
of the muscarinic receptor on the rat aortic endothelium. Br. J. Pharmacol, 93, 240P
D a in t y , I.A., McGr a t h , J.C., M il l e r , D.J. & Sp e d d in g , M., (1988). Further 
observation on the effect of Ca2+ re-addition in the presence of phenylephrine and 5-HT 
in rat aortic rings. Br. J. Pharmacol., 95, 693P
e g l e n , R.M ., M o n t g o m e r y , W .W ., D a in t y , I.A., D u b u q u e , l .k . & w h it in g , 
R.L., (1988). The interaction of methoctramine and himbacine at atrial, smoth muscle 
and endothelial muscarinic receptors in vitro. Br. J. Pharmacol., 95 (4), 1031-1038
xvi
Summary
The purpose of the work presented in this thesis was to examine the influence of the 
vascular endothelium on the effect of stimulation of a-adrenoceptors, 5-HT receptors 
and muscarinic receptors in the isolated rat thoracic aorta. The work has been divided 
into five main areas, i) the dependence on extracellular Ca2+ of the contractions to the 
relatively selective a!-adrenoceptor agonist phenylephrine and to 5-hydroxytryptamine 
and also the effect of the presence of the endothelium on their contractile responses, ii) 
the role of the initial tension placed on the tissues in the subsequent responses of the 
tissues to agonists and influence of the endothelium on this ‘length-tension’ 
relationship, iii) the effect of the endothelium on activation mediated by 5-HT 
receptors, iv) classification of the muscarinic receptor mediating endothelium- 
dependent relaxations in this preparation and v) the effect of a lipid metabolite of 
ischaemia (palmitoyl carnitine) which may have a modulatory role on the effect of the 
endothelium in ischaemic conditions. The major findings of the study are briefly 
summarised below.
1. When rat aortic rings are incubated in PSS with no added Ca2+0, addition of 
C aC l2 in the presence of PhE but not 5-HT caused a contraction of the 
preparation. The contractions to CaCl2 in the presence of 5-HT were much 
smaller than those observed when 5-HT was added in the presence of 2.5mM 
[Ca2+]0. In contrast, the responses to PhE were consistent at each concentration 
of Ca2+0 irrespective of whether the agonist was added before or after Ca2+.
2. Pre-exposure of the preparations to 5-HT but not PhE appeared to attenuate the 
subsequent contractile response to CaCl2 in the presence of the same agonist.
3. Pre-incubation with BAY K 8644 caused a significant increase in the contraction 
to CaCl2 in the presence of both 5-HT and PhE. The magnitude of this increase 
was greatest for ‘5-HT/Ca2+-re-addition\
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4. Addition of BAY K 8644 at the end of a cumulative concentration-response 
curve (CCRC) to CaCl2 produced a marked contraction in the presence of PhE 
and also 5-HT.
5. Mild depolarisation with KC1 and hyperpolarisation with BRL 34915 caused 
similar degrees of potentiation and attenuation of the concentration-response 
curves to 5-HT and PhE.
6. Chronic pretreatment of the rats with LiCl caused attenuation of the response of 
the aorta to both PhE and 5-HT. This effect was greatest for PhE and in the 
presence of the endothelium.
7. The optimum conditions for resting tension (hence length) of the tissue for 
demonstration of contraction per se and the basal release of EDRF (depression of 
contractility) or stimulated release of EDRF (relaxation) did not necessarily 
coincide and were dependent upon how the data was expressed.
8. The degree of' induced tone influenced the apparent sensitivity of the tissue to 
endothelium-dependent relaxations such that the higher the degree of induced 
tone then the lower the subsequent sensitivity to endothelium-dependent 
relaxations.
9. Removal of the endothelium increased the sensitivity and maximum contractile 
response of the preparations to both 5-HT and PhE.
10. The depression of the maximum contractile response by the presence of the 
endothelium was inversely related to the intrinsic activity of a series of 5-HT2- 
receptor agonists.
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11. There was no evidence for an endothelium dependent relaxation to 5-HT receptor 
stimulation though an endothelium-independent relaxation at high concentravion: 
of 5-HT and 5-CT was revealed.
12. Using selective antagonists, the muscarinic receptor mediating endothelium- 
dependent relaxations was found to be of the M2 muscarinic receptor subtype.
13. The receptor subtype was different from the M2 subtype found in the atria but 
similar to that found in non vascular smooth muscle.
14. In contrast to the muscarinic receptor found in non-vascular smooth muscle 
preparations, the endothelium-dependent relaxations to muscarinic agonists of 
different efficacies were unaffected by chronic pre-treatment of the animals with 
LiCl.
15. In addition to reversing the relaxation induced by ACh, palmitoyl carnitine 
caused concentration-dependent inhibition of the endothelium-dependent 
relaxations to ACh, ATP and A23187 but had no significant effect on the 
endothelium-independent relaxations to sodium nitroprusside and did not 
augment the agonist-induced tone of the preparation.
16. BAY K 8644 reversed and inhibited the ACh-induced relaxations. This effect 
was accompanied by an increase in the agonist-induced tone of the preparation.
17. Using a simple overflow techniquethe inhibitory action of palmitoyl carnitine 
was found be at a site at the endothelium to inhibit release/synthesis of EDRF.
xix
General Introduction
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The purpose of this introduction is to provide a general overview of aspects of my 
work which are presented later in this thesis. The introduction comprises: i) a very 
brief account of the Ca2+ requirement for contraction of smooth muscle and the 
mechanisms by which this Ca2+ requirement can be met; and ii) a more comprehensive 
overview of the discovery and evaluation of nature and effect of endothelium-derived 
relaxing factor(s) (EDRF).
Each chapter of the thesis has a separate introduction which is intended to give a 
more precise indication of the topic area covered by that particular section of work and 
the reasons for carrying out that work.
Ca2+ Requirement for Contraction of Smooth Muscle
In common with a number of cellular functions (including cellular secretion), 
smooth muscle contraction is controlled by fluctuations in the free Ca2+ ion 
concentration in the cytosol. Using chemically skinned smooth muscle preparations 
which are exquisitely sensitive to the Ca2+ concentration of the bathing PSS, it has been 
shown that activation of the contractile proteins in vascular smooth muscle to produce 
contraction depends on an increase in the concentration of free Ca2+ ions in the cytosol 
(Filo et al., 1965; Endoh et al., 1977; Gordon, 1978). These studies have shown that 
the threshold for contraction of the vascular smooth muscle is of the order 0.1 |iM free 
Ca2+ with a maximal contraction being obtained at around 10|iM free Ca2+.
Source o f Intracellular Free Ca2+
Studies using photoproteins have shown that the concentration of extracellular free 
Ca2+ ([Ca2+]0) in smooth muscle is in excess of IOOOjiM (Daniel et al., 1983) whilst the 
concentration of intracellular free Ca2+ ([Ca2+]i) is around 0.1 |iM  (Defoe and Morgan, 
1985; Willaims and Fay, 1986). There exists therefore, a large, inwardly directed
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concentration gradient for Ca2+ ions of the order of 10 000 fold. This concentration 
gradient is maintained principally by the low permeability of the sarcolemma under 
resting conditions, an efficient Ca2+ pumping ATPase (an active extrusion pump) and 
uptake of Ca2+ by intracellular organelles such as the sarcoplasmic reticulum and 
mitochondria. Thus there are both intra- and extracellular pools of Ca2+ available for 
utilisation in the contractile process in smooth muscle and contractions of vascular 
smooth muscle can be initiated by influx of extracellular Ca2+ and/or mobilisation of 
intracellular Ca2+ stores.
Influx o f Ca?*0
Extracellular Ca2+ enters the cell via calcium channels that are anchored in the plasma 
membrane. Whilst there is a small influx of Ca2+ under resting conditions through 
channels termed ‘leak’ channels (shown by a small 45Ca influx in the absence of 
excitation and unaffected by Ca2+ entry blockers: Godfraind, 1983; Schramm et a i , 
1985) the principal route of entry of Ca2+ is via two separate types of excitable Ca2+ 
channels. In 1979, both Bolton and van Breemen and co-workers independently 
postulated the existence of two distinct excitable Ca2+ channels in smooth muscle: 
receptor operated channels (ROC) activated by agonists in a number of preparations 
without a change in the membrane potential and insensitive to blockade by Ca2+ entry 
blockers; and voltage-operated channels (VOC) activated by a change in membrane 
potential (see Reuter, 1983; Schramm and Towart, 1985). The separate identity of the 
ROC and VOC was confirmed by the observation that simultaneous stimulation with 
80mM K+ and NA produced a unidirectional 45Ca influx, which was additive, 
indicating that the influx was not via a common mechanism (Meisheri et al., 1981). 
Thus, by receptor activation and/or membrane depolarisation Ca2+ channels open in the 
cell membrane and this results in the influx of Ca2+ ions into the cell and subsequent 
activation of the contractile proteins.
3
Release ofCa2+l
As mentioned above another source of Ca2+i arises from the release of Ca2+ from 
intracellular stores. This release can be seen by a phasic (transient) contraction in the 
absence of extracellular Ca2+ which is accompanied by a transient efflux of 45Ca (Deth 
and Casteels, 1977; Deth and Van Breemen, 1977; Droogmans et al., 1977). Under 
these conditions, the tonic component of contraction which is due to influx of Ca2+0 
(Godfraind and Kaba, 1972; Yamashita et al., 1977; Godfraind et al., 1982) is 
abolished indicating that the remaining transient contraction is dependent on the release 
of Ca2+ from intracellular sites. These stores may be located on the inner surface of the 
sarcolemma and in the mitochondria but it is thought that the stores are principally 
located in the sarcoplasmic reticulum (Somlyo, 1984).
In 1975, Michell proposed that the mobilisation of Ca2+ may arise from agonist- 
induced breakdown of cell membrane phosphatidylinositol 4,5-bisphosphate (PIP2). 
Receptor-stimulated hydrolysis of PLP2 by agonist-induced activation of phospholipase 
C generates two second messengers: 1,2 diacyl glycerol (DG) and inositol 1,4,5- 
triphosphate (IP3) which modulate the release of intracellular Ca2+ and possibly influx 
of extracellular Ca2+ (Berridge, 1984; Berridge, 1987; Taylor, 1987; Penner et al., 
1988). DG activates protein kinase C (Nishizuka, 1984) whilst IP3 can release Ca2+ 
from intracellular pools and inhibit Ca2+ extrusion ATPase (Berridge, 1984; Popescu, 
et al., 1986) producing an increase in the concentration of intracellular free Ca2+ which 
consequently causes contraction of vascular smooth muscle (Suetmatsu et al., 1984; 
Somlyo et a i, 1985; Hashimoto et al., 1986; Popescu, et al., 1986).
Although DG and IP3 are products of the same substrate and each has separate 
actions it is likely that these two second messengers act synergistically to produce the 
physiological effect seen. This has been suggested from studies involving stimulation 
of each signal pathway by phorbol esters (activating protein kinase C and thereby 
mimicking the effect of DG) and calcium ionophores such as A23187 (to raise [Ca2+]i
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and thereby mimic the effects of IP3); these produced a maximal response only when 
both pathways were activated simultaneously (see Rasmussen, 1986).
Thus, the contraction of vascular smooth muscle can be initiated by the influx of 
Ca2+0 or release of Ca2+i< Whilst activation by both processes can occur independently, 
under normal circumstances it is likely that contraction of smooth muscle is a 
combination of both the release of Ca2+i and the influx of Ca2+0 though the relative size 
of these two components will vary between species, preparations and type of stimulus. 
For example, release of Ca2+i plays a major role in the activation of rat and rabbit aorta 
(Godfraind and Kaba, 1972; Deth and Van Breemen, 1977) but not dog basilar or 
coronary artery (Allen and Banghart, 1979; Van Breemen and Seigl, 1980).
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The Vascular Endothelium
The vascular endothelium is the layer of squamous epithelial cells that is in direct 
contact with the blood. Until the last twenty years this endothelial cell layer was 
considered to be a nucleated amorphous membrane which functioned as a metabolically 
inert, non-thrombogenic, semi-permeable barrier between the circulating blood and the 
interstitial space (Florey, 1966). In subsequent years, following development in 
techniques such as cell culturing (Jaffe et al., 1973), the possible ability of the 
endothelium to alter the smooth muscle tone became apparent. The endothelial cells 
have been shown to be able to inactivate bradykinin, activate angiotensin I to produce 
angiotensin II, synthesise prostacyclin, and to degrade adenine nucleotides and 
biogenic amines such as 5-HT and noradrenaline (see Cryer, 1983 and Ryan et al., 
1984 for references). In the past eight years a great deal of work has been carried out 
to evaluate the effects and nature of a vasoactive substance(s) which is released from 
the vascular endothelium to induce vasodilatation. The remainder of this general 
introduction will describe the discovery and investigation of this so called endothelium- 
derived relaxant factor (EDRF).
Endothelium Derived Relaxant Factors(s)
Historical Viewpoint
Prior to a report by Jelliffe (1962) which demonstrated ACh-induced relaxations of 
rabbit descending thoracic aorta the response to ACh in this preparation was contractile 
in nature (Furchgott and Bhadrakom, 1953; Furchgott, 1955). These ACh-induced 
relaxations to ACh, but not other non-muscarinic relaxing agents such as glyceryl 
trinitrate and isoprenaline, were later shown to be abolished in preparations in which 
the endothelial cell layer had been disrupted by rubbing the intimal layer of the vascular 
preparations (Figure 1.1; Furchgott and Zawadski, 1980). This partly explained the 
paradox that whilst ACh induced a depressor response in vivo, ACh-induced 
vasodilatation could not be demonstrated in vitro.
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Figure 1.1
Loss of relaxant response of preparations of rabbit aorta to ACh after rubbing the 
intimal surface of the preparations or exposure to collagenase in order to remove the 
vascular endothelium.
Figure is taken from Furchgott and Zawadzki, 1980.
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In this initial study, Furchgott and Zawadski demonstrated that the endothelium- 
dependent relaxations to ACh were mediated by muscarinic receptors which are 
assumed to be located on the endothelial cells. In addition, by using a simple 
‘sandwich’ technique, these workers showed that activation of muscarinic receptors in 
endothelium-intact preparations produced a diffusible substance (or substances) which 
mediates the observed vasodilatation. In these experiments, ACh-induced relaxations 
of endothelium-disrupted strips only occurred when an endothelium-intact strip was 
placed in contact with the rubbed preparation with the intimal surfaces touching. These 
original observations have been confirmed in a number of studies. Whilst the location 
and subtype of the muscarinic receptor may be questioned (see discussion, Chapter 
Four) the release of a vasoactive substance(s) from the endothelium of vascular tissue 
mediating relaxation is now without doubt. The release of this so called endothelium 
derived relaxing factor(s) (EDRF; Cherry et al., 1982) has been confirmed by bioassay 
experiments in which the perfusate flowing through endothelium-intact blood vessels 
or over cultured endothelial cells is passed over or through pre-contracted, endothelium- 
disrupted preparations to produce relaxation (Cocks et a i , 1983; Gryglewski et al., 
1986; Griffith et al., 1984; Rubanyi et al., 1985).
Stimulated release o f EDRF
Since the original study by Furchgott and Zawadski, the actions of a variety of 
substances have been shown to be dependent on the presence of an intact endothelium. 
These endothelium-dependent relaxations have been shown to occur in most 
mammalian isolated blood vessels studied including preparations from rat, rabbit, cat, 
dog, monkey and man and to be induced by a number of vasodilators including 
acetylcholine, histamine, hydralazine, thrombin, the calcium ionophore A23187, ATP, 
ADP and also substance P (Table 1.1). In addition to these agonist-induced 
relaxations, endothelium dependent relaxations are also produced by other stimuli such 
as aggregating platelets, hypoxia and increased blood flow (Table 1.1).
Stimulus
Acetylcholine
A23187
Angiotensin II 
ATP, ADP
Bradykinin
Histamine
Hydralazine
5-HT
Noradrenaline
Preparation
rabbit thoracic aorta(a); dog femoral artery0*5; human coronary 
artery(c); endothelial/smooth cell cultures(d)
human coronary artery(c); rabbit aorta(e); pig aorta(f); rat aorta®; 
dog femoral artery0*5
dog renal and mesenteric arteries015,
dog femoral artery0*5; endothelial/smooth cell cultures015; rat 
aorta®; dog coronary arteries05
pig aorta(f); dog coronary arteries05; dog renal and pulmonary 
arteries®
rat aorta^05, dog renal and mesenteric arteries0*5, guinea-pig 
pulmonary artery0**5
rat caudal artery0*5; rabbit aorta(o)
dog coronary arteries0,1*5; pig coronary arteries0*5
pig coronary arteries(p); dog coronary artery (q); rat thoracic
aorta(r,s)
Substance P dog coronary arteries0*5; pig coronary arteries0*5; guinea pig
mesenteric artery05
Thrombin dog femoral artery0*5; dog coronary artery®
Aggregating Platelets dog coronary artery® w)
Hypoxia dog coronary arteries®; rabbit femoral artery®
Increased Flow dog coronary arteries®; dog femoral artery®5
Furchgott and Zawadski, 1980°°; De Mey and Vanhoutte, 1981°*5; Ginsberg and Zera 
1984(c); Loeb et al., 1985(d); Furchgott, 1983(c); Gordon and Martin, 1983(f5; Toda, 
19830*5; Cohen et al., 1983b05; Cherry et al., 198205; Van de Voorde and Leusen, 
198305; Satoh and Inui, 19840**5; Spokas et al., 19830*5; Spokas et al., 19840*5; Cocks 
and Angus, 19830*5; Matsuda et al., 1985(q); Lues and Schumann, 1984(r); Miller and 
Vanhoutte(s); Bolton and Clapp, 198605; Cohen et al., 1984(u); Cohen et al., 1983c(v); 
Houston etal., 1985(w); Busse etal., 1984®; Busse et al., 1985®; Holtz et al., 1984®; 
Rubanyi etal., 1986(aa)
Table 1.1
Examples of stimuli inducing endothelium-dependent relaxations.
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Basal Release of EDRF
The presence of the endothelium has been shown to reduce the sensitivity of a 
number of arterial preparations to a number of agents including 5-HT, angiotensin, 
PGF2a, K+, BAY K 8644, and a-adrenoceptor agonists (Allan et al., 1983; Egleme et 
al., 1984a,b; Godfraind et al., 1985; Lues and Schumann, 1984; Miller and Stoclet, 
1985; Spedding et al., 1987; Carrier and White, 1985). This inhibitory effect of the 
endothelium is thought to be due to the relaxatory action of EDRF. Both mechanical 
disruption of the endothelium and haemoglobin, which blocks the actions of EDRF 
(Martin et al., 1985a, b), potentiate the responses to 5-HT and a-adrenoceptor 
agonists in endothelium-intact preparations compared with those in endothelium- 
disrupted preparations (Martin et al. 1986a). In the latter study, Martin and co­
workers, by reducing the receptor reserve for a full a-adrenoceptor agonist using an 
irreversible antagonist, showed that agonists with a low relative efficacy were affected 
to a greater extent than ‘full’ agonists.
In addition to its vasodilator activity EDRF inhibits platelet aggregation (Azuma et 
al., 1986; Furlong etal., 1987; M oncadaetal., 1987). When platelets do aggregate, 
the substances released (e.g., 5-HT, ADP, ATP) can induce endothelium-dependent 
relaxations or contractions of the underlying smooth muscle. However, contractions 
induced by products of platelet aggregation, e.g. thromboxane, are greater in the 
absence of endothelium (Cohen et al., 1983b,c; Houston et al., 1985).
Substances generated during the process of hemostasis can result in endothelium- 
dependent relaxations. For example thrombin causes endothelium-dependent 
relaxations in dog femoral, basilar and coronary arteries (De Mey et al., 1982; De Mey 
and Vanhoutte, 1982; Katusic et al., 1984; Ku., 1982) though this relaxation can be 
counteracted in many tissues by a direct contractile action of thrombin on the smooth 
muscle (Ku., 1982; De Mey et al., 1982).
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Noradrenaline and selective ^-adrenoceptor agonists can cause relaxation of canine 
and porcine coronary and systemic arteries and canine pulmonary arteries and veins if 
the endothelium is present (Cocks and Angus, 1983; Miller and Vanhoutte, 1984). 
Therefore, absence or malfunction of the endothelium would favour vasoconstriction 
due to the action of catecholamines on the a-adrenoceptors of the vascular smooth 
muscle.
Thus the endothelial cell layer exerts a profound depressent effect on the ability of 
vasoconstrictor substances in a variety of preparations. This may indicate that EDRF 
is an important regulator of vascular tone. Moreover, the effect of haemoglobin on this 
basal release may be of some importance in the pathology of vasospasm particularly in 
cerebral vessels (Defeudis, 1985).
Mechanism o f Action
Following the observation of endothelium-dependent relaxations, the mechanism by 
which EDRF relaxes vascular smooth muscle was soon elucidated. Endothelium- 
dependent relaxations to the stimulated release of EDRF are thought to be mediated by 
an increase in the levels of smooth muscle guanosine 3’:5’-cyclic monophosphate 
(cGMP). EDRF stimulates soluble guanylate cyclase activity in the smooth muscle and 
increases intracellular cGMP (Holzmann, 1982; Furchgott and Jothianandan, 1983; 
Rapoport and Murad, 1983; Miller et al., 1984; Griffith et al., 1985; Forstermann et 
al., 1986). This leads to a lowering of the concentration of Ca2+0 possibly by 
stimulation of the plasmalemmal Ca2+-extrusion ATPase and sequestration of free Ca2+ 
by the sarcoplasmic reticulum or by reducing the phosphorylation of myosin light 
chain (Popescu etal., 1985; Twort and Van Breemen, 1988; Rapoport etal., 1983).
In a similar manner, the presence of a basal release of EDRF was further confirmed 
by the observation that the smooth muscle cGMP content was greater in endothelium- 
intact preparations than in preparations with a disrupted endothelium (Holzmann, 
1982; Rapoport and Murad, 1983; Furchgott and Jothianandan, 1983; Miller et al.,
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1984). Moreover, in the rat aorta (in which the tonic influence of EDRF is marked; 
Martin et al., 1986a) phosphodiesterase inhibitors induce endothelium-dependent 
relaxations (Martin et al., 1986b).
Recent studies have indicated that some agents that produce endothelium-dependent 
relaxations also generate endothelium-dependent hyperpolarisations (Bolton and 
Clapp, 1986; Beny etal., 1986). This transient hyperpolarisation may be independent 
of the stimulation of guanylate cyclase by EDRF and appears to be due to activation of 
smooth muscle Na+/K+-ATPase or K+ channels (Feletou and Vanhoutte, 1988; Taylor 
et al., 1988) by a substance other than nitric oxide (Vanhoutte, 1987; see below for 
nature of EDRF). One substance which has been shown to activate K+ channels has 
been termed endothelium-dependent hyperpolarising factor (EDHF; Taylor and 
Weston, 1988). The significance of EDHF(s) is dependent upon the species and 
preparation used (Taylor and Weston, 1988).
Nature o f EDRF
The chemical nature of EDRF(s), in contrast to its mechanism of action, was 
somewhat more difficult to determine. Even now, after eight years of research in a 
great number of laboratories the precise nature of all EDRF(s) is not certain though 
recent work has provided evidence for the identity of at least one distinct EDRF.
Part of the problem in the isolation and identification of EDRF was the very labile 
nature of the substance(s) itself. Using a bioassay technique where a pre-contracted 
rabbit coronary artery was relaxed by the effluent from an ACh-stimulated endothelium- 
intact rabbit aorta, Griffith et al. (1984), showed that the half life of EDRF was 6.3 
seconds. In contrast, using another bioassay technique, Forstermann and co-workers 
(1985), showed that the half lives of EDRF from rabbit aorta and dog femoral artery 
were different (24 and 49 seconds respectively) and greater than that reported by 
Griffith and co-workers. This suggested that there might exist a heterogeneity in the 
nature of EDRF possibly indicating the existence of more than one EDRF.
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Early work by Furchgott and Zawadski (1980), eliminated the possibility that EDRF 
was bradykinin, prostacyclin, cAMP or cGMP since these substances applied 
exogenously to the rabbit aorta produced little relaxation. Other cyclo-oxygenase 
products were eliminated as mediators of endothelium-dependent relaxations since 
cyclo-oxygenase inhibitors such as indomethacin and aspirin had little effect on ACh- 
induced relaxations. Since arachidonic acid had been shown to induce the release of 
EDRF attention was focussed on the possibilty that EDRF might be a non-cyclo- 
oxygenase product of arachidonic acid.
Phospholipase A2 (the Ca2+ sensitive enzyme producing arachidonic acid from 
membrane phospholipids) is inhibited by quinacrine. Quinacrine prevents and reverses 
endothelium-dependent relaxations in a variety of blood vessels from different species 
including dog femoral artery (De Mey etal., 1982); dog coronary arteries (Rubanyi 
and Vanhoutte, 1985); rabbit aorta (Furchgott and Zawadzki, 1980; Singer and Peach, 
1983); and rat aorta (Van de Voorde and Leu sen, 1983). The site of action of 
quinacrine has been determined by bioassay techniques as being at the endothelium and 
not via an action on EDRF in transit or at the smooth muscle (Griffith et al., 1984) 
though this inhibition may be due to an action other than inhibition of phospholipase 
A2. Endothelium-dependent relaxations to ACh are also blocked by ETYA (5,8,11,14 
Eicosatetraynoic acid) which is an inhibitor of both cycloxygenase and lipoxygenase 
and also NDGA (nordihydroguiracetic acid) which is an antioxidant that blocks 
lipoxygenase (see Furchgott et al., 1984). In addition, free radical scavengers such as 
hydroquinone have also been shown to significantly attenuate endothelium dependent 
relaxations in the rat aorta (Van de Voorde and Leuson, 1983). These observations 
prompted Furchgott to speculate that ACh, and other stimulants of EDRF, may activate 
a reaction sequence where arachidonic acid or an unsaturated fatty acid is released from 
the membrane phospholipids and is then oxidised by lipoxygenase in the endothelial 
cells to produce a labile hydroperoxide or free radical intermediate product (Furchgott, 
1981).
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Whilst the use of the inhibitors described above support this proposal of Furchgott, 
subsequent studies provided new findings which were in contradiction to this 
hypothesis. Evidence against the proposal by Furchgott was provided by Furchgott 
himself (see Cherry et al., 1983; Fuchgott et al., 1984). Using arteries from both 
rabbit and dog in the presence or absence of cyclooxygenase inhibitirs, Furchgott and 
co-workers showed that other unsaturated fatty acids such as ci.y-4,7,10,13,16,19- 
docosohexanoic, oleic, eladeic and czs-vaccenic produced endothelium-dependent 
relaxations. Even stearic acid (a saturated fatty acid) produces graded endothelium- 
dependent relaxations (Fuchgott et al., 1984). Thus it is unlikely that arachidonic acid 
acts as a precursor of EDRF but is more likely to interact with the endothelium to 
induce the release of production of EDRF possibly by increasing membrane fluidity 
(Cherry etal., 1983).
The possibility that EDRF is a free radical was disputed by Griffith et al. (1984). On 
the basis of the very short half life of EDRF (6.3 secs) and the lack of effect of spin 
trap reagents and specific oxygen centered radical scavengers these workers suggested 
that EDRF was neither a lipoxygenase derivative or free radical but an unstable 
compound with a carbonyl group at or near its active site.
There is a marked parallelism between the effects of EDRF and nitrovasodilators 
(which are known to be mediated by nitric oxide; NO). Similarities are found in the 
transient nature of the vasoactive substances, inhibitors of their action including 
methylene blue which inhibit guanylate cyclase, ferrous hemoproteins and 
haemoglobin which bind and inactivate these substances (Martin et al., 1985a, 1985b, 
1986c) and in their mechanism of relaxation i.e., increasing cGMP levels (Holzmann, 
1982; Furchgott and Jothianandan, 1983; Rapoport and Murad, 1983; Miller et al., 
1984; Griffith etal., 1985; Forstermann et al., 1986). Moreover, the relaxing effects 
of both EDRF and NO are markedly prolonged by superoxide dismutase (Gryglewski 
et al., 1986; Rubanyi and Vanhoutte, 1986; Palmer et al., 1987). These similarities 
prompted Furchgott to suggest that EDRF was in fact NO. More recendy, Moncada
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and co-workers have confirmed that at least some relaxations induced by EDRF are 
mediated by the production of NO.
Palmer and co-workers (1987), demonstrated the similarity in properties of NO 
obtained from NO gas and EDRF obtained from cultured porcine aortic endothelial 
cells. The comparative pharmacology clearly demonstrated that both agents were 
indistinguishable. Relaxations to both EDRF and NO were qualitatively similar with a 
similar half life in oxygenated PSS and down a bioassay cascade (Palmer et. al., 
1987). Also both relaxations were blocked by haemoglobin and Fe2+ (binding and 
inactivating the vasoactive moiety), hydroquinone and pyrogallol (generating 
superoxide ions; 0 2') and enhanced by superoxide dismutase (SOD) (Hutchinson et 
al., 1987). In a similar manner the anti-aggregating action of both compounds in 
platelets was the same (Radomski et al., 1987). Confirmation of the identity of EDRF 
in these studies was provided by the measurement of NO released by stimulation of 
cultured endothelial cells with bradykinin using chemoluminescent detection of the 
product of NO and ozone (Palmer et. a i , 1987). This group have also recently 
presented evidence using cultured endothelial cells that EDRF (NO) is formed as a 
product of the metabolism of 1-arginine (Palmer et al., 1988).
Although the identity of one EDRF has now been confirmed the heterogeneity of the 
effect of inhibitors of EDRF, species variation in the effects of EDRF and possible 
release of different EDRFs by various agonists suggests that there are more than one 
EDRF. Moreover, NO and endogenous EDRF have been shown to have a differential 
selectivity for different smooth muscles: EDRF relaxes vascular smooth muscles but 
not respiratory, gastro-intestinal or reproductive smooth muscles whilst NO can relax 
vascular and gastro-intestinal but not respiratory or reproductive smooth muscles 
(Shikano and Berkowitz, 1987; Shikano etal., 1987).
Vanhoutte (1987), has suggested that in addition to the EDRF which stimulates 
guanylate cyclase (NO) another substance (possibly NH3) released by the endothelium
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can produce hyperpolarisation of the vascular smooth muscle. Recently, Taylor and 
Weston (1988), have suggested the existence of an endothelium-dependent substance 
which induces hyperpolarisation by activation of K+ channels which they have named 
endothelium-dependent hyperpolarising factor (EDHF; see Mechanism of Action 
(above) for more detailed references on endothelium-dependent hyperpolarisations).
Role o f Ca2+ in release o f EDRF
The presence of extracellular calcium is a pre-requisite for the production of 
endothelium-dependent relaxations since exclusion of Ca2+0 attenuates endothelium- 
dependent relaxations (Singer and Peach, 1982; Griffith et al. 1984; Long and Stone, 
1985; Winquist et al., 1985). Moreover, the requirement of the endothelium for 
relaxations to the calcium ionophore A23187 in rabbit aorta and its relatively high 
potency (10-30 times greater than ACh) supports the suggestion that Ca2+ plays an 
important role in producing endothelium-dependent relaxations. In the study by Singer 
and Peach (1982), eliminating Ca2+0 from the PSS inhibited methacholine-induced 
relaxation of rabbit aortic rings pre-contracted with phenylephrine. The relaxation to 
methacholine was inhibited to a lesser degree than that to the ionophore (67% and 
97% inhibition of maximal response respectively). This was attributed to the receptor- 
induced relaxation having greater access to a ‘Ca2+-pool’ than the ionophore. Calcium 
channel blockers, verapamil and nifedipine, inhibited the maximum relaxation to both 
the methacholine and A23187 to the same extent ( 40-45%). This was unexpected as 
the ionophore is believed to transfer Ca2+ across the membrane directly rather than via 
the calcium channels. They speculated that this effect might reflect direct interaction 
between the blockers and A23187.
Rubanyi et al. (1985), using the Ca2+ channel activators BAY K 8644 and (+) 202, 
791, have shown that, in dog femoral arteries, activation of Ca2+ channels by 
subcontractile concentrations of these agents can stimulate the release and augment the 
action of EDRF. In contrast however, in the rat aorta, BAY K 8644 does not increase
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the release of EDRF although the basal release of EDRF depresses the contractile 
response to the Ca2+ channel activator possibly indicating modulation of Ca2+ channel 
function by EDRF (Spedding et al., 1987). Moreover, in contrast to the study by 
Singer and Peach, some studies have reported a lack of effect of calcium antagonists 
(Miller et al., 1985; Winquist et al., 1985; Jayakody et a i, 1987). Thus although Ca2+ 
is a requirement for the production/release of EDRF the precise involvement of Ca2+ 
channels is still under question.
Endothelium-Dependent Contractile Factor
In addition to the production and release of endothelium-dependent relaxant factors, 
endothelium-dependent contractions have also been demonstrated.
In a study by Rubanyi and Vanhoutte (1985), the role of the endothelium in the 
facilitation by anoxia of contractile responses of isolated coronary arteries was 
examined. They found that coronary arteries without endothelium could be contracted 
by hypoxia when layered with femoral arteries and veins with endothelium due to the 
release of a vasoactive substance from the endothelium. Inhibitors of cyclo- 
oxygenase, lipoxygenase and phospholipase A2 did not inhibit these responses to 
hypoxia or the augmentation of noradrenaline-induced contractions by anoxia and 
hypoxia. In addition, inhibitors of EDRF such as quinacrine and methylene blue did 
not affect the anoxic augmentation. Moreover, the release of substances inducing 
endothelium-dependent contractions occurs in spontaneously hypertensive rats 
(Luscher and Vanhoutte, 1986), stretch in dog basilar arteries (Katusic et al., 1987) 
and cultured bovine aortic endothelial cells (Gillespie et al., 1985; Hickey et al., 1985). 
These endothelium-dependent contractions have been attributed to prostaglandins or 
substances whose identity has not yet been unequivocally established. Recent studies 
have indicated that the endothelium is capable of releasing a highly potent 
vasoconstictor substance which has been termed Endothelin (Yanagisawa et al., 1988). 
In addition, Vanhoutte (1988) has suggested that the superoxide anion (.0 2') may be
17
responsible for endothelium-dependent contractions in tissues such as the dog basilar 
artery.
Thus, although the endothelial cell layer does function as a non-thrombogenic, semi- 
permeable barrier between the circulating blood and the interstitial space the ability of 
the endothelium to alter the smooth muscle tone by release of vasodilator substances 
and also vasoconstrictor substances makes it a highly physiologically significant 
structure that has become a target for pharmacological manipulation in disease states.
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Aims of the Study
The work presented in this thesis examines the influence of the vascular endothelium 
on the effect of stimulation of a-adrenoceptors, 5-HT receptors and muscarinic 
receptors in the isolated rat thoracic aorta. Since the depressant effects of the basal 
release of EDRF may be partly due to modulation of Ca2+ channel activity, I have 
examined the dependence on extracellular Ca2+ of the contractions to the relatively 
selective a r adrenoceptor agonist phenylephrine and to 5-hydroxytryptamine and also 
the effect of the presence of the endothelium on their contractile responses. As a joint 
study with Dr A.G.B. Templeton, we have examined how the initial tension placed on 
the tissues affected the responses of the tissues to agonists and whether the 
endothelium had any influence on this length-tension relationship. The presence of the 
endothelium was found to depress the contractions to both PhE and 5-HT. This 
depression of the response to a-adrenoceptor activation has been well characterised. 
Therefore I decided to examine more closely the effect of the endothelium on activation 
mediated by 5-HT receptors. There is some doubt as to the type of muscarinic receptor 
mediating the release of EDRF. Thus, I have used specific antagonists in order to 
attempt a definitive classification of the muscarinic receptor mediating endothelium- 
dependent relaxations in this preparation. Finally, I have made a brief study of the 
effect of a lipid metabolite (palmitoyl carnitine) which may have a modulatory role on 
the effect of the endothelium in ischaemic conditions.
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General Methods
Throughout the study male Wistar or Sprague Dawley rats (270-340 g. wt.) were 
used. The rats were killed by a blow to the back of the head followed by exsan- 
guination or decapitation taking care to avoid stretching the aorta at any stage. The 
descending thoracic aorta was exposed by removal of the heart and lungs, and cut just 
above the diaphragm and just below the aortic arch. Whilst in situ the aorta was 
cleared of all connective tissue, removed from the animal and placed in a petri dish 
containing warm Krebs’ physiological salt solution (PSS). In early studies the excised 
aorta was then cut into 2-3mm long ring segments measured by eye. In later studies 
however, ring segments precisely 3mm long were cut using a device consisting of a 
series of dissection blades set at a separation of 3mm by perspex spacers.
When required, endothelium was mechanically removed from ring segments by one 
of two methods; i) inserting the bent tip of a pair of forceps into the lumen and gently 
rubbing the intima whilst rolling the ring segment back and forth, ii) gently rolling the 
ring between thumb and forefinger rubbing the intima of the ring against the opposite 
intimal wall. In the majority of studies the latter method was used since the use of 
forceps sometimes caused damage to the vascular smooth muscle as seen by a 
depressed contractile response to phenylephrine (PhE) compared to that seen in a 
paired intact vessel (Figure G .l). The presence or absence of a functional endothelium 
was later demonstrated by the ability or inability of acetylcholine (ACh) to relax the 
vessel pre-contracted with PhE. In addition, in some cases the presence or absence of 
an intact endothelium was determined histologically (figure G.2).
Each ring segment was suspended between an isometric force transducer and a wire 
support in a 10ml isolated organ bath containing PSS. The rings were attached to the 
transducers by either cotton thread (forming a ‘stirrup’ holding the ring) or a rigid wire 
tissue holder (figure G.3). The latter method was preferred since the resultant agonist
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Figure G.l
Response o f  the rat aortic to l | iM  PhE (A) and I jiM  ACh (▼) in preparations with 
(a) an intact endothelium and (b) an endothelium disrupted by rubbing the intimal 
surface o f  the r ing segm ent with a pair o f  curved  forceps. PhE produced 
contraction of the aorta w hich was smaller in the rubbed  preparation. In the 
unrubbed preparation only, ACh produced relaxation of  induced tone indicating the 
presence o f  functional endothelium.
The depressed contraction in the rubbed preparation indicates that the vascular 
smooth muscle has been damaged by over-zealous rubbing of the intima whilst 
attempting to remove the endothelium since removal o f  the basal release of EDRF 
by rubbing would normally increase contractile responses (see Chapter 1).
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Figure G.3
Diagram representing the method of suspension of a rat aortic ring segment in an 
isolated organ bath between an isometric tension transducer and lower wire tissue 
holder by (a) cotton thread and (b) a wire tissue holder. As can be seen in (a) the 
use of a cotton ‘stirrup’ tended to lead to a ‘bowing’ of the aortic ring segment. 
When a wire tissue holder was used (b) the upper and lower edges of the aortic ring 
are kept parallel. This bowing of the ring segment may be responsible for the 
depressed size of contractions of the preparation when used.
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induced contractions were significantly greater than those seen using the former 
method presumably due to the bowing of the tissue on the ‘stirrup’.
Unless otherwise stated the PSS used had the following composition (mM): NaCl 
118.4, KC1 4.7, KH2P 0 4 1.2, M gS04.7H20  1.2, Glucose 11.1, N aH C 03 25.0, 
CaCl2.6H20  2.5 and was aerated with a gas mixture of 95% 0 2 and 5% C 0 2 and 
maintained at 37°C.
Unless otherwise stated, after suspension in the organ baths the ring segments were 
washed at 5 minute intervals for 15 minutes by twice exchanging the PSS in the bath. 
This schedule was used as the standard wash cycle throughout the study. During this 
initial procedure, the resting tension of the rings was re-adjusted to lOOOmg. wt. 
following each wash at 5 minute intervals, and then left unchanged throughout the 
remainder of the experiment. The tissues were allowed to equilibrate for a further 15 
minutes after which time each was exposed to PhE (1-lOp.M). A sufficient time for the 
contractile response to reach a plateau was allowed and then ACh (l-10fiM) was added 
to the organ bath and any relaxation observed. After any relaxant response to ACh had 
reached equilibrium the tissues were again washed according to the above schedule. 
Unless stated otherwise each preparation was left for 45 minutes after washing before 
any further treatment was given. When required, cumulative concentration response 
curves (CCRC) were obtained by cumulative addition of agonist in 0.5 log Molar 
increments (Van Rossum, 1963).
Isometric tension changes (mg. wt.) were measured using either Harvard, Grass 
FT03 or H.S.E. K30 force transducers and recorded on either a Linseis six channel 
or a Watanabe WB4101 chart recorder. All data was stored on a BBC microcomputer 
using a program system developed by myself (DATAFILE - see Appendix A). In 
addition, when using the Linseis chart recorder, data was collected directly from the 
recorder using DATAFILE and later ‘measured’ on a BBC microcomputer. The stored 
data was then processed on the BBC microcomputer (calculation of percentage
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response values, EC50 values etc) before transfer to an Apple Macintosh 
microcomputer for further processing, statistical analysis and plotting.
Statistical Analysis
Unless stated otherwise values given are the arithmetic mean with the ± standard 
error of the mean. All statistical analysis was carried out on the Apple Macintosh 
microcomputer using the software application StatWorks™. When necessary, 
statistical comparison of group means was made using Student’s t test for paired or 
unpaired data where appropriate. Statistical analysis of correlations was earned out for 
two dependent variables and slopes of Schild plots were determined using linear 
regression analysis.
A probability level of P<0.05 was taken as being statistically significant from e.g. 
control values. Probability levels are denoted as follows:
* P<0.05 
** P<0.01 
*** P<0.005
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Drugs
C om pound S ource A bbrev iation
Acetylcholine chloride Sigma ACh
Atropine sulphate BDH Atropine
BAY-K 8644 Bayer
Bethanecol Sigma
BRL 34195 Beecham
5-carboxamidotryptamine Syntex 5-CT
4DAMP Syntex
Himbacine Syntex
5-Hydroxytryptamine creatinine sulphate Sigma 5-HT
Imiloxan Syntex
Indomethacin Sigma
Methoctramine Syntex
5-methyltryptamine hydrochloride Sigma 5-MeT
N-methyltryptamine Sigma N-MeT
Noradrenaline Sigma NA
Palnitoyl-d/-camitine Sigma PC
Panuramine hydrochloride Wyeth Panuramine
1-Phenylephrine hydrochloride Sigma PhE
Pilocarpine Sigma
Pindolol Sandoz
Pirenzepine Syntex
Sodium nitroprusside Sigma SNP
U46619 Upjohn
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Drugs were dissolved in distilled water with the following exceptions: Nifedipine 
and BAY-K 8644 were dissolved in absolute alcohol. Approximately 7mg of 
panuramine was dissolved in di-methyl formamide (200p.l). Concentrated hydro­
chloric acid (40{il) was added to this solution and then the final concentration (ImM) 
was made by addition of distilled water. This was then added when required to the 
PSS to produce a concentration of 0.1 p.M.
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Chapter One
Contractions of the rat aorta to phenylephrine and 
5-hydroxytryptamine: dependence on extracellular 
Ca2+ and effect of lithium pre-treatment.
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Introduction
The smooth muscle of rat aorta can be contracted by adrenoceptor agonists or 5-HT 
(Krishnamurty, 1971) by activation of a-adrenoceptors or 5-HT-receptors 
respectively. Whilst the subtype of a-adrenoceptors in the rat aorta has been 
questioned it is generally accepted that the predominant subtype present is the a r  
adrenoceptor (Ruffolo et a i, 1980; Randriantsoa et a i,  1981; Godfraind et al., 1982; 
Digges and Summers, 1983; Downing et al., 1983). Contractions to 5-HT are 
mediated by a distinct receptor (Downing et a i, 1983; Doggrell, 1987) which has been 
classified as a 5-HT2 subtype (Cohen et al., 1981).
The common factor involved in agonist-induced contraction is an increase in the 
concentration of intracellular Ca2+ ([Ca2*]*). This effect can occur via an increase in the 
influx of extracellular Ca2+ (Ca2+0) and/or the release of intracellular Ca2+ (Ca2+0 from 
intracellular binding sites. In the rat aorta, activation of both a r-adrenoceptors and 5- 
HT2- receptors can cause the release of Ca2+i and influx of Ca2+0 as seen by a two 
component contractile response: the second, tonic phase (due to the influx of Ca2+0) in 
contrast to the first phasic component (due to the release of Ca2*) is abolished in the 
absence of extracellular Ca2+ (Godfraind and Kaba, 1972; Yamashita et al., 1977; 
Godfraind et al., 1982; Downing et al., 1983; Hughes and Doggrell, 1985; Chiu et al., 
1985; Doggrell, 1987).
The influx of Ca2+0 into the cytosol can occur via voltage operated Ca2+ channels 
(VOCs) and receptor operated Ca2+ channels (ROCs) located in the outer cell membrane 
(Bolton, 1979; Zschauer et al., 1988; Van Breemen et al., 1979; Meisheri, et al., 
1981). Receptor linked hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2) 
leads to the formation of inositol 1,4,5-trisphosphate (IP3) This produces an increase 
in the free [Ca2+]i by releasing Ca2+i from intracellular stores and also by inhibiting Ca2+ 
extrusion ATPase (Berridge, 1984; Popescu, et al., 1986) which consequently causes 
contraction of vascular smooth muscle (Somlyo et al., 1985; Hashimoto et a i, 1986;
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Popescu, et al., 1986). In the rat aorta activation of both a r adrenoceptors (Legan et 
al., 1985; Chiu et al., 1987) and 5-HT2 receptors (Roth et al., 1984; Nakaki et al., 
1985; Doyle et al., 1986) can activate phospholipase C hydrolysis of PIP2 to produce 
LP3 and release intracellularly stored Ca2+.
In this part of the study I have compared the requirement for extracellular Ca2+ of the 
responses to 5-HT and the a!-adrenoceptor agonist PhE. Using lithium (which leads 
to a disruption of the hydrolysis of inositol phospholipids; Sherman et a i,  1986) I 
have attempted to examine indirectly the possible involvement of receptor mediated 
hydrolysis of inositol phospholipids in contractions to these agonists. Preliminary 
studies indicated that PhE and 5-HT had different requirements for extracellular Ca2+. 
Since the attenuation of agonist-induced contractions by basal release of EDRF may be 
due, at least in part, to alteration of Ca2+ fluxes (Malta et al., 1986) I have also 
examined the effect of the presence of the vascular endothelium on contractions to PhE 
and 5-HT.
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Methods
Male Wistar rats (290-340g) were killed by stunning followed by decapitation. Ring 
segments (2-3mm) of aorta were prepared as described in General Methods. When 
required, the endothelial cell layer was disrupted by gently rolling the ring between 
thumb and forefinger mbbing the intima of the ring against the opposite intimal wall. 
For all other rings care was taken to maintain an intact endothelium and the ring 
segments were suspended in 10ml isolated organ baths in PSS maintained at 37°C for 
isometric tension recordings.
For Ca2+ dependency experiments a modified PSS was used with a low concentration 
of P 0 4' (KH2P 0 4, 0.12mM) in order to allow the use of a high concentration of Ca2+0: 
for all other experiments a normal PSS was used (see General Methods).
Ccf+ Dependency o f PhE and 5-HT
Ring segments with a disrupted endothelium were used in this part of the study. The 
effect of re-addition of Ca2+0 in the presence of PhE or 5-HT was examined. 
Preparations were first tested for responsiveness to PhE or 5-HT in 2.5mM Ca2+0 and 
removal of the endothelium demonstrated by the inability of the contracted tissue to 
relax to ljiM  ACh. PhE (0.1 jiM) and 5-HT (3fiM) were selected as equipotent and 
equieffective concentrations, i.e., in 2.5mM Ca2+0 these concentrations produced 
similar sized contractions which were approximately 50 percent of the maximum 
response to that agonist. For Ca2+ re-addition experiments the following protocol was 
used: the [Ca2+]0 was reduced to ‘nominal zero’ by ‘washing’ the contracted tissue 
with PSS containing no added Ca2+ and left to equilibrate in this solution for 30 
minutes. Either PhE or 5-HT was then added and 3 minutes later CaCl2 was added 
cumulatively (0.01-20mM) over a 15-20 minute period. In some preparations, 
following cumulative addition of CaCl2 in the presence of 3|iM 5-HT to produce a final 
concentration of 3mM Ca2+0, PhE (0.1 JiM) was added to the bath before washing the 
preparations and any contraction observed.
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The effect of adding PhE and 5-HT in the presence of ‘fixed’ concentrations of 
Ca2+0 was examined. Ring preparations were contracted with PhE (0.1 p.M) or 5-HT 
(3(iM) in PSS containing 2.5mM Ca2+0. The contracted tissues were ‘washed’ with 
2.5mM Ca2+ PSS, the bathing solution was reduced to the appropriate [Ca2+]0 and left 
for 15 minutes to equilibrate before the agonist was added. This was repeated for the 
whole range of [Ca2+]0 examined (2.5-0.16mM).
The effect of pre-exposure to PhE or 5-HT on subsequent contractions to Ca2+ re­
addition in the presence of the agonist was also examined. Four ring preparations 
from each rat were used for this part of the study. Two of the preparations were 
maximally contracted with 10qM PhE and two with 30|iM 5-HT. The absence of a 
functional endothelium was demonstrated by addition of lq M  ACh and the 
preparations were prepared for Ca2+ re-addition in the manner described above. Ca2+ re- 
addition was then carried out in the presence of PhE in tissues which had been 
maximally contracted previously with PhE or 5-HT. In a similar manner, Ca2+ re­
addition was then carried out in the presence of 5-HT in tissues which had been 
maximally contracted previously with PhE or 5-HT.
Effects o f BAY K  8644
In some experiments l|iM  BAY K 8644 (a concentration shown to produce maximal 
contractions in partially depolarised rat tail artery; Su et al., 1984) was added 10 
minutes prior to addition of 5-HT or PhE and then re-addition of Ca2+. The effect of 
addition of l|iM  BAY K 8644 at the end of a CCRC to re-addition of Ca2+ in the 
presence of 5-HT or PhE was also examined.
Effects o f Potassium and BRL 34915
Since experiments using BAY K 8644 showed a differential effect on the responses 
to re-addition of Ca2+ in the presence of 5-HT and PhE the effects of procedures 
designed to alter the smooth muscle membrane potential (and therefore VOC function)
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on contraction to 5-HT and PhE in 2.5mM Ca2+ PSS was examined. Ring segments 
with a disrupted endothelium were used in this part of the study. Four ring segments 
from each rat were used: two were kept as controls whilst the others were partially 
depolarised by increasing the [K+]0 with addition of KC1 to the PSS to create a final, 
subcontractile concentration of 20mM. Following 45 minutes equilibration in high K+ 
PSS or control PSS, CCRCs to PhE and 5-HT were obtained as described in the 
General Methods in the presence or absence of 20mM KC1.
In a separate group of preparations the K+ channel activator BRL 34915 was used to 
produce partial hyperpolarisation (Southerton et al., 1987) of the rat aortic smooth 
muscle. Five preparations from each rat were used: one preparation was used as a 
control and the other four preparations were incubated in PSS containing O.OlqM, 
0.1 pM, lpM  or 10pM BRL 34915 for 20 minutes before obtaining a CCRC to 5-HT. 
The preparations were washed and left to equilibrate for 30 minutes before repeating 
the procedure with PhE as the agonist.
For the remainder of the study, PSS with a normal composition (see General 
Methods) and 2.5mM [Ca2+]0 was used.
Effect o f Endothelium
The effect of the presence of a functional endothelium on contractions to PhE, 5-HT 
and the thromboxane-mimetic U46619 (11a, 9a, -epoxymethano-prostaglandin H2; 
Coleman et al., 1981) was examined. Paired rubbed/unrubbed ring preparations were 
used. After demonstration of the presence of a functional endothelium CCRCs to 5- 
HT and then PhE were obtained in the same preparation with a 45 minutes 
equilibration period between CCRCs. When U44619 was used only one CCRC was 
obtained since it is difficult to ‘wash out’ this agonist. The responses in endothelium- 
intact and disrupted preparations were compared.
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Effects o f Lithium
In order to examine if there is a differential utilisation of receptor-mediated 
phosphatidylinositol hydrolysis in the contractions induced by 5-HT and PhE, the 
effect of chronic pre-treatment of rats with lithium on subsequent agonist-induced 
contractions of the aorta with intact and disrupted endothelium was examined. Four 
aortic ring segments from rats chronically pretreated with LiCl (‘treated’ preparations) 
or rats receiving no pre-treatment (‘control’ preparations) were prepared as normal. 
The endothelium of two of these preparations was disrupted by rubbing whilst care 
was taken to avoid disruption of the endothelium in the remaining rings. After the 
initial setting up procedure and demonstration of the presence of a functional 
endothelium, CCRCs to 5-HT followed by PhE were obtained in control and treated 
preparations with a 45 minutes equilibration period between each CCRC. The 
responses in control and treated preparations to each agonist in the presence and 
absence of a functional endothelium were compared.
Animal Pretreatment
The protocol used for pre-treatment of animals was that described by Eglen et a i, 
(1987). Animals were given 6.8 mmol kg'1 LiCl dissolved in distilled water by intra- 
peritoneal injection at the same time each day for four consecutive days (control 
animals received no pretreatment). The dose was given by two injections of a 
relatively dilute LiCl solution (3.4 mmol ml'1 in a volume of 1 ml kg'1 body weight), 
one on each side of the abdomen. Eighteen hours following the last injection the rat 
was killed as described above, blood collected for determination of the plasma lithium 
concentration and the aorta excised in the normal manner. Pre-treatment of the rats 
with LiCl in this manner causes natriuresis and therefore the rats were allowed access 
to water and 0.9% NaCl (w/v) throughout the treatment period. In experiments where 
the rats were pre-treated with myoinositol, the myoinositol was administered by 
addition to the drinking water at a concentration of 30mM. For practical reasons 
(limitations of availability of additional animal housing which would have allowed a
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more comprehensive control protocol), these rats were allowed access to 0.45% NaCl 
(w/v) only (containing myoinositol for treated rats and no myoinositol for the control 
rats).
The sensitivity of the preparation to agonist-induced contraction was estimated as the 
concentration of agonist producing 50 percent of the agonist’s own maximum 
contraction (EC50) and expressed as its negative log10, i.e. the pEC50. Differences in 
the sensitivity of the agonist between stated treatments or conditions were expressed as 
A pEC50 where:
A  p E C s o  =  p E C s o  (control) " p E Q o  (test)
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Results
C<£+ Dependency o f PhE and 5-HT
In aortic ring segments with a disrupted endothelium incubated in PSS containing 
nominally zero [Ca2+]0, addition of 0.1 JiM  PhE or 3jiM 5-HT produced a small 
transient contraction (Figure 1.1). Re-addition of Ca2+ (0.01-3mM) in the presence of 
PhE caused a concentration dependent contraction of the preparations. Further 
addition of CaCl2 to produce higher concentrations of Ca2+c (10-20mM) resulted in a 
decrease in the Ca2+-induced tone. In marked contrast, whilst addition of 3|iM 5-HT 
in 2.5mM Ca2+ produced a relatively well maintained contraction, re-addition of Ca2+ 
(0.01-20mM) in the presence of this concentration of 5-HT produced little increase in 
smooth muscle tension (Figure 1.1). At all concentrations of added CaCl2 the 
contraction induced in the presence of PhE was significantly greater (P<0.05; 
Student’s unpaired t test) than that seen in the presence of 5-HT (Figure 1.2). 
Addition of 0.1 |iM PhE after obtaining a CCRC to CaCl2 in the presence of 5-HT 
resulted in a rapid contraction of the ring preparation even though there was no marked 
contraction seen to the re-addition of Ca2+ itself (Figure 1.3).
When 5-HT or PhE were added to PSS containing a ‘fixed’ concentration of Ca2+, 
both agonists produced a contraction the size of which increased with increasing Ca2+0 
concentration (Figure 1.4). The size of the contractions to PhE were not significantly 
different from those to 5-HT (P>0.05; Student’s unpaired t test) except at the lowest 
concentrations of Ca2+ used (Figure 1.4). Thus, when Ca2+ was ‘re-added’ in the 
presence of 5-HT but not PhE, the tissue produced unexpectedly small responses at 
sub-physiological and physiological concentrations of Ca2+0. These responses were 
considerably smaller than the responses seen with PhE present and much smaller than 
that observed when 5-HT was added in the presence of 2.5mM Ca2+ (Figure 1.5). In 
contrast, the responses to PhE were consistent at each concentration of Ca2+0 
irrespective of whether the agonist was added before or after Ca2+ (Figure 1.5).
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Figure 1.2
Effect of re-addition of [Ca2+]0 in the presence of 0.1 }iM PhE (# )  or 3jiM 5-HT 
(O ) in endothelium-denuded aortic ring preparations previously contracted in 
2.5mM [Ca2+]0 with 10|iM PhE or 30(iM 5-HT.
Points shown are mean ± s.e.m. (n=9). Statistically significant differences 
between [Ca2+]0 re-addition response in the presence of PhE and 5-HT using 
unpaired Student’s t test; *** P<0.005
39
2 mins
Figure 1.3
Representative trace showing contractile response to 0.1 |iM PhE (A) following re- 
addition of Ca2+ in the presence of 3|iM 5-HT (A). For clarity, the cumulative 
addition of Ca2+ which caused no contraction of the tissue has not been shown.
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Figure 1.4
Contractions of endothelium-disrupted rat aortic rings to 0.1 p.M PhE (# )  and 
3|iM 5-HT (O) in PSS containing a fixed concentration of [Ca2+]0.
Points shown are mean ± s.e.m. (n=9). Statistically significant differences 
between contractions to PhE and 5-HT using unpaired Student’s t test; * P<0.05
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Figure 1.5
Contractions of endothelium-disrupted rat aortic rings to (a) PhE and (b) 5-HT. 
Data represents the contraction to re-addition of [Ca2+]0 in the presence of the 
agonist (O) and also addition of the agonist in a fixed concentration of [Ca2+]0 (# ).
Points shown are mean ± s.e.m. (n=6-9).
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There was no significant difference (P>0.05; Students unpaired t test) in the 
response to Ca2+ re-addition at each concentration of Ca2+0 tested in the presence of PhE 
whether the preparations had been previously exposed to PhE or 5-HT (Figure 1.6). 
However, the response to re-addition of Ca2+ (0.3-10mM) in the presence of 5-HT was 
significantly greater in tissues which had been previously contracted with PhE but not 
5-HT (Figure 1.6).
Effects o f BAY K 8644
Incubation of ring preparations with lp.M BAY K 8644 for 20 minutes prior to re- 
addition of Ca2+ had no effect on the tension of the tissue per se but caused a 
significant increase (P<0.05; Student’s unpaired t test) in the contractile response seen 
in the presence of both PhE and 5-HT (Figure 1.7). This effect was significantly 
greater for 5-HT than for PhE (Figure 1.7). Moreover, addition of BAY K 8644 at 
the end of a CCRC to CaCl2 produced a marked contraction in the presence of 5-HT 
and a reversal (contraction) of the decreased tension induced by high concentrations of 
Ca2+0 in the presence of PhE (Figure 1.8).
Effects o f Potassium and BRL 34915
Raising the [K+]0 of the bathing PSS to 20 mM had no effect on the resting tension 
of ring preparations. This partial depolarisation with KC1 caused a significant increase 
in both PhE- and 5-HT-induced contractions (Figure 1.9). The maximum responses to 
both PhE and 5-HT were not significantly different (P>0.05; Student’s unpaired t test) 
in either normal or high K+ PSS (Figure 1.10, Table 1.1). In a similar manner, the 
sensitivity of the preparation (pEC50) to both agonists was significantly greater in high 
K+ PSS (P<0.05; Student’s unpaired t test) compared with that in normal PSS (Figure 
1.10, Table 1.1). However, the change in sensitivity (i.e., A pEC50) for PhE and 5- 
HT was similar (Figure 1.11, Table 1.1). Thus, the potentiation of the contractile 
response to both 5-HT and PhE in terms of increased maximum response and 
increased sensitivity of the preparations to the agonists was similar.
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Figure 1.6
Effect of re-addition of [Ca2+]0 in the presence of (a) 0.1 p.M PhE or (b) 3|iM 5-HT 
in tissues previously contracted in PSS containing 2.5mM [Ca2+]0 with 30|iM 5-HT 
(O) or 10|iM PhE (# ).
Points shown are mean ± s.e.m. (n=4). Statistically significant differences
between tissues previously exposed to PhE and 5HT using Student’s unpaired t
test; * P<0.05, ** P<0.01
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Figure 1.7
Contractile response of rat aortic rings to re-addition of [Ca2+]0 in the presence of 
(a) 0.1 p.M PhE or (b) 3fiM 5-HT in control preparations (O) and preparations pre­
incubated with l(iM BAY K 8644 (# ).
Points shown are mean ± s.e.m. (n=6-9). Statistically significant differences
between contractile responses in the presence and absence of BAY K 8644 using
Student’s unpaired t te s t; ** P<0.01, *** P<0.005
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Figure 1.9
Contractions of rat aortic rings to (a) PhE and (b) 5-HT in 2.5 mM [Ca2+]0 PSS in 
the presence (# )  or absence (O) of a subcontractile concentration (20mM) of KC1.
Points shown are mean ± s.e.m. (n=9-10). Statistically significant differences
between contractile responses in the presence and absence of KC1 using unpaired
Student’s t test; * P<0.05, ** P<0.01, *** P<0.005
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Figure 1.10
Effect of a subcontractile concentration (20mM) of KC1 on (a) the maximum 
contraction and (b) the sensitivity (pEC50) of endothelium-disrupted rat aortic rings 
to PhE (O /# ) and 5-HT (A/A). Open bars and symbols indicate values in control 
PSS and closed bars and symbols indicate values in 20mM KC1 PSS.
Data shown represents mean ± s.e.m. (n=9-10). There was no statistically 
significant difference (P>0.05) between the contractile response to PhE and 5-HT in 
control and 20mM KC1. Statistically significant differences for each agonist 
between contractile responses in the presence and absence of KC1 using unpaired 
Student’s t test', * P<0.05, ** P<0.01, *** P<0.005
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C ontro l 20mM [K+]0
Maximum Response (mg.wt.)
PhE 1812.3 ± 189.0 2427.7 ± 105.7 **
5-HT 2043.6 ± 122.4 2339.9 ± 50.3 *
Tissue Sensitivity (pECS0) A pEC50
PhE 7.01 ± 0.07 7.70 ± 0.07 *** 0.68 ± 0.10
5-HT 5.31 ± 0.07 5.82 ± 0.09 *** 0.57 ± 0.08
Table 1.1
Effect of incubation in 20mM [K7]0 PSS of rat aortic ring segments on the 
maximum contractile response (expressed in mg.wt.) and sensitivity (expressed 
as the pEC50) to PhE and 5-HT.
Differences between control and 20mM [K+]0 preparations are shown as A pEC50 
for potency (i.e. pEC50 (2omM kcd - pEC50(comroi)). The values shown are the means 
± s.e.mean for n=9-10.
There was no significant difference either between the maximum contractile 
responses to PhE and 5-HT in both control and 20mM [K+]c PSS or the 
difference in sensitivity (A pEC50) for each agonist in control and 20mM [K+]0 
PSS. Significant differences from control preparation using Student’s unpaired t- 
test: * P<0.05, *** P<0.005
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In PSS containing 2.5mM Ca2+, 0.01-10juM BRL 34915, which has been shown to 
produce hyperpolarisation of the smooth muscle of the rat aorta in the concentration 
range used, produced a concentration-dependent unsurmountable inhibition of the 
contractions to both PhE and 5-HT (Figure 1.12). The maximum response to both 
agonists was similar at each concentration of BRL 34915 used indicating a similar 
degree of depression of contractility of each agonist by BRL 34915.
Effect o f Endothelium
Contractions induced by both PhE and 5-HT in rings with a disrupted endothelium 
were significantly greater than in rings with a functional endothelium (Figure 1.14). 
The maximum response of PhE was similar to that of 5-HT in both rubbed and 
unrubbed rings. Thr maximum responses were significantly greater for each agonist in 
rubbed rings (P<0.05; Student’s unpaired t test) compared with the response in the 
unrubbed ring (Figure 1.15, Table 1.2). In a similar manner, the sensitivity of the 
preparation (pEC50) to both agonists was significantly greater in endothelium-disrupted 
preparations (P<0.05; Student’s unpaired t test) compared with intact rings (Figure 
1.15, Table 1.2). However, the change in sensitivity (A pEC50) for both PhE and 5- 
HT was similar (Figure 1.16, Table 1.2). Thus, the increase in the contractile 
response to both 5-HT and PhE by disruption of the endothelium in terms of increased 
maximum response and increased sensitivity of the preparations to the agonists was 
similar.
At low concentration of U46619, the contractions induced in rubbed preparations 
were significantly greater (P<0.05; Student’s unpaired t test) than in unrubbed 
preparations. However, at higher concentations the converse was seen, i.e. the 
response in the presence of a functional endothelium was greater than that in the 
rubbed preparations (Figure 1.17). The maximum contractile response to U46619 was 
significantly less (P<0.05; Student’s unpaired t test) in the endothelium-disrupted rings 
compared with the contractions in intact preparations (Figure 1.17, Table 1.2). In
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Figure 1.11
Difference in sensitivity of endothelium-disrupted rings (A pEC50) to PhE (open 
bars) and 5-HT (filled bars) between responses in control PSS and PSS 
containing 20mM KC1.
Data shown represents mean A pEC50 values ± s.e.m. (n=9-10). There was no 
statistically significant difference (P>0.05) between A pEC50 for PhE and 5-HT 
using unpaired Student’s t test.
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Figure 1.12
Contractions of endothelium-disrupted rat aortic rings to (a) PhE and (b) 5-HT in 
2.5 mM [Ca2+]0 PSS in the presence of BRL 34195; control (O). O.OljiM (# ) , 
0.1 }iM (A), l|iM  (A), and 10|uM (□).
Points shown are mean ± s.e.m. (n=6).
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Figure 1.13
Effect of increasing concentrations of BRL 34195 on the maximum contraction of 
endothelium-disrupted rat aortic rings to PhE (open bars) and 5-HT (filled bars).
Points shown are mean ± s.e.m. (n=6). There was no statistically significant 
difference (P>0.05) between the maximum contractile response to PhE and 5-HT in 
control and 20mM KC1. Statistically significant differences between contractile 
responses for each agonist in the absence and presence of BRL 34195 using 
unpaired Student’s t test; *** P<0.005
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Figure 1.14
Effect of disruption of the endothelium on contractions of rat aortic rings to (a) PhE 
and (b) 5-HT.
Points shown represent mean contraction ± s.e.m. (n=9-10). Statistically 
significant differences between contractile responses in the absence (O ) and 
presence (# ) of a functional endothelium using unpaired Student’s t test; * P<0.05, 
** P<0.01, *** P<0.005
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Figure 1.15
Effect of disruption of the endothelium on (a) the maximum contraction and (b) the 
sensitivity (pEC50) of rat aortic rings to PhE (O /# ) and 5-HT (A/A). Open bars 
and symbols indicate values in rubbed preparations and closed bars and symbols 
indicate values in unrubbed preparations.
Data represents mean ± s.e.m. (n=9-10). Statistically significant differences 
between contractile responses for each agonist in the absence and presence of a 
functional endothelium using unpaired Student’s t test; * P<0.05
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Figure 1.16
Difference in sensitivity of endothelium-disrupted rings (A pEC50) to PhE (open 
bars) and 5-HT (filled bars) between responses in the absence and presence of an 
intact endothelium.
Data shown represents mean A pEC50 values ± s.e.m. (n=9-10). There was no 
statistically significant difference (P>0.05) between A pEC50 for PhE and 5-HT 
using unpaired Student’s t test.
56
U n rubbed  R ubbed
Maximum Response (mg.wt.)
PhE 2964.2± 142.6 2469.2 ± 191.3 *
5-HT 3038.5 ± 122.4 2464.8 ± 122.0 *
Tissue Sensitivity (pEC50) A pEC50
PhE 7.48 ± 0.07 6.85 ± 0.09 *** 0.63 ± 0.10
5-HT 5.69 ± 0.02 4.97 ± 0.07 *** 0.71 ± 0.05
Table 1.2
Effect of removal of the endothelial cell layer of rat aortic ring segments on the 
maximum contractile response (expressed in mg.wt.) and sensitivity (expressed 
as its pEC50) to PhE and 5-HT.
Differences between nibbed and unrubbed preparations are shown as A pEC50 
for potency (i.e. pEC50 (pihbcti) - pEC50 (unrubbcd)). The values shown for the 
unrubbed and rubbed vessel are the means ± s.e.mean for n=9-10.
There was no significant difference between the two agonists either in the 
maximum contractile responses (rubbed or unrubbed) or in the difference in 
sensitivity (A pEC50) caused by rubbing. Significant differences from unrubbed 
preparation using student’s unpaired r-test: * P<0.05, *** P<0.005
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contrast, the sensitivity of the rat aortic rings to this agonist was significantly greater in 
rubbed preparations compared with that in unrubbed preparations (Figure 1.17, Table 
1.2).
Effects o f Lithium
In endothelium-denuded rings the contractile response to PhE was significantly 
smaller in LiCl pre-treated rats (treated preparations) compared with untreated rats 
(control preparations). In the same preparations however, in general, the contractile 
response to 5-HT in treated rings was the same as that in control rings (Figure 1.18). 
In a similar manner the sensitivity to PhE but not 5-HT in rubbed preparations was 
significantly greater in control rings compared with treated rings (Figure 1.19).
In the presence of an intact endothelium the responses to PhE and high 
concentrations of 5-HT were significantly less in treated preparations than in control 
preparations (Figure 1.20). Whilst the maximum response to each agonist was 
depressed in unrubbed rings the sensitivity to PhE but not 5-HT was significantly 
greater in control rings compared with treated rings (Figure 1.21).
The contractile responses to both PhE and 5-HT in endothelium-disrupted rings from 
rats pretreated with myoinositol and LiCl (myo/LiCl preparations) were not 
significantly different (P>0.05; Student’s unpaired t test) from the responses in rings 
from rats pre-treated with LiCl alone (Figure 1.22). In contrast whilst the contractile 
response to PhE in unrubbed myoi/LiCl preparations was not significantly different 
from the response in unrubbed rings from rats treated with LiCl alone, the contractile 
response to high concentrations of 5-HT in the same preparations were significantly 
greater (P<0.05; Student’s unpaired t test) in the myoinositol/lithium treated rings 
compared with the LiCl treated rings (Figure 1.23). Thus, concomitant pre-treatment 
of rats with LiCl and myoinositol had no effect on agonist-induced contractions except 
in the case of 5-HT where the contractions in the presence of the endothelium were 
significantly greater compared with those in LiCl pre-treated rings.
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Figure 1.17
Effect of disruption of the endothelium on (a) the contractile response and (b) the 
sensitivity (pEC50) of rat aortic rings to U46619.
Data represents mean ± s.e.m. (n=9-10). Values shown are from rubbed (O) and 
unrubbed (# )  preparations. Statistically significant differences between contractile 
responses in the absence and presence of a functional endothelium using unpaired 
Student’s t test; * P<0.05, *** P<0.005
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F igure 1.18
Contractions of aortic rings with a disrupted endothelium to (a) PhE and (b) 5-HT 
from control rats (O ) and rats chronically pre-treated with LiCl ( • ) .
Points shown are mean ± s.e.m. (n=6). Statistically significant differences
between contractile responses in control and treated preparations using unpaired
Student’s t test,; * P<0.05, *** P<0.005
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Figure 1.19
Sensitivity (pEC50) to PhE (O  and • )  and 5-HT (A and A)  in endothelium- 
disrupted aortic rings from control rats (open symbols) and rats chronically pre­
treated with LiCl (closed symbols).
Data shown represents mean pEC50 values ± s.e.m. (n=9-10). There was no 
statistically significant difference (P>0.05) in pEC50 for 5-HT between control and 
treated preparations using unpaired Student’s t test. Statistically significant 
differences in pEC50 for PhE between control and treated preparations using 
unpaired Student’s t test; *** P<0.005
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Figure 1.20
Contractions of aortic rings with a functional endothelium to (a) PhE and (b) 5-HT 
from control rats (O ) and rats chronically pre-treated with LiCl ( • ) .
Points shown are mean ± s.e.m. (n=6 ). Statistically significant differences
between contractile responses in control and treated preparations using unpaired
Student’s t test; * P< 0.05, *** P<0.005
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Figure 1.21
Sensitivity (pEC50) to PhE (O  and • )  and 5-HT (A and A ) in endothelium- 
intact aortic rings from control rats (open symbols) and rats chronically pre-treated 
with LiCl (closed symbols).
Data shown represents mean pEC50 values ± s.e.m. (n=9-10). There was no 
statistically significant difference (P>0.05) in pEC50 for 5-HT between control and 
treated preparations using unpaired Student’s t test. Statistically significant 
differences in pEC50 for PhE between control and treated preparations using 
unpaired Student’s t test, * P<0.05
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Figure 1.22
Contractions of aortic rings with a disrupted endothelium to (a) PhE and (b) 5-HT 
from rats chronically pre-treated with LiCl (O) and rats chronically pre-treated with 
a combination of LiCl and myoinositol (# ).
Points shown are mean ± s.e.m. (n=4-5). There was no statistically significant 
difference (P>0.05) in responses to PhE and 5-HT between both pre-treatments 
using unpaired Student’s t test.
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Contractions of aortic rings with a functional endothelium to (a) PhE and (b) 5-HT 
from rats chronically pre-treated with LiCl (O) and rats chronically pre-treated with 
a combination of LiCl and myoinositol (#).
Points shown are mean ± s.e.m. (n=4-5). There was no statistically significant 
difference (P>0.05) in responses to PhE between both pre-treatments using 
unpaired Student’s t test. Statistically significant differences in responses to PhE 
between both pre-treatments using unpaired Student’s t test; * P<0.05
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It should be noted that the effects of chronic pre-treatment with LiCl on the responses 
of the rat aorta to endothelium-dependent relaxations has been examined and is 
discussed in detail in Chapter Four of this thesis.
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D iscussion
In the first part of this study I have compared the requirement for extracellular Ca2+ 
of the responses to 5-HT and the oq-adrenoceptor agonist PhE in rat aortic rings. 
Agonists were added in the presence of a) nominally ‘zero’ [Ca2+]0, i.e. the absence of 
‘added’ Ca2+ and b) various ‘fixed’ concentrations of Ca2+0. Endothelium-disrupted 
rings were used because the responses of the rat aorta, and other vascular smooth 
muscles, to a variety of contractile agents are depressed in the presence of a functional 
endothelium due to a basal release of EDRF (Allan et al., 1983; Fortes et al., 1983; 
Egleme et al., 1984b; Carrier and White, 1985; Furchgott et al., 1985; Miller and 
Stoclet, 1985). Thus, disruption of the endothelium excludes any possible variation in 
the contractile response to the agonists due to changes in the basal release of EDRF 
which might contribute to any differences seen in the response to Ca2+ re-addition in 
the presence of either PhE or 5-HT.
The results show that when rat aortic rings are incubated in PSS with no added Ca2+, 
re-addition of Ca2+ in the presence of 0.1 |iM PhE but not 3|iM 5-HT results in a 
contraction of the circular smooth muscle of the preparations. This is in marked 
contrast to the effect seen when 0.1 pM PhE or 3pM 5-HT are added in the presence of 
a concentration of Ca2+0 which allows the development of an agonist-induced 
contractions. Under these conditions the responses to both PhE and 5-HT are similar 
except at the lowest concentration of Ca2+0 when the response to 5-HT is significantly 
less than the response to PhE: this observation is consistent with the lack of contractile 
response to Ca2+ re-addition in the presence of 5-HT when the agonist is added in 
nominally zero Ca2+ PSS. The contraction of vascular smooth muscle to 5-HT and 
PhE has been shown to be mediated by both release of intracellular Ca2+ and influx of 
Ca2+0. A possible explanation for the lack of effect of ‘5-HT/Ca2+ re-addition’ might 
have been that 5-HT, in contrast to PhE is wholly dependent on the release of 
intracellular Ca2+ for production of its contractile response and is not able to open Ca2+ 
channels to allow the influx of extracellular Ca2+. This is unlikely to be the case
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however, since the major part of the response is proportional to the concentration of 
Ca2+0. Furthermore, BAY K 8644 inhibited and reversed the densensitisation or 
depression of contraction seen with 5-HT/Ca2+ re-addition. The Ca2+ channel activation 
produced by this dihydropyridine requires the pre-activation of the vascular smooth 
muscle and presumably therefore the opening of voltage operated Ca2+ channels 
(Schramm et al., 1984, Su et al., 1984). Thus, the effect of BAY K 8644 on 5- 
HT/Ca2+ re-addition indicates that there is some activation of VOCs by 5-HT in the 
absence of added Ca2+.
Another explanation for the absence of contraction to 5-HT/Ca2+ re-addition could be 
that pre-incubation of the rat aorta in PSS containing nominally zero [Ca2+] 0 in some 
way densensitises the smooth muscle to subsequent agonist-induced contraction. 
Whilst this is not the case for 5-HT-induced contractions in 2.5mM Ca2+ (no marked 
attenuation is seen in consecutive CCRCs to 5-HT), 5-HT-induced desensitisation of 
subsequent contractions to 5-HT/Ca2+ re-addition appears to occur since pre-exposure 
of the preparations to PhE results in contractions to subsequent 5-HT/Ca2+ re-addition 
which are significantly greater than in preparations pre-exposed to 5-HT. This 
‘desensitisation’ is specific for 5-HT/Ca2+ re-addition in that contractions to ‘PhE/Ca2+ 
re-addition’ in preparations pre-exposed to 5-HT are not significantly different from 
those in preparations pre-exposed to PhE alone. Moreover, this desensitisation does 
not prevent contraction to addition of PhE at the end of a CCRC to CaCl2 in the 
presence of 5-HT indicating that the contractile processes in the smooth muscle have 
not been disrupted.
Contractions of vascular smooth muscle have been shown to be modulated by the 
presence of 5-HT. In addition to its direct contractile effect on vascular smooth 
muscle, 5-HT can enhance the contractile response to a number of agonists possibly 
by enhancing the influx of extracellular Ca2+ (Van Nueten et al., 1982; Medgett et al., 
1983; Su and Uruno, 1985; Felix et al., 1986; Meehan et al., 1988). Also, 5-HT can 
attenuate responses to contractile agents of vascular smooth muscle including the dog
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mesenteric artery and rabbit ear artery even after it has been washed from the tissue 
(Bohr and Elliot, 1962; Rapaport and Bevan, 1982). Moreland et al. (1985), have 
suggested that in the dog mesenteric artery, 5-HT, acting via ketanserin-resistant 
receptors (i.e. not 5-HT2 receptors) attenuates contractile responses as a result of an 
increased sodium influx that stimulates the electrogenic sodium pump to cause 
membrane hyperpolarisation and decreased stimulated calcium influx. In contrast to 
the present study however, Moreland demonstrated that in addition to attenuating its 
own response, 5-HT attenuated the responses to a wide range of agonists including 
noradrenaline, methoxamine, prostaglandin and non-receptor mediated contractions 
to KC1. Thus, it is unlikely that the attenuation by 5-HT in the present study is 
brought about by the same mechanism as that seen in the dog mesenteric artery.
In the present study, BAY K 8644 inhibited and reversed the densensitisation or 
depression of contraction seen with 5-HT/Ca2+ re-addition indicating that 5-HT under 
the conditions used can activate dihydropyridine sensitive Ca2+ channels. In addition, 
BAY K 8644 potentiated the responses to PhE Ca2+ re-addition as would be expected 
of this agent which prolongs mean open times of Ca2+ channel (Hess et al., 1984; 
Triggle, 1984). However, BAY K 8644 produced a much greater potentiation of the 
response to 5-HT/Ca2+ re-addition than to PhE/Ca2+ re-addition. This might simply 
indicate that the opening of VOCs by PhE is near the maximum possible for this 
agonist whereas there is a much greater scope for increasing the number of channels 
for a given concentration of 5-HT.
Another possible explanation for the differential effect of BAY K 8644 is that PhE 
and 5-HT induce contraction of the vascular smooth muscle of the aorta by recruiting 
both receptor operated Ca2+ channels (ROCs) and VOCs (Bolton, 1979; Van Breemen 
et al., 1979; Meisheri, et al., 1981) but in different proportions. For example, the Ca2+ 
channels involved in the response to PhE may be predominantly ROCs whilst those 
involved in the response to 5-HT may be VOCs and require some extracellular Ca2+ for 
their opening. This would explain the apparently differential effect of BAY K 8644 on
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the responses to 5-HT/Ca2+ re-addition. In order to test this hypothesis I examined the 
effects of changing the membrane potential on the responses to PhE and 5-HT since 
the function of VOCs can depend on the membrane potential of the smooth muscle.
Partial depolarisation of the aortic smooth muscle with a subcontractile concentration 
of KC1 (20mM) caused a potentiation of the response to 5-HT as would be expected 
since such treatment would predispose to the opening of more VOCs thus producing a 
greater contraction by agonists acting at least in part by activation of VOCs. However, 
the response to PhE was also potentiated by incubation of the ring preparations in 
partially depolarising PSS. Moreover, the degrees by which responses to the two 
agonists were potentiated were not significantly different (P>0.05; Students unpaired t 
test). Therefore it is unlikely that contractions to the agonists are mediated by different 
proportions of VOC and ROC since, if this were the case, partial depolarisation would 
be expected to have a preferentially greater effect on the contractions of the agonist 
which recruits the greater number of VOCs for its contraction. This suggestion is 
supported by the observation that the concentration-dependent contractions to both PhE 
and 5-HT were inhibited to a similar extent by hyperpolarisation of the rat smooth 
muscle by the K+ channel activator BRL 34915 (Southerton et al., 1987). In a similar 
manner to depolarisation with KC1, hyperpolarisation would be expected to 
differentially inhibit the contractions to agonists which act mainly via activation of 
VOC since mild hyperpolarisation would inhibit the opening of VOCs.
Thus the preferentially greater effect of BAY K 8644 versus 5-HT/Ca2+ re-addition is 
not simply due to a clear difference in the activation processes utilised by 5-HT and 
PhE under ‘normal’ conditions. This effect is more likely to be due to a greater scope 
by which 5-HT/Ca2+ re-addition can be potentiated since alteration of the membrane 
potential by partial depolarisation with KC1 or hyperpolarisation with BRL 34915 did 
not differentially affect the contractions to 5-HT and PhE in 2.5mM Ca2+0.
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To summarise so far: when 5-HT is added in a low concentration of extracellular 
Ca2+ (thereby preventing production of a significant contractile response), activation of 
receptors changes the excitation-contraction coupling process in such a way that a 
subsequent increase in [Ca2+] 0 is no longer effective at producing contraction, possibly 
due to an alteration of Ca2+ channel function. This does not, however, occur with 
activation of the cq-adrenoceptor indicating a difference in the excitation-contraction 
coupling process between activation of 5-HT2 receptors and oq-adrenoceptors in this 
tissue. The effect does not cause a disruption of the contractile processes in the 
smooth muscle or even of Ca2+ channel function in general since addition of PhE at the 
end of a CCRC to CaCl2 in the presence of 5-HT induced a rapid contraction. This 
interesting phenomenon does not appear to be a simple function of a differential 
activation by PhE and 5-HT of VOC and ROC since depolarisation and 
hyperpolarisation of the smooth muscle in 2.5mM [Ca2+] 0 had no differential effect on 
the contraction induced by these agonists.
The basal release of EDRF attenuates the response to a number of contractile agents 
in vascular smooth muscle and its action may be due at least in part to alteration of Ca2+ 
fluxes (Malta et al., 1986). Since there is a difference in the excitation-contraction 
coupling process between activation of 5-HT2 receptors and a!-adrenoceptors in the rat 
aorta (with respect to the requirement for extracellular Ca2+ of responses to 5-HT and 
PhE), in the second part of this study I tested to see if EDRF has a differential effect on 
the contractions to PhE and 5-HT. In addition I investigated the possible involvement 
of receptor-mediated inositol phospholipid hydrolysis in contractions to PhE and 5-HT 
by chronic pre-treatment of rats with LiCl to inhibit receptor-mediated increases in 
inositol phospholipid hydolysis: this was done both in the presence and absence of the 
endothelium.
In ring preparations with a disrupted or intact endothelium both PhE and 5-HT 
caused concentration-dependent contractions. The response to both PhE and 5-HT 
was greater in the absence of the endothelium presumably due to the basal release of
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EDRF directly opposing the contractile response to the agonists. The difference in 
maximum response and sensitivity for both agonists between rubbed and unrubbed 
preparations was the same. This clearly indicates that EDRF does not have a 
differential effect on the contractions mediated by 5-HT2-receptors or a!-adrenoceptors 
in this tissue even though these agonists appear to have a subtly different excitation- 
contraction coupling mechanism which is only revealed in nominally zero [Ca2+] 0 PSS.
For comparative purposes, I also examined the effect of disruption of the 
endothelium on responses of the rat aorta to the thromboxane-mimetic U46619 
(Coleman et al., 1981). Contractions of the rabbit jugular vein and rat aorta to U46619 
have been reported as being unaffected by the presence of the vascular endothelium 
(Leff et al., 1987; A.G.B. Templeton, PhD thesis, 1988). The results obtained in this 
study do not confirm these observations. In contrast to these studies, the presence of 
the endothelium had a marked and somewhat surprising effect on the contractions to 
U46619. Although the sensitivity of the preparation to U46619 was greater in rings 
with a disrupted endothelium, the maximum contraction produced by this agonist was 
greatest in the presence of a functional endothelium. A similar effect was noted in a 
study by Bullock et al., (1986) though these workers simply reported the observation 
and made no attempt to explain it. The most likely explanation of this phenomenon is 
that at high concentrations, U46619 is able to release an endothelium-dependent 
substance that can augment the contractile response to the agonist without inducing a 
contraction per se (an effect seen with anoxia and neuropeptide Y; De Mey and 
Vanhoutte, 1982, 1983; Daly and Hieble, 1987). Alternatively, U46619 may produce 
an endothelium-dependent substance that can contract the smooth muscle of the aorta, 
as occurs in spontaneously hypertensive rats (Luscher and Vanhoutte, 1986), hypoxic 
conditions in dog coronary artery (Rubanyi and Vanhoutte, 1985), stretch in dog 
basilar arteries (Katusic et al., 1987) and cultured bovine aortic endothelial cells 
(Gillespie et al., 1985; Hickey et al., 1985). These endothelium-dependent 
contractions have been attributed to prostaglandins or substances whose identity has
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not yet been unequivocally established. Recent studies have indicated that the 
endothelium is capable of releasing a highly potent vasoconstictor substance which has 
been termed Endothelin (Yanagisawa et al., 1988). This substance may be of some 
physiological significance and therefore this effect of the endothelium on contractions 
of the rat aorta to U46619 and possibly other vascular preparations warrants further 
investigation. Furthermore, the possible involvement of cycloxygenase products in the 
endothelium-dependent augmenation of U46619-induced contractions needs to be 
evaluated.
In addition to the differential effect of Ca2+ re-addition in the presence of 5-HT and 
PhE, chronic pre-treatment of rats with LiCl revealed differences in the contractile 
response to 5-HT and PhE. Receptor mediated increases in inositol phospholipid 
hydrolysis are thought to be important in the agonist-induced release of intracellular 
Ca2+. In addition to this direct release of intracellular Ca2+, inositol phospholipid 
metabolites, specifically diacylglycerol (DG), can activate protein kinase C by a Ca2+ 
dependent process (see Berridge, 1987) and hence indirectly modify the function of 
VOCs (Harris et al., 1986; Osugi et al., 1986; Wakade et al., 1986). Lithium has been 
shown to inhibit myo-inositol-l-phosphate phosphatase activity and therefore prevent 
the metabolism of the metabolites of inositol phospholipids: this decreases receptor- 
mediated inositol phospholipid hydrolysis possibly by decreasing membrane 
polyphosphoinositide levels (Figure 1.24; Allison and Stewart, 1971; Berridge et al., 
1982; Drummond and Raeburn, 1984; Sherman et al., 1986; Kendall and Nahorski, 
1986; Menkes et al., 1986). Thus if 5-HT or PhE has a relatively large degree of 
action via the hydrolysis of inositol phospholipids then this pretreatment will have a 
preferential effect on that agonist.
In rings from rats pre-treated with LiCl (treated preparations) the contractile response 
of the vascular smooth muscle to PhE in the absence and presence of a functional 
endothelium were markedly depressed in terms of both a decreased maximum response 
and a decreased sensitivity of the preparation to PhE. In contrast however, the
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+Li 2+Increase in Ca‘
Figure 1.24
Simplified diagram representing the proposed pathway for agonist-induced 
turnover of membrane inositol phospholipids. Agonists bind to the membrane 
receptor (R) and, via a regulator protein (G), stimulate the hydrolysis 
phosphatidylinositol 4,5-bisphosphate (PIP2 ) by phospholipase C (PLC). This 
process generates two second messengers: inositol 1,4,5-triphosphate (IP3 ) and 
1,2 diacylglycerol (DG) which can directly or indirectly modulate [Ca2^ .  
Chronic pre-treatment with LiCl blocks the metabolism of IP3 and its metabolites 
such that a build up of inositol monophosphate isomers and a decrease in cellular 
inositol occurs. Ultimately the levels of membrane PIP2 will become so low that 
agonists are unable to produce sufficient amounts of second messengers to ilicit a 
cellular response.
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responses to 5-HT in treated preparations where depressed only at high concentrations 
in unrubbed rings and there was no difference in sensitivity to 5-HT. These results 
suggest that at least part of the response to PhE is mediated by oti-adrenoceptor inositol 
phospholipid hydrolysis. A similar effect of LiCl on o^-adrenoceptor mediated 
responses has been demonstrated by Mantelli etal., (1988). These workers showed 
that acute administration of LiCl attenuated the inotropic effects of a- but not 13- 
adrenoceptors in the guinea-pig heart.
The greater depression of PhE-induced contractions in the presence of a functional 
endothelium by LiCl pre-treatment is consistent with the effect of EDRF being greater 
on agonists which have a lower intrinsic efficacy (Martin et al., 1985). Disruption of 
the receptor mediated hydrolysis of inositol phospholipids would necessarily reduce 
the efficiency of the receptor-response coupling for a r adrenoceptors in the smooth 
muscle of the aorta. This would effectively reduce the receptor reserve for PhE- 
induced responses and hence lower its intrinsic efficacy.
The effect of LiCl pre-treatment on the responses to 5-HT is more difficult to 
explain. The absence of effect of LiCl in the rubbed preparation suggests no role for 
the hydrolysis of inositol phospholipids in 5-HT2-receptor mediated contractions or 
that this is not a rate limiting step. However in the presence of the endothelium the 
contractions to high concentrations of 5-HT are depressed in treated preparations. This 
might indicate that the effective receptor reserve for 5-HT2-induced contractions of the 
rat aorta is much greater than that for PhE and consequently an effect of LiCl can be 
seen only when the intrinsic efficacy is lowered by the influence of a basal release of 
EDRF directly opposing the contractile response to 5-HT. However, this is unlikely to 
be the case since reductions in the relative efficacy of an agonist (e.g., by reducing 
receptor reserve with irreversible receptor antagonists) should, theoretically, cause a 
change in the sensitivity to the agonist particularly when the depression of the 
maximum contraction is as great as that seen in the present study (see Kenakm, 
1982). An alternative explanation for this effect of LiCl in unrubbed preparations
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might be that, at high concentrations, 5-HT acts via activation of a!-adrenoceptors and 
it is this activation that is preferentially blocked in treated preparations. This is also 
unlikely since it is well established that, in the rat aorta, 5-HT acts via activation of 5- 
HT2-receptors (Cohen et al., 1981; Downing et al., 1983; Doggrell, 1987). Moreover 
this requires an explanation of why the action of 5-HT should be mediated by 
activation of a r adrenoceptors only in the presence of the endothelium. Possibly 
explanation of this effect is that at high concentrations, 5-HT induces endothelium 
dependent contractions which are highly sensitive to LiCl either in the mechanism of 
contraction per se or the mechanism of production of the mediators of this contraction. 
To my knowledge, such an effect at high concentrations of 5-HT has not been reported 
although the existence of such endothelium-dependent contractile factors has been 
shown in a number of studies (Rubanyi and Vanhoutte, 1985; Luscher and Vanhoutte, 
1986; Katusic et al., 1987; Vanhoutte, 1988) and this may explain the results obtained 
in the present study.
Chronic pre-treatment with myoinositol has been shown to prevent the inhibitory 
effects of LiCl when both substances are administered together (Eglen et al., 1987; 
Mantelli et al., 1988) presumably by circumventing the blockade of metabolism of 
inositol phosphates. In the present study, myoinositol (when given in drinking water 
as a supplement to the LiCl pretreatment) caused partial inhibition of the effect of LiCl 
on 5-HT-induced contractions in unrubbed preparations. This would suggest an 
involvement in inositol phosphilipid turnover in this apparendy endothelium-dependent 
effect of lithium pre-treatment on the responses of the rat aorta to 5-HT. The effect on 
5-HT at high concentrations may be highly sensitive to lithium and therefore would be 
more susceptible to reversal by low concentrations of myoinositol. Alternatively, the 
effect of myoinositol may be a function of the ability of the endothelium to more easily 
utilise extracellular inositol than the smooth muscle.
In contrast to the effect seen with 5-HT-induced contractions in preparations with an 
intact endothelium, myoinositol had no effect on the attenuation of the contractile
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response to PhE in treated preparations. This would suggest that the effect of LiCl on 
PhE-induced contractions in the present study is not at the level of phosphoinositol 
lipid turnover. An alternative mode of action at the level of G-protein interactions for 
LiCl has recently been suggested (Avissar et al., 1988) and it may be at this level that 
lithium exerts its effects on the contractions to a-adrenoceptor activation. Whilst this 
may be the case a more likely explanation for the lack of effect of myoinositol in this 
study is that the route of administration used may lead to variability in the dose of 
myoinositol administered which, in any case, was not sufficient to overcome the effect 
of lithium on a-adrenoceptor mediated responses. The apparent lack of effect may 
also be due to differences in the effect of lithium on responses of the aorta in both 
groups of animals, i.e. the rats used in the initial comparison between control and LiCl 
treatment and the second group of rats used for comparison of responses in LiCl and 
LiCl/myoinositol treated rats: the effect of lithium pre-treatment on PhE-induced 
contractions in the second group of rats was less marked than in the first group and 
therefore it would be expected that the responses in the second group would not be 
affected to a large extent by concomitant pre-treatment with myoinositol. Cells can 
obtain inositol by de novo synthesis, active uptake and passive diffusion (Downes and 
Stone, 1986). Different cell types show different requirements for extracellular 
inositol and de novo synthesis of inositol (Drummond, 1987). The smooth muscle of 
the rat aorta may be unable to utilise extracelluar inositol and depend almost entirely on 
de novo synthesis of inositol for any effects mediated by this system. If this were so 
then it would explain the marked effect seen with lithium treatment on PhE-induced 
contractions and also the lack of effect of myoinositol on the lithium-induced 
inhibitions of those contractions.
To conclude: the responses of the rat aorta to PhE and 5-HT can be differentiated by 
both their utilisation of extracellular Ca2+ in Ca2+ re-addition experiments and also by 
pre-treatment of lithium (presumably by blocking receptor-mediated inositol 
phospholipid hydrolysis). The difference in the effect of Ca2+ re-addition in the
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presence of either agonist is dependent on pre-exposure to 5-HT and not due to 
activation of different proportions of ROCs and VOCs despite the observation that 
BAY K 8644 appears to have a preferential effect in the presence of 5-HT. The 
densensitisation seen with 5-HT only in low [Ca2+] 0 is difficult to explain. It may 
indicate that the 5-HT2-receptor induced activation of Ca2+ channels (at least to a level 
at which Ca2+ influx is possible) is somehow highly dependent on extracellular Ca2+. 
Either the opening of the channels themselves, or the binding of 5-HT to a binding site 
which results in the opening of the channels, may require Ca2+ ions. These 
suggestions are purely speculative and further more detailed experimentation is 
required to define precisely the mechanism of this phenomenon.
Finally, using lithium pre-treated rats I have demonstrated indirectly that the 
contractile response to PhE in contrast to that of 5-HT is likely to be dependent, at least 
in p a rt, on the hydrolysis of membrane inositol phospholipids. This does not exclude 
the possibility that this system may play a minor role in the effect of 5-HT but it would 
appear that the contractions of the aortic smooth to 5-HT in 2.5mM [Ca2+] are on the 
whole, independent of receptor mediated hydrolysis of membrane inositol 
phospholipids. It would be interesting to see if pre-treatment with LiCl would block 
the effect of BAY K 8644 on reversal/inhibition of 5-HT/Ca2+ re-addidon since the 
partial opening of VOCs (as indicated by the effect of BAY K 8644 in these 
experiments) might result from modulation by 5-HT of the VOC by some metabolite of 
inositol phospholipid hydrolysis.
Despite the possible differences in utilisation of Ca2+ to induce their contractions, the 
presence of the vascular endothelium appears to have no differential effect between the 
responses to PhE and 5-HT.
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Chapter Two
The influence of the initial stretch and 
the agonist induced tone on the effect 
of basal and stimulated release of EDRF
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In tro d u c tio n
Variation between different laboratories with respect to the demonstration of both the 
basal and the stimulated release of EDRF can be marked. For example there has been 
some debate concerning a possible differential effect of vascular endothelium on 
contractile responses to different a-adrenoceptor agonists. Egleme et al. (1984) 
showed that the contractile effect of the mixed a r  and a 2-adrenoceptor agonist 
clonidine was markedly greater in rat aortic ring segments with a disrupted 
endothelium yet this was not seen with the relatively more selective a!-adrenoceptor 
agonist phenylephrine. It was suggested that clonidine released EDRF via a 2- 
adrenoceptors and this normally offset contraction mediated via stimulation of oq- 
adrenoceptors. In another study Martin et al. (1986) found qualitatively similar but 
quantitatively different phenomena. These workers suggested an alternative 
explanation that clonidine did not actually release EDRF but that its responses were 
somehow more susceptible because the spontaneous release of EDRF has a greater 
effect on the contractile response to agonists of lower efficacy than on that to ‘full’ 
agonists.
In studies carried out within the Institute of Physiology, Glasgow University we 
were unable to reproduce, to the same extent, the potentiation of the response to 
clonidine by removal of the vascular endothelium but did find potentiation of responses 
to phenylephrine (Templeton, PhD thesis 1988). This suggested that variations in 
experimental protocol might affect the perceived influence of the endothelium on 
contractile responses of the smooth muscle. Consequently we carried out the present 
study to examine the influence of the initial stretch of the smooth muscle and the 
agonist-induced tone in experiments designed to demonstrate quantitatively the effects 
of basal or stimulated release of EDRF. The results indicate that both factors can have 
a marked influence.
80
M ethods
General
Aortic ring segments from male Wistar rats (250-300g) were prepared as indicated 
earlier (see General Methods). For the length-tension study the rats were age and 
weight matched ( 1 0  weeks and 265g) in order to reduce any variation that may occur 
due to possible differences in responseiveness with age and ring size. When required, 
endothelium was mechanically removed from ring segments by inserting the bent tip of 
a pair of forceps into the lumen and gently rubbing the intima whilst rolling the ring 
segment back and forth. Each 2-3 mm long ring segment was suspended between an 
isometric force transducer and a wire support in a 10 or 30ml isolated organ bath 
containing Krebs’ solution.
The Krebs’ solution used throughout the study had the composition outlined earlier 
(see General Methods). In addition, when noradrenaline (NA) was used, the Krebs’ 
solution also contained 23 pM ethylene diaminetetra-acetic acid (EDTA) in order to 
prevent degradation of the NA. Isometric tension changes were measured using either 
Harvard or Grass force transducers and recorded on a Linseis four channel chart 
recorders.
Effect o f Resting Length (Tension)
Paired, rubbed/unrubbed aortic ring segments were used. In a first group of 
experiments the effects of endothelial disuption on resting tension at different degrees 
of stretch, the contractile response to lqM  PhE, and subsequent relaxation to lp.M 
ACh were assessed. The apparatus used allowed accurate measurement of the distance 
between lower and upper tissue holders using a vernier scale (Figure 2.1). The 
measurements of ‘stretch’ (length) allow for the thickness of the upper and lower 
tissue holders (500|im) and indicate the distance between the upper and lower edges of 
the top and bottom tissue holders respectively (see Figure 2.1). The tissue holders
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Diagram representing a ‘side-on’ view of a rat aortic ring segment suspended 
between an upper and lower wire tissue holder for measurement of isometric tension 
at different degrees of ‘stretch’. From the initial degree of ‘stretch’ (1500pm) 
tissues were stretched in 300pm increments to the final degree of ‘stretch’ 
(2700pm). At each degree of ‘stretch’ examined resting tension, response to lpM  
PhE and any subsequent relaxation to lpM  ACh were measured. Values of 
‘stretch’ indicate wire separation with ‘zero’ indicating the position where the upper 
and lower edge of the upper and lower wire holders theoretically meet.
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were separated by an initial distance of 1500p.m. From this point each tissue was 
‘stretched’ (i.e. its resting length increased) by increasing the separation of the tissue 
holders in steps of 300pm to a final separation of 2700p.m. After each alteration of 
length, the ring segments were allowed 15 minutes to equilibrate before administering 
lp.M PhE to produce 90-95% maximal contraction. When the contractile response had 
reached a plateau a concentration of acetylcholine lpM  ACh (a concentration producing 
near maximal relaxation) was added to the baths and any relaxation monitored. The 
tissues were then washed by exchanging the bathing Krebs’ solution three times over a 
15 minute period before further increasing the degree of stretch of the tissue.
In a separate group of tissues the effects of initial passive tension (hence stretch) on 
the quantitative assessment of sensitivity to PhE and ACh were examined. The 
contractile response to cumulative addition of PhE (0.01-30p.M) was examined over 
the range of resting tensions corresponding to those seen at each degree of ‘stretch’ 
used in the first set of experiments (see above). Relaxations of lpM  PhE-induced tone 
by cumulative addition of ACh (0.01-10p.M) in endothelium-intact preparations at 
various resting tensions were then obtained. The sensitivity of the preparation to PhE- 
induced contraction was estimated by interpolation of the concentration of PhE 
producing 50% maximal contraction (EC50) and expressed as its negative log10 i.e. the 
pEC50 or pD2. The sensitivity of the preparation to ACh-induced release of EDRF was 
estimated as the concentration of ACh producing 50% maximal relaxation (IC50) and 
expressed as its negative logi0 i.e. the pIC50.
Effect o f Agonist-Induced Tone
The effect on sensitivity to ACh-induced relaxations of inducing tone with different 
concentrations of NA and PhE was examined.
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Noradrenaline
Aortic ring segments with an intact endothelium were used. Each ring segment was 
set at the same initial tension of 1500 mg. wt. The preparations were washed twice by 
exchanging the bathing Krebs’ solution and left for 60 minutes to equilibrate before a 
cumulative-concentration response curve to NA (0.003- 10qM) was obtained. After 
reaching maximum contraction, the tissues were washed by exchanging the bathing 
Krebs’ solution three times over a 15 minute period and allowed to equilibrate for a 
further 30 minutes. Muscle tone was then raised by adding a fixed amount of NA. 
After the contractile response had reached a plateau, ACh was added cumulatively 
(0.03-10|iM). This was repeated for three different concentrations of NA (3, 10, and 
30 nM) in each ring segment added in a randomised order. NA-induced tone was 
expressed as a percentage of the initial maximum response to NA. The sensitivity of 
the preparations to ACh-induced relaxation was expressed as pIC50 values.
Phenylephrine
From each rat, five aortic ring segments with an intact endothelium were used. In 
this case each ring segment was set at the same initial tension of 1000 mg. wt. The 
preparations were washed by exchanging the bathing Krebs’ solution three times at 
five minute intervals (re-adjusting the resting tension to 1 0 0 0  mg. wt. after each wash) 
and left for 15 minutes to equilibrate. The presence of a functional endothelium was 
demonstrated as described in General Methods. Muscle tone was then raised by 
adding a concentration of PhE to each of the preparations (0.1, 0.3, 1, 3, or lOpM). 
After the contractile response had reached a plateau, ACh was added cumulatively 
(0.01-10|iM) to all preparations thus avoiding any variation in ACh sensitivity that 
might occur with time. The sensitivity of the preparations to the ACh-induced 
relaxations was expressed as pIC50 values.
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Results
In rat aortic ring segments with an intact endothelial cell layer lpM  ACh produced a 
rapid, well maintained reduction in lpM  PhE-induced tone. With the endothelium 
disrupted, ACh had little effect but the responses to PhE were greater than those seen 
with intact endothelium (Figures 2.2 and 2.4).
Effect o f Resting Length (Tension)
With or without an intact endothelium, there was a length dependent increase in the 
resting tension of the aortic rings. Disruption of the endothelium had no significant 
effect (P>0.05) on the resting tension of the preparations compared with paired intact 
controls at all degrees of ‘stretch’ examined (Figure 2.3).
lpM  PhE produced a well maintained contractile response in both rubbed and 
unrubbed praparations (Figure 2.2). The size of this contractile response was 
dependent on the initial length of the preparation. In both rubbed and unrubbed 
vessels the contractile response increased with increasing resting length, reaching a 
maximum at 2400pm, after which no further increase in the response to PhE was seen. 
The response to PhE was significantly greater (unpaired Student’s t test; P<0.05) at all 
resting lengths with a disrupted endothelium than with an intact endothelium (Figure 
2.4). The ‘absolute’ difference in contractile response between the rubbed and 
unrubbed preparation (expressed in mg. wt.) was greatest at 1800pm but similar at the 
other lengths tested (Figure 2.5a). The ‘absolute’ difference at 1800pm was 
significantly greater (P<0.05) than at 2400pm i.e. at the optimum degree of stretch for 
contraction per se. The ‘proportionate’ difference in contractile response to PhE 
(expressed as the percentage of the response in the intact, paired vessel), was 
dependent on the initial length of the preparation. This was greatest at the lowest 
degree of stretch (1500pm) declining rapidly until 2 1 0 0 pm after which the difference 
was constant Figure 2.5b). The ‘proportionate’ difference at 1500pm was 
significantly greater (P<0.05) than at 2400pm.
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F igure 2.3
Effect of increasing the degree of ‘stretch’ on the resting tension of rat aortic rings in 
the presence (# )  and absence (O) of a functional endothelium.
Points shown are mean ± s.e.m. (n=7). No statistically significant difference in 
resting tension between rubbed and unrubbed preparations was seen using unpaired 
Student’s t test at all degrees of ‘stretch’ examined.
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F igure 2.4
Effect of increasing the degree of ‘stretch’, hence resting tension, on contractile 
response of rat aortic rings to lfiM PhE in the presence (# )  and absence (O) of a 
functional endothelium.
Points shown are mean ± s.e.m. (n=7). Statistically significant differences betweei 
contractile responses in rubbed and unrubbed preparations; * P<0.05, ** P<0.01, 
using unpaired Student’t t test.
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F igure 2.5
Effect of increasing the degree of ‘stretch’, on the difference in contractile response 
of rat aortic rings to 1(J.M PhE in the presence and absence of a functional 
endothelium. The difference is expressed as (a) the ‘absolute’ effect (i.e. in terms 
of mg. wt.) and (b) the ‘proportionate’ effect (i.e. as a percentage of the contraction 
in the intact vessel).
Points shown are mean ± s.e.m. (n=7). Statistically significant difference between
effect at 2.4 mm and other degrees of ‘stretch’ examined; * P<0.05, ** P<0.01,
*** P<0.005, using unpaired Student’s t test.
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In rings with an intact endothelium, pre-contracted with IjiM  PhE, ACh (l|lM ) 
induced a rapid, well-maintained relaxation (Figure 2.2b). The ACh-induced 
relaxation was dependent on the initial length of the preparation. The ‘absolute’ 
relaxation of induced tone (i.e. in terms of mg. wt.) increased with increasing length 
reaching an optimal relaxation at 2400|im (Figure 2.6a). The ‘proportionate’ 
relaxation (i.e. the relaxation expressed as the percentage of the induced tone) was also 
length-dependent being optimal at 1500|im and decreasing with increasing length to a 
minimal response at 2100|im. The ‘proportionate’ relaxation at 1500|im was 
significantly greater (P<0.05) than the response at 2400|im (the optimum degree of 
‘stretch’ for contraction per se). At 2400|im and 2700fim the ‘proportionate’ 
relaxation to ACh was slightly greater than that at 2100}im and similar to that seen at 
1800|im (Figure 2.6b).
In the second set of tissues, length was not monitored but the rings were set up at 
initial resting tensions corresponding to those seen at each degree of ‘stretch’ used in 
the first set of tissues (see Figure 2.1). Cumulative concentration-response curves to 
PhE were obtained at each of the five increasing tensions. Paired time controls were 
run at a fixed resting tension of 1 0 0 0  mg. wt. to determine any possible variation with 
time. This time control showed a small, time-dependent variation in sensitivity to PhE 
(Figure 2.7) possibly complicating demonstration of any change in sensitivity of the 
preparations to PhE-induced contractions which might occur with increasing initial 
resting tension of the preparation. When account was taken of this, the initial resting 
tension had no effect on sensitivity to PhE (as indicated by the pD2 values; P>0.05) in 
either endothelium-intact (Figure 2.7a) or endothelium-denuded (Figure 2.7b) 
preparations. The sensitivity to PhE-induced contractions in the endothelium-denuded 
preparations was consistently greater than in the endothelium-intact vessel whether the 
resting tension of the preparation was increased or fixed (Figure 2.8). The difference 
in sensitivity between rubbed and unrubbed preparations varied with time to a similar 
degree both in preparation with fixed and increasing resting tensions. This difference
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Figure 2.6
Effect of increasing the degree of ‘stretch’ on ACh-induced relaxations of rat aortic 
rings precontracted with lp.M PhE. The response is expressed as (a) the ‘absolute 
effect (i.e. in terms of mg. wt.) and (b) the ‘proportionate’ effect (i.e. as a 
percentage reduction of the induced tone).
Points shown are mean ± s.e.m. (n=7). Statistically significant difference between
effect at 2.4 mm and other degrees of ‘stretch’ examined; * P<0.05, ** P<0.01,
*** p<0.005, using paired Student’s nest.
91
8.0 1
6.0
0 1000 2000 3000 4000 5000 6000 7000
Resting Tension (mg. wt.)
(b)
(N
Qa
6.5 -
6.0
0 1000 2000 3000 4000 5000 6000 7000
Resting Tension (mg. wt.)
Figure 2.7
Effect of increasing the resting tension, hence degree of ‘stretch’, on sensitivity of 
rat aortic rings to PhE-induced contractions expressed as the pD2 for PhE. Data 
shown represents the pD2 values in (a) the absence and (b) the presence of a 
functional endothelium for time controls (O ) and with increasing initial resting 
tension ( • ) .
Points shown are mean ± s.e.m. (n=6). There was no significant difference
(P>0.05) in pD2 values between time controls and increasing initial resting tension
in the absence and presence of endothelium using unpaired Student’s t test
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Figure 2.8
Effect of increasing the resting tension, hence degree of ‘stretch’, on sensitivity of 
rat aortic rings to PhE-induced contractions expressed as the pD2 for PhE. Data 
shown represents the pD2 values for time controls in the absence (O) and presence 
(A) of a functional endothelium and the pD2 values with increasing initial resting 
tension in the absence (# ) and presence (A) of a functional endothelium.
Points shown are mean ± s.e.m. (n=6 ). Statistically significant differences between 
pD2 values for time controls and pD2 values with increasing initial resting tension in 
the absence and presence of a functional endothelium using unpaired Student’s r test; 
* P<0.05, ** P<0.01, *** P<0.005 for comparison of time controls and f P<0.05, 
++ PcO.Ol,+++ P<0.005 for comparison of preparations with increasing tension.
in sensitivity appeared to be greater for the first and last CCRC (Figure 2.9). 
Statistical analysis however showed that the difference was not statistically greater 
(Student’s unpaired t test; P>0.05) for either the first or last CCRC compared to the 
second, third and fourth CCRC.
The sensitivity to ACh-induced relaxations of lp.M PhE-induced tone in endothelium- 
intact aortic rings decreased slightly with time in this set of experiments (Figure 
2.10a). This again complicated demonstration of any change in sensitivity to ACh- 
induced relaxations which might occur with increasing the initial resting tension of the 
preparation (Figure 2.10b). Although the size of the PhE-induced contraction 
increased with increasing initial resting tension, when account was taken of the time 
dependent change in sensitiity to ACh, the initial resting tension of the tissue had no 
effect on sensitivity to ACh-induced relaxations (as indicated by the pIC50 values, 
P>0.05) in the presence of an intact endothelium (Figure 2.11).
Effect o f Agonist Induced Tone 
Noradrenaline
In tissues with an intact endothelium, ACh produced a concentration-dependent 
inhibition (relaxation) of 0.3 p.M NA-induced tone. In this set of experiments the 
sensitivity of the intact vessels to ACh-induced relaxations showed no significant 
change with time (Figure 2.12). When the tissues were contracted with various 
concentrations of NA (0.01-3 p.M) to produce different degrees of tone (35-145% of 
initial maximum contraction to NA: the maximum contraction to NA commonly 
increases in the course of such experiments without a significant change in sensitivity 
(Figure 2.13)), the relaxations to ACh varied with the degree of induced tone (Figure 
2.14). When the concentration of NA used was low (0.03|iM), the sensitivity of the 
tissue was high (pIC50 = 7.36 ± 0.07). When the degree of NA-induced tone was 
increased by increasing the concentration of NA used to induce that tone (0.1 and 
0.3jiM), the tissues were less sensitive to ACh (pICso = 6.89 ± 0.06 and 6.57 ± 0.07,
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Figure 2.9
The increase in sensitivity to PhE-induced contractions due to removal of the 
vascular endothelium of rat aortic rings in preparations with increasing resting 
tension (tilled bars) and in concomitant time controls (open bars) set at a resting 
tension of 1 0 0 0  mg. wt.
Points shown are mean ± s.e.m. (n=6 ).
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Figure 2.10
Relaxations of intact rat aortic rings by successive cumulative concentration- 
response curves for ACh in terms of the percentage maximum response. Effect of
(a) time; first (CO, second (# ) , third (A), fourth (A) and fifth (□ ) successive 
CCRC for ACh, and (b) increasing initial resting tension; approximately (O) 153 ± 
35, (# )  347 ± 52, (A) 1466 ± 56, (A) 3377 ± 138, and (□) 6036 ± 176 mg.wt..
Points shown are mean ± s.e.m. (n=8 ).
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Figure 2.11
Effect of increasing the resting tension, hence degree of ‘stretch’, on sensitivity of 
rat aortic rings to ACh-induced relaxations of l|iM  PhE-induced tone expressed as 
the pIC50 for ACh (i.e. the negative log10 of the concentration of ACh producing 
50% maximal relaxation). Data shown represents the pIC50 values for time controls 
(O) and the pIC50 values with increasing initial resting tension (#).
Points shown are mean ± s.e.m. (n=6 ). pIC50 values for relaxations at increasing 
initial resting tensions were not significantly different from pIC50 values in time 
controls; P>0.05 using unpaired Student! t test.
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F igure 2.12
Effect of time on relaxations of intact rat aortic rings to successive cumulative 
concentration-response curves for ACh. Tone was induced by addition of 0.3[iM 
NA. Data shown represents first (0)> second (# ) , and third (A) successive 
CCRC for ACh in terms of the percentage maximum response.
Points shown are mean ± s.e.m. (n=13).
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Figure 2.13
Effect of time on contraction of intact rat aortic rings to successive cumulative 
concentration-response curves for NA. Data shown represents first (O), second 
(# ) ,  third (A), and fourth (A) successive CCRC for NA in terms of (a) the 
absolute response (i.e. mg. wt.) and (b) the proportionate response (i.e. percentage 
maximum response).
Points shown are mean ± s.e.m. (n=13).
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F igure 2.14
Effect of increasing the degree of NA-induced tone (by increasing the concentration 
of NA used to induce that tone) on ACh-induced relaxations of intact aortic rings. 
Relaxations are expressed as (a) the ‘absolute’ effect (i.e. in terms of mg. wt.) and
(b) the ‘proportionate’ effect (i.e. as a percentage reduction of the induced tone). 
The concentrations of NA used to induce tone were; 0.03|iM (O), 0.1|iM (# )  
and 0.3|iM (A). Single symbols in (a) represent the degree of tone induced by 
0.03p.M (O), 0.1 jiM (# )  and 0.3}iM (A) NA before addition of ACh
Points shown are mean ± s.e.m. (n=13).
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respectively) since a greater concentration was required to elicit a similar percentage 
relaxation (Figure 2.15). The sensitivity of the tissues for ACh-induced relaxations of 
0.03 and 0.1 [iM NA-induced tone was significantly greater (Student’s paired t test; 
P<0.05) than that for ACh-induced relaxations of 0.3|iM NA-induced tone.
Analysis of correlation for two dependent variables (namely induced tone (expressed 
as a percentage of the initial maximum contractile response to NA) and subsequent 
pICso values for ACh-induced relaxation) using pooled data showed an inverse 
correlation which was statistically significant (P<0.0005) (Figure 2.16a). A similar 
analysis of correlation for the same data but substituting the logi0 molar concentration 
of NA for values of induced tone, again showed an inverse correlation which was 
statistically significant (P<0.0005) (Figure 2.16b). These correlations indicate an 
apparent decrease in tissue sensitivity to ACh with increasing initial tone or with an 
increase in the concentration of NA causing that tone. Correlations of the data obtained 
for individual tissues showed a similar effect but the slopes of the correlation lines 
were most similar when the log10 molar concentration of NA was used (Figure 2 .17b) 
instead of the percentage of the control maximum contractile response (Figure 2.17a) 
(data for slopes not shown for clarity). An attempt was made to correlate tissue 
sensitivity to NA expressed as its pD2 (i.e. the negative log10 of the concentration of 
NA producing 50% maximal contraction) and the subsequent responsiveness of the 
tissue to ACh-induced relaxation. Responsiveness to ACh-induced relaxation was 
expressed in terms of the maximum relaxation of induced tone and as the sensitivity 
(pIC50) of the tissue to ACh. At each of the concentrations of NA used in the study to 
induce tone there was no statistically significant correlation between NA sensitivity and 
ACh responsiveness (Figure 2.18).
Phenylephrine
In this set of experiments the protocol used eliminated any possible variation in 
sensitivity of the intact vessels to ACh-induced relaxations with time. In tissues with
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F igure 2.15
Effect of increasing the degree of NA-induced tone on ACh-induced relaxations of 
rat aortic rings. Tone was induced with 0.03|J.M (O), 0.1p.M (# )  and 0.3p.M (A) 
NA.
Points shown are mean ± s.e.m. (n=13). Statistically significant differences 
between relaxant responses in the presence of 0.3|iM NA and 0.1 or 0.03fiM NA; 
* P<0.05, ** P<0.01, *** P<0.005 using paired Student’t t test.
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Figure 2.16
Correlation of sensitivity of intact aortic rings to ACh-induced relaxations of NA- 
induced tone expressed as the pIC50 for ACh (i.e. the negative log10 of the 
concentration of ACh producing 50% maximal relaxation) and the degree of 
induced tone expressed in terms of (a) a percentage of the initial control maximum 
response to NA and (b) the log10 molar concentration of NA used to induce the 
tone.
Points shown represent pooled data for n=13. Correlations in both (a) and (b) are 
statistically significant (P<0.01) for correlation of two dependent variables.
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Figure 2.17
Correlation of sensitivity of intact aortic rings to ACh-induced relaxations of NA- 
induced tone expressed as the pIC50 for ACh (i.e. the negative log10 of the 
concentration of ACh producing 50% maximal relaxation) and the degree of 
induced tone expressed in terms of (a) a percentage of the initial control maximum 
response to NA and (b) the logio molar concentration of NA used to induce the 
tone.
Points shown represent data for individual preparations (n=20).
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Figure 2.18
Correlation of tissue sensitivity to the contractile response of NA expressed as its 
pD2 and the subsequent responsiveness of the tissue to ACh-induced relaxation of 
tone induced by 0.03fiM (O), 0.1 fiM (# )  and 0.3|iM (A) NA expressed in terms 
of (a) the maximum relaxation of induced tone and (b) the sensitivity of the 
preparations to ACh (pIC50).
Points shown are mean ± s.e.m. (n=13). There was no statistically significant 
correlation between sensitivity to NA and responsiveness to ACh at any of the 
concentrations of NA used to induce tone. Values of the correlation coefficient (R) 
are shown above.
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an intact endothelium, ACh produced a concentration-dependent inhibition (relaxation) 
of PhE-induced tone. When the tissues were pre-contracted with various 
concentrations of PhE (0.1, 0.3, 1, 3, or 10|iM) to produce different degrees of tone, 
the relaxations to ACh varied with the degree of induced tone (Figure 2.19). When the 
concentration of PhE used was low (0.1 pM), the sensitivity of the tissue to ACh was 
high (pIC 50 = 7.27 ± 0.04). When the degree of PhE-induced tone was increased by 
increasing the concentration of PhE used to induce that tone (0.3, 1, 3 and 10}iM), the 
tissues were less sensitive to ACh (pIC50 = 7.09 ± 0.08, 6.76 ± 0.08, 6.83 ± 0.14 and 
6.80 ± 0.04 respectively) since a greater concentration was required to elicit a similar 
percentage relaxation (Figure 2.20). The sensitivity of the tissues to ACh-induced 
relaxation of lp.M and 3p.M PhE-induced tone was not significantly different from that 
for relaxation of tone induced by 10|iM PhE. However, the sensitivity to ACh- 
induced relaxation of 0.1 and 0.3 jiM PhE-induced tone was significantly greater than 
that for relaxation of lOqM PhE-induced tone (Student’s paired t test; P<0.05)
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Effect of increasing the degree of PhE-induced tone (by increasing the 
concentration of PhE used to induce that tone) on ACh-induced relaxations of intact 
aortic rings. Relaxations are expressed as (a) the ‘absolute’ effect (i.e. in terms of 
mg. wt.) and (b) the ‘proportionate’ effect (i.e. as a percentage reduction of the 
induced tone). The concentrations of PhE used to induce tone were; O.lfiM (O), 
0.3|iM (# ) , ljiM  (A) 3|iM  (A) and 10}iM (□). Single symbols in (a) represent 
the degree of tone induced by O.ljiM (O), 0.3|iM (# ) , lp.M (A) 3|iM (A) and 
10p.M (□) PhE before addition of ACh
Points shown are mean ± s.e.m. (n=6 ).
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F igure 2.20
Effect of increasing the degree of PhE-induced tone (by increasing the concentration 
of PhE used to induce that tone) on sensitivity to ACh-induced relaxations of intact 
aortic rings. Relaxations are expressed as a percentage of the maximum relaxation. 
The concentrations of PhE used to induce tone were; 0.1 (O ), 0.3|iM  (# ) ,
1|J.M (A) 3|iM (A) and 10|iM (□).
Points shown are mean ± s.e.m. (n=7).
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D iscussion
The method which we employed to cause functional disruption of the endothelium of 
the aortic ring segments was clearly effective since vessels in which the vascular 
endothelium had been disrupted showed no relaxation to ACh. In addition, the 
responses to contractile agents such as PhE were greater in preparations with a 
disrupted endothelium presumably indicating the removal of a basal release of EDRF 
with little damage to the underlying smooth muscle layer.
The basal release of EDRF has been shown to modulate the response of vascular 
smooth muscle to contractile agents (Martin et al., 1986; Bullock et al., 1986). 
Removal of this basal release of EDRF might change the resting tone of isolated blood 
vessels such that tissues with and without endothelium would be stretched to different 
degrees to achieve the same resting tension. This might contribute to differences in 
contractile response between tissues with and without endothelium. We found, 
however, that over a wide range of lengths, removal of the endothelium had no 
significant effect on the resting tension of the preparations. This is not surprising since 
the failure of sodium nitroprusside (IOjiM) to relax the preparations under resting 
conditions (data not shown) indicates that they have no resting tone under the 
conditions used in this study. However, this does indicate that in experiments where 
paired ring segments with and without endothelium are set at the same resting tension, 
the degree of stretch (and hence length) in each tissue is similar. This therefore, will 
not play a significant part in the difference seen in the responses to contractile agents in 
paired rubbed/unrubbed preparations of rat aorta. This might not remain true in other 
vascular smooth muscle preparations particularly if they have intrinsic tone or 
myogenic activity e.g. portal vein. A corollary of the lack of influence of the 
endothelium on resting tone is that pharmacological blockade of EDRF, like 
mechanical disruption, should not increase vessel tone per se. Thus contractions to 
haemoglobin (Martin et al., 1986) cannot be due solely to the loss of the effect of 
EDRF and may be at least partly attributable to an action of the haemoglobin leading to
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activation of the quiescent muscle. This may lead to errors in interpretation of the 
effects of haemoglobin since it has recently been shown that in preparations such as the 
dog portal vein (Furuta et al.„ 1988) and the whole perfused rat tail (Templeton et al., 
1988) activation of the smooth muscle uncovers a previously ‘unseen’ population of 
functional a 2-adrenoceptors. Activation of these receptors might contribute to the 
increase in contractility of the preparations which might be attributed wholly to the 
blockade of the basal release of EDRF by haemoglobin.
The response to lpM  PhE increased with increasing stretch and reached a maximum 
at the same degree of stretch in both rubbed and unrubbed preparations. Therefore the 
presence of a functional endothelium (and hence the basal release of EDRF) does not 
affect the optimal conditions (in terms of initial tension) for demonstration of the 
contractile effects of the ai-adrenoceptor agonist PhE. Thus, when paired rubbed and 
unrubbed preparations of rat aorta are set at the optimum resting tension for contraction 
of the rubbed preparation then the conditions (in terms of resting tension) will be 
equivalent in the unrubbed preparation or vice versa.
The contractile response to l|iM  PhE seen in the absence of endothelium was 
consistently greater than in the intact vessel. This was observed at all degrees of 
stretch measured. This clearly demonstrates that in the rat aorta the presence of the 
vascular endothelium depresses the contractile response to (Xi-adrenoceptor activation 
by PhE. This inhibition of contractility is presumably due to the basal release of EDRF 
which directly opposes the contractile response to PhE. However, whilst the initial 
length appeared to have no differential effect on the resting tension between rubbed and 
unrubbed preparations, the increase in contractility which was seen in the absence of 
endothelium was dependent on the initial tension of the preparation. In addition, the 
optimum stretch for demonstration of this difference varied with the manner in which 
the increase was expressed. The optimum length for demonstration of the ‘absolute’ 
difference in contractility to PhE (i.e. in terms of milligrams) was 2400|im whilst the 
optimum length for demonstration of the ‘proportionate’ difference in contractility to
110
PhE (i.e. as a percentage increase from the response seen in the intact vessel) was 
1500|im. Irrespective of the method used to express the increased contractility seen in 
the absence of the endothelium, the optimum length for demonstration of this 
phenomenon does not coincide with the optimum stretch for demonstration of the 
contractile response per se (summarised in Figure 2.21). Clearly, the higher the initial 
resting tone, and hence stretch, the less will be the apparent effect of the endothelium 
on the PhE-induced contractions particularly when the increase in response in the 
absence of a basal release of EDRF is expressed as a proportion of the response in the 
intact vessel. This may account, at least in part, for conflicting reports of the effect of 
the vascular endothelium on the contractility of vascular smooth muscle. The basis of 
this is not clear but it could be due to recruitment by stretch of cells resistant to EDRF, 
e.g. cells near the adventitia where the effect of EDRF are less apparent due a greater 
diffusion distance between the endothelium and the contracting smooth muscle cells. 
This effect however, is more probably due stretching causing an increased efficiency 
of excitation-eontraction coupling for agonist induced contraction thereby increasing 
the degree of contraction which the EDRF must overcome.
Demonstration of the relaxation produced by ljiM  ACh in the intact vessel was 
dependent on the initial length of the preparation. As with the demonstration of the 
influence of the vascular endothelium on contraction to PhE, the optimal conditions for 
demonstration of the ‘absolute’ and ‘proportionate’ relaxation (i.e. percentage 
relaxation of induced tone) to ACh did not coincide. The optimum stretch for 
demonstration of the ‘proportionate’ effect of ACh (1500|im) did not coincide with the 
optimum for PhE-induced contractions. However, the optimum stretch for 
demonstration of the ‘absolute’ relaxation (2400|im) did coincide with the optimum for 
PhE-induced contractions. This is presumably because at this length there is a greater 
absolute amount of tone that can be inhibited. However, it is common practice to 
express ACh-induced relaxations as a percentage of the induced tone and this is not 
optimised by the use of conditions optimal for contraction. This has several important
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Figure 2.21
Summary of study examining the effect of varying the initial degree of stretch, 
hence length, of rat aortic ring segments on the contractile response to l|iM  PhE 
and the subsequent relaxant response to lfiM  ACh in the presence of an intact 
endothelium. Diagram indicates the optimum degree of stretch for demonstration of 
contraction per se and the proportionate and absolute influence of both basal and 
stimulated release of EDRF.
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implications. When the responsiveness of different vessels to EDRF is examined 
either from different anatomical sites, from different species or from different patho­
physiological states, the resting tensions (hence length) at which the vessels are set is 
usually that at which the response to the contractile agent is at a maximum (Collins et 
aL, 1986; Christie and Lewis, 1987) or is entirely arbitrary, based on evolved practice. 
Clearly, since this resting length may not be ideal for ACh-induced relaxations, it may 
be unrealistic to compare differences in responsiveness to ACh-induced release of 
EDRF without evaluating the influence of the initial stretch or induced tone on 
relaxations.
Changes in the distension of small arteries of the rat causes a change in the sensitivity 
of vascular preparations to contractile agents (Nilsson and Sjoblom, 1985). If this 
were so in the case of the rat aorta then the differences in responsiveness to single 
concentrations of PhE and ACh with stretch might be due to a change in sensitivity of 
the preparation to PhE-induced contractions or ACh-induced relaxations. In addition, 
there may be a change with time of the effect of basal release of EDRF which could 
contribute to the apparent differences seen with increasing stretch. In the case of PhE 
however this is not so since the sensitivity of neither endothelium-intact nor disrupted 
vessels varied with resting tension or with time. Moreover, the effect of basal release 
of EDRF, when expressed in terms of an increase in sensitivity (pD2) to PhE in the 
rubbed preparation did not significantly change with time or increasing resting tension. 
Whilst the sensitivity of endothelium-intact preparations to ACh-induced relaxations 
did decrease slightly with time, there was no evidence for an influence of resting 
tension. It is unlikely that the decrease in sensitivity with time contributed a great deal 
to the differences in response to l|iM  ACh at each degree of stretch examined since the 
degree of relaxation to this near maximal concentration of ACh seen in the time 
controls varied only a small amount.
The sensitivity of rat aortic ring segments to ACh was also found to be dependent on 
the level of induced tone. We found that with increasing levels of tone (produced by
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increasing concentrations of NA) the sensitivity of the tissue to ACh-induced 
relaxations (expressed as its pIC50) decreased. This relationship was validated by the 
significant inverse correlations seen between the tissue sensitivity to ACh and either the 
level of induced tone produced by NA or the log10 molar concentration of NA used to 
induce that tone. By extrapolation to zero % of the correlation between the tissue 
sensitivity to ACh-induced relaxations and the level of induced tone produced by NA, 
(Figure 2.16a), it is possible to estimate the maximum possible sensitivity of the tissue 
to ACh (pIC50(max) = 7.87) i.e. the theoretical sensitivity of the tissue with no induced 
tone. It is interesting to note that slopes of the correlation lines between ACh 
sensitivity and degree of induced tone were most similar when the log10 molar 
concentration of NA was used (indicating the degree of ‘activation ‘ of the tissue) than 
when the percentage of the control maximum contractile response was used (indicating 
the degree of ‘responsiveness’ of the tissue). This shows a better ‘inter tissue’ 
correlation between ACh sensitivity and tissue ‘activation’ than tissue 
‘responsiveness’, suggesting that, with respect to induced tone the degree of 
‘activation’ (best represented by the concentration of agonist used assuming no change 
in agonist sensitivity) and not the degree of ‘responsiveness’ (i.e. absolute size of 
response) is more important in determining the subsequent sensitivity to ACh-induced 
relaxations. This suggestion is supported by the observation that whilst the size of 
contraction to 1|J.M PhE increases with increasing resting tension there is no 
concomitant decrease in sensitivity to ACh-induced relaxations (see below). Thus 
whilst the degree of ‘activation’ of the tissue remains the same i.e. the same 
concentration of PhE is used to induce tone (assuming no change in sensitivity) despite 
an increase in ‘responsiveness’ there is no change in sensitivity to the stimulated 
release of EDRF.
In order to exclude the possibility that this phenomenon of increasing sensitivity with 
decreasing tone was due to the use of NA, similar experiments were earned out using 
another, more specific aradrenoceptor agonist namely PhE. Since experiments
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earned out to examine the effect of resting tension on ACh sensitivity revealed a small 
variation in sensitivity with time the protocol used eliminated any time-dependent 
changes in sensitivity to ACh-induced relaxations of PhE-induced tone or PhE induced 
contractions. This again revealed a decrease in sensitivity to ACh-induced relaxations 
with increasing induced tone confirming the observations seen when NA was used to 
induce tone. However, there was a limit to the decrease in ACh sensitivity seen with 
increasing activation of the tissue by PhE (no further decrease when tone was induced 
by >lp.M PhE). This lack of effect of increasing the degree of activation on sensitivity 
to ACh-induced relaxations is somewhat surprising particularly since the maximum 
relaxation of the induced tone as a percentage of that tone decreased with the higher 
concentrations of PhE. This might suggest that the sudden increase in sensitivity with 
decreasing concentration of contractile agonist is at least partly due to the ACh-induced 
relaxations reaching a maximum ‘response’ (i.e. complete loss of the EDRE sensitive 
part of the induced tone) although the agonist induced release of EDRF is not itself yet 
at a maximum: thus there is merely an illusion of change in sensitivity. The 
observation that ACh is unable to produce complete relaxation even when the 
concentration of agonist used to induce a sustained contraction is very low supports 
this view. The ‘EDRF resistant’ component of agonist induced contraction may be due 
to an inability of EDRF to reach the outer contracted layers of the blood vessel. Since 
EDRF is a highly labile substance (half life 6-80 seconds; see General Introduction) 
there would presumably be a limit to the distance that released EDRF could diffuse 
through the smooth muscle cells of the blood vessel wall from the intimal layers, 
closely associated with EDRF’s site of production, to the outer adventitial layers. This 
resistance of the outer layers of a blood vessel to the influence of EDRF might produce 
a differential effect of basal release of EDRF on contractile agents if the agent causes a 
preferential activation of the adventitial rather than intimal layers of the vessel wall. In 
addition it is reasonable to expect vessels with a thinner wall to be more susceptible to 
both the stimulated and basal release of EDRF.
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In a study described later in this thesis, (see Chapter 3), where the endothelium of 
aortic ring segments was intentionally damaged to varied degrees such that the 
responsiveness of ring segments to ACh-induced relaxations varied, the sensitivity of 
the tissue to contractile agents showed an inverse, statistically significant correlation 
with the responsiveness to ACh-induced relaxations. In the present study the lack of a 
significant correlation between the sensitivities of the tissues to NA-induced 
contractions and subsequent ACh-induced relaxations indicates that the basal release of 
EDRF (and hence the integrity of the endothelium) in the preparations used in this 
study is consistent and therefore this plays no significant role in the difference in 
sensitivity observed at different levels of induced tone. There was, therefore, no 
evidence that variation in the spontaneous release of EDRF was a major factor 
determining the sensitivity to NA.
In conclusion, differences seen in the quantitative demonstration of both the basal 
and stimulated release of EDRF may be, at least in part, a result of the experimental 
protocol used to examine these phenomena. The resting tension of the tissue (hence 
length) is an important determinant in the demonstration of the effects of spontaneous 
or induced release of EDRF. Even within the same tissue the optimum conditions for 
demonstration of these different relaxant effects or of contractile effects do not 
necessarily coincide and are dependent upon how the data is expressed. In addition, 
the degree of induced tone can influence the perceived effects of stimulated release of 
EDRF. The apparent sensitivity of the tissue is altered when different levels of 
induced tone are employed and this may obscure any real changes in sensitivity to 
agents releasing EDRF. This apparent change in sensitivity may be due, at least in 
part, to the relaxation to agonist-induced release of EDRF appearing to reach a 
maximum at a concentration of agonist lower than that needed to produce a maximal 
release of EDRF per se. This may occur even if the maximum relaxation induced is 
less than 100% of the induced tone since there is likely to be a component of the 
induced tone that is resistant to endothelium-dependent relaxation.
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These factors may account for the variations in interpretation of the role of EDRF 
between different vessels, pre-treatments and laboratories. The conditions used to 
compare vessels from different species or in different patho-physiological states, 
should be carefully chosen to ensure optimum demonstration of the effects of basal, 
and stimulated, release of EDRF. There is no simple prescription for this. The 
protocol may need to vary in order to optimise the particular phenomenon under 
analysis. Alternatively, and perhaps more satisfactorily, the vessels to be compared 
may be suspended under conditions where the transmural pressure in each vessel is the 
same or at a physiological level for each tissue being examined (Mulvaney & Halpem, 
1986; Cocks & Angus, 1986). With respect to the level of induced tone used to 
examine the effects of stimulated release of EDRF, it seems advisable to use a 
concentration of agonist which produces a sufficient level of tone such that there would 
be no decrease in the sensitivity to agonist induced release of EDRF if a higher 
concentration of contractile agent were used. This would ensure that the apparent 
sensitivity to EDRF release is not affected by a component of the induced tone resistant 
to released EDRF.
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Chapter Three
The influence of the endothelium on 
5HT-induced responses of the rat aorta.
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Introduction
An intact endothelial cell layer has been shown to have a marked depressant effect 
on the response of a variety of vascular smooth muscle to spasmogens (Criscione et 
al., 1984; Carrier and White, 1985; Angus et al., 1986; Calvette et al., 1984). Egleme 
et al. (1984) showed that in the absence of the endothelium the response of the rat aorta 
to the c^-adrenoceptor agonist clonidine was enhanced much more markedly than was 
the response to the relatively selective -adrenoceptor agonist PhE. This suggested 
that in the presence of endothelium, an 0C2-adrenoceptor stimulated release of EDRF (a 
phenomenon seen in canine and coronary arteries; Cocks and Angus, 1983), directly 
opposed the contractile effects of the agonist. This suggestion was somewhat 
controversial since the authors showed no evidence for clonidine-stimulated release of 
EDRF in the absence of its contractile effects. Furthermore there was evidence 
indicating that o^-adrenoceptors mediating release of EDRF were not present in the rat 
aorta since the relatively specific a 2-adrenoceptor antagonist rauwolscine did not 
produce the potentiation of a-adrenoceptor mediated contractile responses seen 
following disruption of the endothelium (Lues and Schumann, 1984).
Studies examining the effect of removal of vascular endothelium on smooth muscle 
cGMP levels (Rapaport and Murad, 1983; Bigaud et al., 1984), superfusion 
experiments (Griffith et al., 1984) and the effect of haemoglobin (Martin et al., 1985a 
and b) provided evidence for the existence of a tonic, basal release of EDRF which, in 
preparations with an intact endothelium, produced an elevation of tissue cGMP levels 
and depression of contractile responses (effects which could be blocked by inhibitors 
of EDRF). Subsequently, Martin et al., (1986) suggested that this difference was 
more probably due to spontaneously released EDRF depressing the contractions 
induced by the agonist of lower efficacy, namely clonidine, to a greater extent than the 
contractions to PhE. Despite the observations of Lues and Schumann (1984), Bullock 
et al., (1986) did find an 0C2-adrenoceptor mediated release of EDRF in this tissue but
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suggested that the spontaneous release of EDRF accounts for most of the inhibitory 
effect of the endothelium on depression of contractile agents.
Thus there are two ways in which EDRF may reduce the response to contractile 
stimuli. Firstly, the basal release of EDRF may directly depress agonist induced 
contractions. For example the Ca2+ channel activator Bay K 8644 does not induce 
endothelium-dependent relaxations but Bay K 8644-induced contractions are inhibited 
by basal release of EDRF (Spedding et al., 1987). Secondly, in addition to the basal 
release of EDRF depressing agonist induced contractions, the agonist itself may evoke 
release of EDRF which will directly oppose the contractile effects of the agonist. For 
example a 2-adrenoceptor agonists such as UK 14304 stimulate the release of EDRF 
even though the basal release of EDRF plays a major role in the depression of the 
contractions induced by these agonists (Bullock et al., 1986; Spedding, et al., 1987).
5-Hydroxytryptamine (5-HT), has been shown to produce contractions of a variety 
of vascular smooth muscle preparations including; rat mesenteric bed (Criscione et al., 
1984); dog saphenous vein (Feniuk et al., 1985); bovine coronary arteries (Kaumann 
and Frenken, 1985); aorta from the rabbit (Apperley et al., 1976) and rat 
(Krishnamurty, 1971; Forster and Whalley, 1982); and human basilar artery (Forster 
and Whalley, 1982). In many instances these contractions have been shown to be 
mediated via the 5-HT2 receptor subtype (Cohen et al., 1981 and 1983). In addition, 
5-HT can produce both endothelial dependent and independent relaxations of vascular 
smooth muscle (Cocks and Angus, 1983; Cohen et al., 1983; Feniuk et al., 1983; 
Mecca and Webb, 1984; Trevethick et al., 1984). In some preparations (e.g. the rat 
mesenteric bed) under appropriate conditions both the relaxant and contractile response 
to 5-HT can be demonstrated (MacLennan and Taylor, 1984). In other tissues both 
relaxant and contractile responses can be shown to be mediated by different 5-HT 
receptor subtypes (Houston and Vanhoutte, 1988).
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In the rat aorta I have found that 5-HT-induced contractions of the vascular smooth 
muscle are depressed by the presence of an intact endothelial cell layer (see Chapter 
One). To determine if the spontaneous release of EDRF is the main cause of the 
inhibitory effect of the endothelium I have examined the relative effects of the presence 
of a functional endothelium on contractions induced by 5-methyltryptamine (5-MeT), 
N-methyl-tryptamine (N-MeT), and 5-carboxamidotryptamine (5-CT). These 5-HT 
receptor agonists have a lower intrinsic activity than 5-HT and have been reported as 
having a lower relative efficacy at 5-HT2-receptors (Clancy and Maayani, 1985; Cory 
e ta i ,  1986).
In order to determine whether a concomitant, stimulated release of EDRF directly 
opposing the contractile response contributes to the depression of 5-HT receptor- 
induced contractions I decided to compare the relaxant effects of 5-HT and 5-CT in the 
rat aorta. In addition to its contractile effect, 5-CT is a potent agonist at 5-HTr like 
receptors which mediate relaxation of vascular smooth muscle (Feniuk et al, 1984; 
Trevethick et al, 1986) and therefore it is possible that any depression of 5-CT-induced 
contractions may be at least partly due to a receptor mediated, concomitant release of 
EDRF which directly opposes the contractile effects of the agonist.
The results obtained indicate that the depression of 5-HT-induced contractions are 
wholly dependent on the basal relesae of EDRF since in this tissue, endothelium 
dependent relaxations are not induced by 5-HT or 5-CT.
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Methods
Aortic ring segments (2-3mm) were prepared from male Wistar rats (250-300 g. 
wt.) as described earlier (see General Methods). When required the endothelial cell 
layer of the preparations was removed by inserting the bent tip of a pair of forceps into 
the lumen and gently rubbing the intima whilst rolling the ring segment back and forth 
over a finger moistened with Krebs’ solution. The presence or absence of a functional 
endothelium was later demonstrated by the ability or inability of I jiM acetylcholine 
(ACh) to relax the vessel pre-contracted with lpM  PhE.
Surgical thread was carefully passed through the lumen of the ring segments 
forming a stirrup. This was then used to suspend the preparation between an isometric 
force transducer and a wire support in a 10ml isolated organ bath containing Krebs’ 
solution maintained at 37°C (see General Methods).
The Krebs’ solution used throughout this study had the composition described in 
the General Methods. The solution was continuously aerated with a gas mixture of 
95% 0 2 and 5% C 0 2 and maintained at 37°C . In order to increase the potency of the 
5-HT-receptor agonists the Krebs’ solution used also contained 0.1 jiM Panuramine (a 
neuronal 5-HT-uptake blocker; Blurton e ta l ., 1984). Preliminary studies showed that 
0.1-lpM  desmethylimipramine (to block extra-neuronal uptake), 10-100fiM iproniazid 
(to block mono-amine oxidase), or a combination of both agents had no facilitatory 
effect on the contractions to 5-HT. However, panuramine at the optimal concentration 
of 0.1 |iM, produced a small (4-fold) leftward shift in the concentration-response curve 
to 5-HT without producing a contraction per se.
Paired ring segments were used in all experiments. One ring of each pair was left 
intact whilst the endothelial cell layer of the other was disrupted by rubbing.
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Contractile Effects
Cumulative concentration-response curves (CCRC) to either 5-HT, N-MeT, 5-MeT, 
or 5-CT were obtained. Each tissue was again washed and left for a further 45 
minutes prior to obtaining a CCRC to 5-HT.
Relaxant Effects
For relaxation studies, after the demonstration of either the absence or presence of 
an endothelium-dependent relaxation to ACh and therefore the functional state of the 
endothelium, tissues were incubated in Krebs’ solution containing ketanserin (lfiM) 
for the remainder of the experiment. This was done in order to prevent any contraction 
mediated by 5-HT2 receptor activation. After a period of 45 minutes the tissues were 
precontracted to approximately lOOOmg. wt. tension using 10|iM PhE (a high 
concentration of PhE was needed since lpM  ketanserin also blocks a-adrenoceptors) 
prior to cumulative addition of either 5-HT or 5-CT- and relaxations measured. All 
tissues were then washed according to the above schedule and allowed to equilibrate 
for a further 45 minutes in the presence of either lfiM methysergide (to block any 5- 
HT receptors (5-HTrlike) remaining after blockade by ketanserin), 10|iM pindolol (to 
block any relaxations induced by (3-adrenoceptors or 5-HTr like receptors; Middlemiss 
et al., 1977), 3p.M indomethacin (to block any involvement of cyclo-oxygenase 
products), or lp.M imiloxan (to block any relaxations due to a 2-adrenoceptor 
stimulation; Cocks and Angus, 1985) before repeating the cumulative concentration 
response curve to the agonist previously used in that preparation.
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Analysis of Data
The potencies of the 5-HT agonists were estimated as the pEC50 value for each 
agonist, i.e. the negative log10 Molar concentration of the agonist producing 50% of its 
maximum response. For analysis of the effect of removal of the vascular endothelium, 
differences in agonist potency between rubbed and unrubbed preparations were 
expressed as A pEC50 values where:
A pECso = pECso ( r u b b e d )  pEC50 ( u n r u b b e d )
Differences in the maximum response of each agonist between rubbed and unrubbed 
preparations were expressed as A Max Response (%) values, i.e. the difference in 
maximum response expressed as a percentage of the maximum response in the 
unrubbed preparation:
A Max Response (%) = ((Max(unnibbc<J) - Max(mbbed)) / Max(rubbe<1)) x 100
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Results
Contractile Effects
In rat aortic ring segments with an intact endothelial cell layer l(iM ACh produced a 
57 ± 3.6% (n=28) reduction of tone induced by l(iM PhE. In preparations where the 
endothelium had previously been disrupted by rubbing, identical treatment caused 0.9 
± 0.5% (n=28) reduction in induced tone (Figure 3.1).
5-HT (0.01-300|uM), N-MeT (l-300 |iM ), 5-MeT (1-1000^M), and 5-CT (1- 
lOOOfiM) each caused concentration-dependent contractions of rat aortic ring segments 
both in the absence, and presence, of an intact endothelial cell layer, i.e. in rubbed and 
unrubbed preparations (Figures 3.2 and 3.3). Each agonist, with the exception of N- 
MeT which was examined only up to 300pM, caused a depression of the contractile 
response at high concentrations both in rubbed and unrubbed preparations. This 
depression of contractile response was particularly evident for 5-CT-induced 
contractions but was seen for the response to N-MeT only in the unrubbed preparation 
(Figures 3.2b and 3.3b). In the unrubbed preparations the intrinsic activity for 
contraction of each agonist used relative to 5-HT (i.e. maximum response to agonist 
divided by maximum response to 5-HT) was; 5-HT (1.00) > N-M eT (0.70 ± 0.04) 
> 5-M eT (0.67 ± 0.03) > 5-CT (0.44 ± 0.08), (Figure 3.4 and Table 3.1).
The potency of the agonists to induce contractions in aortic ring segments, as 
indicated by the pEC50 i.e. the negative log10 of the concentration of agonist producing 
50% of its maximum response, was significantly greater (Student’s unpaired t test; 
P<0.05) in the rubbed preparations for all agonists tested when compared to the 
potency in the unrubbed preparation (Figure 3.5 and Table 3.1). In terms of 
differences in agonist potency (pEC50) between the rubbed and unrubbed preparations 
(A pEC50), the effect of removal of the endothelium on the responses to the agonist 
tested was in the order 5-M eT (0.75 ± 0.09) > 5-CT (0.59 ± 0.12) > 5-HT (0.48 ±
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Figure 3.1
Representative trace showing contractile response to l(iM PhE (A) and the relaxant 
response to ljiM  ACh (▼) in aortic ring preparations with (a) an intact endothelium 
and (b) a disrupted endothelium.
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Figure 3.2
Effect of increasing concentrations of (a) 5-HT and (b) N-MeT on the rat aorta. 
Points shown are the mean contractile response (mg. wt.) ± s.e.m. (n=6-15) in 
paired preparations with an intact endothelium ( # )  and after disruption of the 
endothelium by gentle rubbing (O).
Statistically significant difference between contractile response in the rubbed and
unrubbed preparation; * P<0.05, ** P<0.01, *** P<0.005, using unpaired
Student’s t test.
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Figure 3.3
Effect of increasing concentrations of (a) 5-MeT and (b) 5-CT on the rat aorta. 
Points shown are the mean contractile response (mg. wt.) ± s.e.m. (n=6-15) in 
paired preparations with an intact endothelium ( # )  and after disruption of the 
endothelium by gentle rubbing (O)-
Statistically significant difference between contractile response in the rubbed and 
unrubbed preparation; * P<0.05, ** P<0.01, *** P<0.005, using unpaired 
Student’s t test.
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Figure 3.4
Effect of increasing concentrations of 5-HT (OX N-MeT (# ) , 5-MeT (A) and 
5-CT (A) on preparations of the rat aorta with an intact endothelium.
Points shown are the mean contractile response (mg. wt.) ± s.e.m. (n=6-15).
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U n ru b b ed  R ubbed
Agonist Potency (pEC50) A pEC50 Intrinsic Activity
5-HT
5-CT
5-MeT
N-MeT
6.13 ±0.07  
4.36 ± 0.06 
4.29 ± 0.05 
4.90 ± 0.09
6 .6 0 1 0 .1 0  
4.95 ± 0.09 
5.03 ± 0.12 
5.35 ±0 .12
*
* *
0.48 ± 0.11 
0.59 1 0 .1 2  
0.75 ± 0.09 
0.45 ± 0.09
1.00 
0.44 ± 0.08 ++' 
0.67 ± 0.03 m 
0.70 ± 0.04 +++
Max Response (mg)
5-HT 845.5 ± 41.4 1086.3 ±
5-CT 455.2 ± 53.7 837.4 ±
5-MeT 550.3 + 40.7 934.7 +
N-MeT 605.0 ± 48.7 940.7 ±
A Max (%) Intrinsic Activity
33.7 ± 9.3 1 . 0 0
141.4 ± 24.3 t+ 0.44 ± 0.08 m
70.6 ± 14.7 f 0.67 ± 0.03 tft
59.0 ± 13.0 + 0.70 ± 0.04 t++
Table 3.1
Effect of removal of the endothelial cell layer of rat aortic ring segments on the 
potency of each 5HT receptor agonist (expressed as its pEC50) and maximum 
contractile response (expressed in mg.wt.).
Differences between rubbed and unrubbed preparations are shown as A pEC50 
for potency (i.e. pEC5o(lubbe<i) ■ pEQo (unmbbed)) and as A Max (%) for the maximum 
response (i.e. ((Max(unrubbc<j) - Max(rubbed)) / Max(rubbe<i)) x 100).The values shown 
for the unrubbed and rubbed vessel are the means ± s.e.mean for n=6-15.
Significant differences from unrubbed preparation using Student’s unpaired t- 
test: * P<0.05, ** P<0.01, *** P<0.005; and for differences from 
corresponding value for 5-H T ,+ P<0.05,++ P<0.01,+t+ P<0.005
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Figure 3.5
The effect of removal of the endothelium of rat aortic rings on the potency (pEC50) 
of 5-CT, 5-MeT, N-MeT and 5-HT.
Data shown represents mean pEC50 values ± s.e.m. (n=6-15) in preparations with 
an intact (# )  and disrupted (O) endothelium. Statistically significant differences 
between potency in rubbed and unrubbed preparations using unpaired Student’s t 
test; * P<0.05, ** PcO.Ol, *** P<0.005.
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0.11) > N-M eT (0.45 ± 0.09). The difference in potency for 5-MeT, 5-CT and N- 
MeT was not significantly different from that for 5-HT (P>0.05; Figure 3.6). 
Moreover, there was no statistically significant difference between the values of A 
pEC50 for 5-CT, 5-MeT or N-MeT. An attempt to correlate the A pEC50 values and 
relative intrinsic activity for each agonist tested using analysis of correlation for two 
dependent variables showed no statistically significant correlation (P>0.05; Figure 
3.7).
In addition to the changes in agonist potency between rubbed and unrubbed 
preparations, the maximum response of the rat aorta to all the agonists tested was 
significantly greater in the preparation with a disrupted endothelium than the intact 
preparation (Student’s unpaired t test; P<0.05; Figures 3.8 and Table 3.1). In the 
absence of the endothelium the maximum responses to N-MeT, 5-MeT, and 5-CT 
were similar though still smaller than that to 5-HT itself (Figure 3.9). With respect to 
the difference in maximum response between rubbed and unrubbed preparations 
(expressed as a percentage of the maximum response in the unrubbed preparation, i.e. 
A Max (%)) the effect of removal of the endothelium on the responses to the agonists 
tested was in the order; 5-C T (141.4 ± 24.3) > 5-M eT (70.6 ± 14.7) > N -M eT  
(59.0 ± 13.0) > 5-HT (33.7 ± 9.3). The value of A Max (%) for N-MeT, 5-MeT and 
5-CT was significantly greater than that for 5-HT (P<0.05; Figure 3.10). In addition 
the value of A Max (%) for 5-CT was significantly greater than that for N-MeT and 5 
MeT though there was no statistically significant difference between the values of A 
Max Response (%) for N-MeT and 5-MeT. An analysis of correlation between A Max 
Response (%) and relative intrinsic activity for each agonist tested) showed a 
statistically significant correlation (Student’s unpaired t tesr, P<0.001; Figure 3.11).
Analysis of correlation between percentage reduction of lfiM  PhE-induced tone by 
l|iM  ACh (i.e. the ‘marker’ of a functional endothelium) and subsequent potency 
(pEC50) of 5 -HT-receptor agonists in the same preparation) showed statistically 
significant correlations (using Student’s paired t test) for 5-HT (0.0025>P>0.001) and
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Figure 3.6
The difference in potency between rubbed and unrubbed preparations expressed as 
values of A pHC50 for 5-CT, 5-MeT, N-MeT, and 5-HT.
Data shown represents mean A pBC50 values ± s.e.m. (n=6-15). There was no 
statistically significant difference between values of A pEC50 for 5-CT, 5-MeT and N- 
MeT compared to that for 5-HT using unpaired Student’s t test (P>0.05).
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Figure 3.7
Correlation of difference in potency (ApEC50) between rubbed and unrubbed 
preparations of rat aorta for 5-CT, 5-MeT, N-MeT and 5-HT and the intrinsic 
activity of each agonist relative to 5-HT.
Points shown represent mean data for n=6-15. There was no statistically significant 
correlation for correlation of two dependent variables (P>0.05; Student’s unpaired t 
test). CoiTelation coefficient (R) is shown above.
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Figure 3.8
The effect of disruption of the endothelium of rat aortic rings on the potency (pEC50) 
of 5-CT, 5-MeT, N-MeT and 5-HT.
Data shown represent mean maximum response (mg. wt.) ± s.e.m. (n=6-15) in 
preparations with an intact (open bars) and disrupted (filled bars) endothelium. 
Statistically significant differences between maximum response in rubbed and 
unrubbed preparations using unpaired Student’s t test; * P<0.05, ** P<0.01, *** 
P<0.005.
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F igure 3.9
Effect of increasing concentrations of 5-HT (O), N-MeT (# ) , 5-MeT (A) and 5- 
CT (A) on preparations of the rat aorta following disruption of the endothelium by 
gentle rubbing.
Points shown are the mean contractile response (mg. wt.) ± s.e.m. (n=6-15).
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Figure 3.10
The difference in maximum contractile response to 5-CT, 5-MeT, N-MeT, and 5-HT 
between rubbed and unrubbed preparations expressed as a percentage of the 
maximum contraction in the unrubbed preparation (A Max Response (%)).
Data shown represents mean A Max Response (%) ± s.e.m. (n=6-15). Statistically 
significant differences between values of A Max Response (%) for 5-CT, 5-MeT an 
N-MeT compared to that for 5-HT; + P<0.05, '+ P<0.01, P<0.005 using unpaired
Student’s t test.
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Figure 3.11
Correlation of difference in maximum response (A Max Response (%)) between 
rubbed and unrubbed preparations of rat aorta for 5-CT, 5-MeT, N-MeT and 5-HT 
and the intrinsic activity of each agonist relative to 5-HT.
Points shown represent mean data for n=6-15. Correlation was statistically 
significant for correlation of two dependent variables (P<0.01; Student’s unpaired t 
test). Correlation coefficient (R) is shown above.
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5-CT (P<0.0005). The analysis showed an inverse correlation indicating that with an 
increase in the degree of ACh-induced relaxation there was a decrease in the 
subsequent potency of both 5-HT and 5-CT (Figure 3.12)
Relaxant Effects
In the presence of lqM  ketanserin, high concentrations of 5-HT and 5-CT relaxed 
PhE-induced contractions of the rat aorta. These relaxations were similar in both intact 
and endothelium-disrupted rings (Figure 3.13) and were unaffected by the presence of 
lfiM methysergide, 10|uM pindolol, 3|J.M indomethacin, or I jiM imiloxan (Figure 
3.14).
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Figure 3.12
Correlation of percentage reduction of lp.M PhE-induced tone by lp.M ACh and 
subsequent potency (pEC50) for (a) 5-HT and (b) 5-CT in the same preparation.
Points shown represent data for n=24. Correlations in both (a) and (b) are 
statistically significant (P « 0 .0 1 ) for correlation of two dependent variables. 
Correlation coefficients (R) are shown above.
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D iscussion
The aim of this study was to examine the effects of the vascular endothelium on the 
responses of the rat aorta to 5-HT-receptor agonists. In order to do this I have 
compared the relative effects of removal of the endothelium on contractions induced by 
5-HT receptor agonists which were known to have different relative efficacies (Clancy 
and Maayani, 1985; Cory et al., 1986).
In the unrubbed preparation, examination of the different maximum contractions 
produced indicates that the agonists used had low intrinsic activities relative to 5-HT 
since the order of magnitude of maximum response was 5-HT > N-MeT > 5-MeT > 
5-CT. Therefore, assuming 5-HT to be a ‘full’ agonist with an intrinsic activity of 
one, 5-CT, 5-MeT, and N-MeT were found to be ‘partial’ agonists using the criteria of 
relative maximum responses (see Ruffolo, 1982). This is, however, likely to be an 
over simplification since each agonist had a bell shaped CCRC suggesting that they 
caused a depression of their own contraction at high concentrations: this was 
particularly evident for 5-CT. Therefore, it is possible that if this relaxation was not 
present or could be blocked by some pharmacological intervention each of the ‘partial’ 
agonists would be able to produce a maximum response similar to 5-HT, and would 
therefore be ‘full’ agonists of low potency. In other words the agonists may appear to 
be ‘partial’ due to depression of the maximum response by an unknown mechanism 
which is particularly evident for agonists of low potency since the depression occurs at 
a concentration at which the agonist has not yet produced its maximum possible 
contractile response. In addition to errors in the estimation of intrinsic activity this 
depression of response at high concentration would greatly affect the measure of 
potency of the agonists in the tissue since a true EC50 could not be obtained.
5-HT and 5-CT are known to produce receptor-mediated relaxations in other 
examples of vascular smooth muscle by activation of 5HTr like receptors (Feniuk et al, 
1983; Trevethick et al, 1984). In this tissue, however, both 5-HT and 5-CT produced
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endothelium -independent which were not mediated by 5HTr like receptors, 
prostaglandins or 0C2-adrenoceptor relaxations at high concentrations and it would seem 
reasonable to assume that this effect is responsible for the depression of response for 
each 5-HT receptor agonist described above. A similar phenomenon has recently been 
reported by Houston and Vanhoutte (1988) in the canine coronary artery. It is unlikely 
that the relaxant effects of 5-HT and 5-CT in the rat aorta and canine coronary artery 
are comparable since a much higher concentration of agonist is needed in the rat tissue 
to produce similar sized responses. However, the relaxant responses in the canine 
coronary artery were highly sensitive to methiothepin and therefore the use of this 
antagonist in the rat aorta would clarify the situation. Since the effect in the rat aorta 
could not be blocked by the antagonists which I tested and therefore, I was unable to 
examine the contractile response of each agonist outside the influence of this relaxatory 
effect, the estimation of the intrinsic activities of the agonists are the best available.
The change in agonist potency that occurs due to removal of the endothelium (A 
pEC50) appears to bear no relationship to either the potency or the intrinsic activity of 
the agonist in the unrubbed preparation. With respect to changes in agonist potency 
the rank order of the effect of removal of the endothelium was
5-MeT > 5-CT > 5-HT > N-MeT,
whilst the rank orders of agonist potency and relative intrinsic activity in the intact 
preparation were
5-MeT < 5-CT < N-MeT < 5-HT
and
5-CT < 5-MeT < N-MeT< 5-HT
respectively. Moreover, there was no statistically significant difference between values 
of A pEC50 for the agonists tested compared to 5-HT or each other (P>0.05). Also, 
analysis of correlation between A pEC50 values and relative intrinsic activity of each 
agonist was not statistically significant (P>0.05; Student’s unpaired t test).
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The difference in the maximum response between rubbed and unrubbed preparations 
to 5-HT, N-MeT, 5-MeT, and 5-CT due to removal of the endothelium is inversely 
related to the intrinsic activity of the agonist used. When this difference was expressed 
as A Max Response (%), i.e. ((Max(unrubbed) - Max(nibbed)) /  Max(rubbcd)) x 100) the rank 
order of the effect of removal of the endothelium was
5-CT > 5-M eT > N-M eT > 5-H T
This corresponds to the rank order of the agonist relative intrinsic activity in the intact 
vessel. Moreover there was a statistically significant inverse correlation between 
values of A Max Response (%) and the relative intrinsic activity for each agonist. 
Therefore, the lower is the intrinsic activity of the agonist (i.e. the greater degree of 
‘partiality’ that it exhibits), then the more marked is the effect of the removal of the 
endothelium on its maximum response.
Assuming that the magnitude of the ACh-induced relaxation of tone is an indicator 
of the amount of functional endothelium present then it would be reasonable to expect 
that the greater the degree of this relaxation then the greater will be the amount of 
basally released EDRF. Since the removal of a basal release of EDRF induces a 
significant increase in the potency of contractile agents, preparations showing a poor 
relaxant response to ACh would be expected to show a relatively greater sensitivity to 
contractile agonists than preparations were there was a good relaxatory response to 
ACh. We have found this to be the case in this study. There was a statistically 
significant correlation between the relaxation of 1|J.M PhE-induced tone by lpM  ACh 
at the start of each experiment (used as an indicator of the presence of a functional 
endothelium) and the subsequent potency of both 5-HT and 5-CT. Thus, if the 
conditions are standardised the magnitude of relaxation of PhE-induced tone by ACh (a 
measure of the viability of the endothelium) can be used as an indicator of the 
subsequent potency of contractile agonists and conversely the less sensitive the tissue 
is to contractile agonists the more viable the endothelium.
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In conclusion, I have found: 1) no evidence for a 5-HT receptor-m ediated release of 
ED R F in the rat aorta. The depression o f the contractile  response to these 5-HT 
receptor agonists in the presence of the endothelium  can be accounted for solely by the 
influence o f a basal release o f EDRF. Thus, there is no concom itant, 5-H T receptor- 
stim ulated release o f ED RF which could oppose the contractile effects o f the agonist; 
2) The response o f  the pre-contracted  aortic ring segm ents to A Ch can, in certain 
circum stances, give a good indication o f the am ount o f functional endothelium  present 
in the vessel and m ight allow prediction o f the sensitivity o f  that vessel to an agonist 
subsequently  adm inistered; 3) A lthough the rem oval o f the endothelium  caused an 
increase in the sensitiv ity  o f this vascular preparation to all o f  the 5-H T recep tor 
agonists tested, the m agnitude o f this increase bore no relationship to the sensitivity o f 
the in tact vessel to that agonist nor to the intrinsic activity o f that agonist. In contrast 
how ever, I found  tha t the  inh ib ito ry  e ffec t o f the endo the lium  on m axim um  
contractions induced by 5-H T receptor stimulation was inversely related to the intrinsic 
activity  o f the agonists used, i.e. the greatest effect was seen w ith agonists o f low er 
efficacy.
Thus, it appears that as in the case o f a -a d re n o ce p to r  s tim u la ted  con tractions, 
spon taneous re lease  o f E D R F largely  accounts for the inh ib ito ry  e ffec t o f  the 
endo thelium  on contractions induced by agonists acting at 5-H T receptors and the 
m agnitude o f the depression  o f contractile reponses is inversely  dependent on the 
intrinsic activity o f the agonist itself in the intact vessel.
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Chapter Four
Classification of the muscarinic receptor subtype 
mediating endothelium-dependent relaxations of the rat aorta.
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In tro d u c tio n
Prior to a report by Jelliffe (1962), which dem onstrated A C h-induced relaxations of 
rabb it descend ing  thoracic  aorta , the response  to A C h in this p repara tion  was 
contractile  in nature (Furchgott and Bhadrakom , 1953; Furchgott, 1955). In 1980 
Furchgott and Zaw adzki showed that these ACh-induced relaxations were abolished in 
preparations in w hich the endothelial cell layer had been d isrup ted  by rubbing  the 
intim al layer o f the vascular preparations. This partly explained the paradox that whilst 
A Ch induced a depressor response in vivo , A C h-induced vasodilatation could  not be 
dem onstrated  in vitro and im plied the presence o f cholinoceptors on the endothelium  
m ediating the relaxant response to ACh in the intact vessel. The estim ated KB value for 
the cho linocep tor antagonist atropine (0.35 ±  0.04nM ) and the rela tive po tencies o f 
ACh, m ethacholine and carbachol to inhibit or induce these relaxations indicated  that 
the cho linocep tor m ediating endothelium -dependent relaxations is o f the m uscarinic 
subtype. Since this tim e A Ch-induced, endothelium -dependent relaxation o f  a num ber 
o f vascular preparations has been reported (see General Introduction).
T he m uscarin ic  recep to r has been p roposed  to ex ist in a num ber o f  subtypes 
(H irschow itz et al ., 1984). The m uscarinic receptor antagonist pirenzepine has been 
used to  d iscrim inate betw een tw o m uscarinic receptor sub-classes in both functional 
and binding studies: high affinity for receptors in the cerebral cortex and sym pathetic 
gang lia , M lf and low  affin ity  for receptors in the atria, ileum  and o ther sm ooth 
m uscles, M 2, (G oyal and Rattan, 1978; Brown et al., 1980 and 1984; H am m er et  al., 
1980; H am m er and G iachetti, 1982; W atson et al., 1983; Eglen and W hiting, 1986). 
In addition, the M 2-receptor subtype can be further subdivided into atrial and sm ooth 
m uscle receptors on the basis o f differential antagonist affinities in functional studies. 
Thus, an tagon ist (ligand) affin ities suggest that m uscarin ic cho linocep tors can be 
subdivided into at least three subtypes (Birdsall and Hulm e, 1983).
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M uscarinic receptors m ay also be differentiated according to the effector system  to 
w hich the recep to r is coupled. H arden et al. (1986) have suggested  that the M, 
m uscarin ic  recep to r m ay be coupled  to inosito l phospho lip id  hydro lysis  via a 
regulatory Np protein whilst the M 2-receptor m ay be coupled to inhibition of adenylate 
cyclase by the regulatory Nj protein. This proposed receptor-effector linkage is likely 
to be an over sim plification since there have been reports that the M r  and M 2-receptors 
m ay be coupled  to both effector system s (Kelly et al., 1985; Brow n et al., 1985). 
Indeed, Eglen et al., (1987), have shown that the M 2-receptor in guinea-pig isolated 
p repara tions, w hich  is subdiv ided  into atrial and ileal recep tors on the basis of 
antagonist affin ities, m ay also be differentiated  by virtue o f the effector system  to 
which they are coupled. This study showed that responses o f the atrial but not the ileal 
M 2-receptor were attenuated by pretreatm ent of the anim als with pertussis toxin which 
A D P -rib o sy la tes  the N) regu la to ry  pro tein  coupling  the m uscarin ic  recep to r to 
adenylate cyclase and therefore functionally inactivating the receptor (Ui, 1984; Endoh 
et al., 1985; Sorota et al., 1985; G ilm an, 1986; B oyer et al., 1986). C onversely, 
responses o f the ileal but not the atrial M 2-receptor were attenuated by pretreatm ent of 
the anim als w ith lith ium  inhibiting  m yo-inosito l-l-phosphate  phosphatase  activity  
(A lliso n  and  S tew art, 1971) th ereb y  d ec reas in g  rec e p to r-m e d ia te d  in o sito l 
phospholip id  hydrolysis.
The aim  o f  the p resen t study was to assess the recep tor profile  o f the m uscarin ic 
receptors m ediating endothelium -dependent relaxations o f the rat aorta. In order to 
confirm  that the receptor resem bles the M 2 receptor subtype present on non-vascular 
sm ooth m uscle I have used pirenzepine, 4D A M P and the atrial selective m uscarinic 
recep to r an tagon ists , h im bacine  and m ethoctram ine  (G ilan i and C obbin , 1986; 
M elchiorre  et a l ,  1987). In addition I have exam ined the effects o f lith ium  on the 
relaxant response o f the rat aorta to ACh and the partial m uscarinic agonists bethanecol 
and pilocarpine in order to determine if the muscarinic receptor m ediating endothelium -
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dependent relaxations is linked to phospholipid hydrolysis as in the case of the ileal M 2 
m uscarinic receptor (Eglen et al ., 1987).
The aim  o f the present study was to assess the recep tor profile o f the m uscarinic 
receptors m ediating endothelium -dependent relaxations o f the rat aorta. In order to 
confirm  that the receptor resem bles the M 2 receptor subtype present on non-vascular 
sm ooth m uscle I have used pirenzepine, 4D A M P and the atrial selective m uscarinic 
recep to r an tagon ists , h im bacine and m ethoctram ine  (G ilan i and C obbin , 1986; 
M elchiorre  et al., 1987). In addition I have exam ined the effects o f lithium  on the 
relaxant response of the rat aorta to ACh and the partial m uscarinic agonists bethanecol 
and pilocarpine in order to determine if the muscarinic receptor m ediating endothelium- 
dependent relaxations is linked to phospholipid hydrolysis as in the case o f the ileal M 2 
m uscarinic receptor (Eglen et a i ,  1987).
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M ethods
M ale Sprague-D aw ley or W istar rats (290-340g) were killed by stunning followed 
by decapitation. 2 -3mm long ring segm ents o f aorta were prepared as described in 
G eneral M ethods. Care was taken to m aintain an in tact endothelium  and the ring 
segm ents were suspended in 10ml isolated organ baths in K rebs’ solution m aintained 
at 37°C for isom etric tension recordings.
Antagonist Studies
The presence o f a vascular endothelium  was first established for each tissue by the 
ability  o f lp.M  A C h to produce relaxation  o f I jiM  PhE -induced  tone. A fter this 
p relim inary  procedure the effect o f atropine (0 .0 1 -ljiM ), p irenzepine (0 .3M 0|iM ), 
4D A M P (0.01-lja.M), m ethoctram ine (0.3-lOOjiM) and himbacine 0.3-10|iM ) on ACh- 
induced relaxations of agonist-induced tone was examined.
Four ring segm ents from  each rat were used. One ring segm ent was used as a time 
control, i.e. w as not exposed to any antagonist, w hilst each o f the o ther tissues was 
incubated w ith a d ifferent concentration o f antagonist. Successive CC RC s for ACh- 
induced relaxations show ed an appreciable decrease in sensitivity to ACh in the fourth 
C C R C  only  (F igure  4 .1). T herefore, w ith the excep tion  o f experim en ts  using 
m ethoc tram ine , a m axim um  o f  three C C R C  to A C h w ere ob ta ined  from  each 
p rep ara tio n : one con tro l C C R C  fo llow ed  by tw o C C R C s in the p resen ce  of 
successively greater concentrations of antagonist.
In m ost cases tone (approx 1000 mg. wt.) w as induced  in the p repara tions by 
addition o f PhE ( ljiM ). A t high concentrations m ethoctram ine acts as a w eak a r  
ad renocep tor an tagonist w ith a pK B o f 5.2 (M elchiorre et al., 1987). P relim inary  
experim ents have shown that PhE-induced contractions are attenuated by the antagonist 
(data not show n). T herefore, fo r experim ents using m ethoctram ine , the stable 
throm boxane-m im etic U 46619 (11a , 9 a , -epoxym ethano-prostaglandin H2; Colem an
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Figure 4.1
E ffect o f tim e on relaxations o f  in tact rat aortic rings to successive cum ulative 
concentration-response curves for ACh. Tone was induced by addition o f 10|iM  
PhE. D ata show n represen ts first (Q ), second ( # ) ,  third (A ) and fourth (A) 
successive CCRC for ACh in terms o f the percentage m axim um  response.
Points show n are m ean ±  s.e.m. (n=28).
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et aL, 1981) (2.5 - 25 nM) was used to induce tone since atttenuation of PhE-induced 
tone could result in changes in sensitivity to A Ch-induced relaxations which reduce the 
effects o f m uscarinic receptor blockade: a r adrenoceptor blockade w ould reduce the 
degree o f PhE-induced ‘activation’ o f the preparation and would result in an increase in 
sensitivity to ACh (see Chapter Two) and therefore an unexpectedly small antagonist- 
induced shift in the ACh CCRC. W hen contractions to either PhE or U 46619 had 
reached a stable plateau, CCRC for endothelium -dependent relaxations were obtained 
by add ition  o f  ACh (0 .01-3000 |iM ) in 0.5 log10 m olar increm ents. W hen used, 
antagonists were left in contact with the tissues for one hour prior to obtaining another 
CC RC for ACh (see Figure 4.2). It is d ifficult to com pletely w ash out U 46619 from  
these preparations and therefore w hen m ethoctram ine was used only one CC RC to 
A Ch w as obtained  per preparation: from  the four p reparations rem oved  from  the 
anim al one was kept as control and a different concentration o f m ethoctram ine used in 
each o f the rem aining preparations (see Figure 4.2).
The sensitivity  o f the preparation to A C h-induced relaxation was estim ated as the 
concentration o f ACh producing 50% m axim al relaxation (IC50) and expressed as its 
negative lo g 10, i.e. the p IC 50. A ntagonist affinities w ere estim ated by the m ethod of 
A runlakshana and Schild (1959) using 3-4 concentrations o f each antagonist. Except 
in experim ents using m ethoctram ine, concentration-ratios in the absence and presence 
o f antagonist w ere determ ined by dividing the IC50 values for A Ch in the presence of 
the an tagonist by the IC 50 value for ACh in the absence o f an tagonist in the same 
preparation. A ny shifts in the concentration-ratio  related  to the length o f tim e in the 
baths or tissue fatigue were elim inated by dividing the observed concentration-ratio  in 
the presence o f the antagonist by the relevant tim e control concentration-ratio  to give 
the corrected concentration-ratio. W hen m ethoctram ine was used, concentration-ratios 
in the absence and presence o f antagonist were determ ined by dividing the IC50 values 
for A Ch in the presence o f the antagonist by the IC50 value for ACh in the absence o f
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Preparations
(a)
PhE/ACh 
CCRC
45 min incubation 
with
vehicle or antagonist 
Wash
PhE/ACh 
CCRC
45 min equilibration
Wash
PhE/ACh
Set Up
U46619/ACh
CCRC
with
Vehicle or Antagonist
Wash
PhE/ACh
Set Up
Figure 4.2
S chem atic  show ing the experim ental p ro toco ls used in determ ination  o f  pA 2 
values fo r m uscarin ic recep tor antagonists using four ring  p repara tions o f  rat 
aorta. Panel a) indicates the protocol for 'paired' (control/antagonist) curves when 
PhE w as used as the contractile agents. W hen U 46619 was used single curves to 
A C h w ere obtained in the presence o f different concentrations o f antagonist. For 
m ore detailed description see M ethods and General M ethods.
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antagonist in the concom itant control preparation. L inear regression analysis was used 
to give values for pA 2 and slope of the Schild plot with 95% confidence intervals.
Effect o f Lithium
T he effect o f  lithium  on m uscarin ic agonist-induced  relaxations o f  rat aorta was 
exam ined . Three aortic ring segm ents from  rats chron ically  p retrea ted  w ith LiCl 
(‘treated’ preparations) or rats receiving no pre-treatm ent (‘con tro l’ preparations) were 
prepared as norm al. Care was taken to avoid disruption o f the endothelium . A fter the 
initial setting up procedure (see above) the rings were exposed to 10|J.M PhE follow ed 
by l |iM  A C h to dem onstrate the presence o f a functional endothelium .
The contractile  response to PhE is m arkedly attenuated in anim als pretreated  with 
LiCl such that a well m aintained contractile response is difficult to obtain (Figure 4.3; 
see C hapter One). C ontractions o f the rat aorta to the throm boxane m im etic U 46619 
are also attenuated but to a m uch sm aller degree and therefore this agonist was used to 
induce  tone w hen exam in ing  the re laxations induced  by A C h, be thaneco l and 
pilocarpine. Tone was induced in control and treated preparations by addition o f equi- 
potent concentrations o f U 46619 (0.03fiM  and 0 .3 |iM  respectively; see C hapter One). 
A fter the U 46619-induced contraction had reached a stable p lateau (up to 15 m inutes 
due to the very slow ly developing nature o f the response) a C C R C  for relaxations to 
either A C h (0.01-10fiM ), bethanecol ( l-1 0 0 0 |iM ), or p ilocarp ine (10-3000qM ) was 
obtained. Since U 46619 was used to induce tone, only one m uscarin ic agonist per 
p repara tion  w as ob tained  fo r the reasons m entioned  above. W hen the m axim um  
relaxations to bethanecol and pilocarpine had been obtained, lOfiM A Ch was added to 
the organ baths in order to give som e indication o f the relative size o f the m axim um  
response o f  the form er two agonists to ACh.
The relaxato ry  response to the m uscarin ic agonists was expressed  in  term s o f the 
percentage o f  the induced tone, absolute tension (mg. wt.) and as a percentage o f each 
agon ist’s ow n m axim um  response. The intrinsic activity o f bethanecol was estim ated
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2 mins
(b)
(a)
Figure 4.3
R epresentative trace show ing contractile response depressed response to l(iM  PhE 
(A )  in aortic rings from  LiC l pre-treated  rats (a) com pared  to preparations from  
control rats (b).
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as m axim um  response to bethanecol relative to the m axim um  response to ACh in 
preparations from the same rat, i.e.
Intrinsic Activity = Max R e s p o n s e ^ ^ /M a x  Response(ACh)
In order to eliminate any variation that might occur due to differences in absolute 
induced tone between preparations the maximum relaxant response for this 
determination was taken as the maximum percentage reduction of induced tone by the 
agonist.
With the exception of pilocarpine the potency of the muscarinic agonists was 
estimated as the concentration of agonist producing 50% maximal relaxation (IC50) and 
expressed as its negative log10 i.e. the pIC50. Pilocarpine induced relaxations at high 
concentrations and it was not possible to raise the concentration of pilocarpine in the 
organ bath to a level sufficient to produce a true ‘maximum’ response. Therefore, for 
determination of the intrinsic activity and potency of pilocarpine the response to 3mM 
pilocarpine was used as its ‘maximum’ response.
Animal Pretreatment
The protocol used for pretreatment of animals was that described by Eglen et al. 
(1987). Animals were given 6 . 8  mmol kg' 1 LiCl (dissolved in distilled water) by intra- 
peritoneal injection at the same time each day for four consecutive days (control 
animals received no pretreatment). The necessary dose was given by two injections of 
a relatively dilute solution of LiCl, one on each side of the abdomen (see Chapter One 
for further details). Eighteen hours following the last injection the rat was killed as 
described above, blood collected for determination of the plasma lithium concentration 
and the aorta excised in the normal manner.
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R esults
Antagonist Studies
ACh induced concentration-dependent relaxations of rat aortic ring segments pre­
contracted with either PhE (pIC50 = 7.05 ± 0.05) or U46619 (pIC50 = 7.10 ± 0.10). 
The sensitivity to ACh-induced relaxation of PhE-induced tone was not significantly 
different from that for relaxation of U46619-induced tone (P<0.05; Student’s unpaired 
t test). Atropine, pirenzepine, 4DAMP, and himbacine each produced parallel, 
concentration-dependent rightward shifts in the CCRC to ACh (Figures 4.4, 4.5, 4.6 
and 4.7). At high concentrations, methoctramine produced non-parallel rightward 
shifts in the ACh CCRC (Figure 4.8). Analysis of the effects of each antagonist using 
the method of Arunlakshana and Schild (1959) indicated a competitive antagonism by 
atropine, pirenzepine and 4DAMP, since the Schild slopes were not significantly 
different from unity (p>0.05) (Figures 4.4, 4.5, and 4.6). The pA2 values for these 
antagonists were 8.72 (8.43-9.01), 7.21 (6.91-7.49) and 8.87 (8.35-9.39) 
respectively (Table 4.1). In contrast, himbacine and methoctramine acted in a non­
competitive manner exhibiting Schild slopes less than unity (0.79 (0.62-0.97) and 
0.74 (0.59-0.88) respectively) (Figures 4.7 and 4.8). The pA 2 values for these 
antagonists were 6.92 (6.57-7.28) and 5.87 (5.62-6.12) respectively (Table 4.1).
Effect o f Lithium
ACh, bethanecol, and pilocarpine produced concentration dependent inhibition 
(relaxation) of U46619-induced tone in control and treated preparations (Figure 4.9). 
The intrinsic activity of bethanecol and pilocarpine in both control and treated 
preparations was significantly less than that for ACh in the corresponding preparation 
(P>0.05; Student’s paired t test). However, in control and treated preparations the 
intrinsic activity for bethanecol was not significantly different from that for pilocarpine 
(P<0.05; Student’s paired t test). There was no significant difference (P<0.05;
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F igure  4.4
Effect of atropine on ACh-induced relaxations of rat aortic rings pre-contracted with 
l |iM  PhE. ACh-induced relaxations are expressed as; a) a percentage of the 
maximum response in the absence (O) and presence of 0 .0ljiM  (# ) , 0.1 (iM (A) 
and l|iM  (A) atropine; b) the Arunlakshana-Schild analysis of the inhibition by 
atropine of these responses.
Points shown in a) are mean ± s.e.m. (n=4-6).
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F igure  4.5
Effect of pirenzepine on ACh-induced relaxations of rat aortic rings pre-contracted 
with lpM  PhE. ACh-induced relaxations are expressed as; a) a percentage of the 
maximum response in the absence (O) and presence of 0.3pM (# ) , lpM  (A) and 
10pM (A) pirenzepine; b) the Arunlakshana-Schild analysis of the inhibition by 
pirenzepine of these responses.
Points shown in a) are mean ± s.e.m. (n=4-6).
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F igure  4.6
Effect of 4DAMP on ACh-induced relaxations of rat aortic rings pre-contracted 
with IjiM  PhE. ACh-induced relaxations are expressed as; a) a percentage of the 
maximum response in the absence (O) and presence of O.OljuM (# ) , 0.1 |iM (A) 
and l(iM  (A) 4DAMP; b) the Arunlakshana-Schild analysis of the inhibition by 
4DAMP of these responses.
Points shown in a) are mean ± s.e.m. (n=4-6).
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F igure  4.7
Effect of himbacine on ACh-induced relaxations of rat aortic rings pre-contracted 
with lp.M PhE. ACh-induced relaxations are expressed as; a) a percentage of the 
maximum response in the absence (O) and presence of 0.3|J.M (# ) , 3(iM (A) and 
10|iM (A) himbacine; b) the Arunlakshana-Schild analysis of the inhibition by 
himbacine of these responses.
Points shown in a) are mean ± s.e.m. (n=4-6).
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F igure  4.8
Effect of methoctramine on ACh-induced relaxations of rat aortic rings pre­
contracted with 2.5 - 25 nM U46619. ACh-induced relaxations are expressed as; 
a) a percentage of the maximum response in the absence (O ) and presence of 
0.3 |iM  (# ) , 10|iM (A) and 100p.M (A) methoctramine; b) the Arunlakshana- 
Schild analysis of the inhibition by methoctramine of these responses.
Points shown in a) are mean ± s.e.m. (n=5).
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A ntagon ist P A2 Slope
Atropine 8.72 1.02
(8 .44-9 .01) (0 .86-1 .18)
Pirenzepine 7.21 0.95
(6 .91-7 .49) (0 .77-1 .12)
4DAM P 8.87 1.02
(8.35-9 .39) (0 .76-1 .27)
M ethoctramine 5.87 0 .74
(5 .62-6 .12) (0 .59-0 .88 ;
Himbacine 6.92 0.79
(6 .57-7 .28) TO.62-0 .97 ;
Table 4.1
E ffect o f atropine, p irenzepine, 4D A M P, m ethoctram ine and h im bacine on 
acetylcholine-induced relaxations of rat aortic ring segments pre-contracted with 
phenylephrine or U46619.
V alues show n for pA 2 and slope o f Schild plot are m ean with 95%  confidence 
intervals derived from  4-6 animals.
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F igu re  4.9
Effect of ACh (O), bethanecol (# )  and pilocarpine (A) on tone induced by a) 
0.03jiM  U46619 in control preparations and b) 0.3jiM U46619 in preparations 
from rats pre-treated with LiCl.
Data shown mean reaponse (expressed as a percentage of the induced tone) ± 
s.e.m. (n=6-9).
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Studen t’s unpaired t test) between the intrinsic activity o f each agonist in control and 
treated preparations (Table 4.2 and Figure 4.10).
T he percen tage  reduction  o f induced  tone p roduced  by A C h, be thanecol and 
p ilocarp ine w as greater in control preparations than in treated preparations and was 
particu larly  pronounced  at the h igher concentrations of agonist used (Figure 4.11). 
W hen the effect o f each agonist was expressed in term s o f absolute tension (mg. wt.) it 
was found that the initial tone was consistently greater in the treated preparations than 
in the control preparations though this d ifference w as not statistically  significant 
(P>0.05; S tuden t’s unpaired  t test). The difference in tension betw een control and 
treated preparations at the higher concentrations of m uscarinic agonist was greater than 
the d ifference  in induced  tone before addition o f the agonist (F igure 4.12). The 
m ax im um  relaxation  to bethanecol and p ilocarp ine  in both con tro l and trea ted  
preparations was significantly less than that for ACh in the corresponding preparation 
(P>0.05; Studen t’s paired t test). In addition, the m axim um  relaxant response to each 
agonist w as significantly  greater (P<0.05; S tuden t’s unpaired  t test) in the control 
preparation com pared to that in the treated preparation (Table 4.2 and Figure 4.13).
The potency o f the agonists tested in this study was o f the order ACh > bethanecol 
> pilocarpine in both control and treated preparations (Table 4.2 and F igure 4.14). 
H ow ever, there w as no significant d ifference (P>0.05; S tu d en t’s unpaired  t test) 
betw een the potency o f each agonist in control and treated preparations (Table 4.2 and 
Figure 4.15).
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C on tro l L ith ium
Intrinsic Activity
ACh
Bethanecol
Pilocarpine
ACh
Bethanecol
Pilocarpine
LOO 
0.67 ± 0.08 * 
0.57 ± 0.05 ***
1.00 
0.73 ± 0.06 *** 
0.54 ± 0.08 ***
Agonist Potency (pIC50)
7.07 ± 0.15
5.01 ± 0.18 ***
3.02 ± 0.06 ***
6.98 ± 0.08 
5.15 ± 0.12 *** 
3.19 ± 0.13 ***
Max Response (% reduction induced tone)
ACh 8 6 . 2 ± 4.6 48.7 ± 5.8 ft+
Bethanecol 57.7 ± 7.9 * 36.1 + 5.1 *** f
Pilocarpine 49.9 ± 6 . 8  *** 24.6 ± 2 . 6 ***
Table 4.2
Effect of chronic pre-treatment of rats with LiCl on the potency of ACh, 
bethanecol and pilocarpine to induce relaxations of precontracted preparations 
(expressed as its pEC50) and their maximum relaxant responses (expressed as % 
reduction of induced tone).
The values shown for the unrubbed and mbbed vessel are the means ± s.e.mean 
for n=6-9.
Significant differences between corresponding value for ACh using Student’s 
unpaired r-test: * P<0.05, *** P<0.005; and between control and treated 
preparations , + P<0.05,tt+ P<0.005
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F igure  4.10
The intrinsic activity for endothelial-dependent relaxations by ACh, bethanecol and 
pilocarpine in control and treated preparations.
Data shown represents mean intrinsic activity values ± s.e.m. (n=6-9) in 
preparations from control animals (open bars) and animals chronically pre-treated 
with LiCl (filled bars). Statistically significant differences in control and treated 
preparations using paired Student’s t test between the intrinsic activity of bethanecol 
and pilocarpine compared to ACh in the corresponding preparation; * P<0.05 and ** 
P<0.005.
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Figure 4.11
Relaxation (expressed as a percentage of the induced tone) of intact rat aortic rings 
by a) ACh, b) bethanecol and c) pilocarpine. Tone was induced by U46619 in 
preparations from control (O) and LiCl pre-treated (# )  rats.
Points shown in are mean ± s.e.m. (n=4-6).
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F igure  4.12
Relaxation (expressed as mg. wt.) of intact rat aortic rings by a) ACh, b) bethanecol 
and c) pilocarpine. Tone (represented by single symbols) was induced by U46619 
in preparations from control (O) and LiCl pre-treated (# )  rats.
Points shown in are mean ± s.e.m. (n=6-9).
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Figure 4.13
The maximum relaxation of induced tone in rat aortic rings (expressed as a 
percentage of the induced tone) to ACh, bethanecol and pilocarpine in control and 
treated preparations.
Data shown represents mean maximum response ± s.e.m. (n=6-9) in preparations 
from control animals (open bars) and animals chronically pre-treated with LiCl 
(filled bars). Statistically significant differences in control and treated preparations 
using paired Student’s t test between the maximum response of bethanecol and 
pilocarpine compared to ACh in the corresponding preparation; * P<0.05 and ** 
P<0.005. Statistically significant differences using unpaired Student’s t test 
between the maximum response of ACh, bethanecol and pilocarpine control and 
treated preparations;f P<0.05 and ++ P<0.005.
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F igure  4.14
The effect of LiCl pre-treatment on the potency (pIC50) of ACh, bethanecol and 
pilocarpine in rat aortic rings.
Data shown represents mean pIC50 values ± s.e.m. (n=6-9) in preparations from 
control animals (open bars) and animals chronically pre-treated with LiCl (filled 
bars). Statistically significant differences in control and treated preparations using 
Student’s paired t test between (i) the potencies of bethanecol and pilocarpine 
compared to ACh in the corresponding preparation; *** P<0.005 and (ii) the 
potency of bethanecol compared to pilocarpine in the corresponding preparation; 
P<0.005.
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Figure  4.15
Relaxation (expressed as a percentage of the agonist maximum response) of intact 
rat aortic rings by a) ACh, b) bethanecol and c) pilocarpine. Tone was induced by 
U46619 in preparations from control (O) and LiCl pre-treated (# ) rats.
Points shown in are mean ± s.e.m. (n=4-6).
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D iscussion
Although the use of selective antagonists such as 4DAMP suggests that the 
muscarinic receptor mediating endothelium-dependent relaxations of the rabbit aorta 
resembles the M2 receptor found on non-vascular smooth muscle (Eglen and Whiting, 
1985; Choo et al., 1986) there is still some controversy as to the affinity of pirenzepine 
for these receptors. Eglen and Whiting (1985) reported a pA2 value for pirenzepine 
(7.6) which was intermediate between that for the Mj and M 2 subtypes (8.4 and 6 . 8  
respectively). In contrast other workers have reported pA2 values for pirenzepine that 
are similar to reported values at M2 receptors (Choo et al., 1986). Therefore, in the 
light of this controversy I have attempted to classify definitively the muscarinic 
receptor subtype which mediates endothelium-dependent relaxations of the rat aorta.
The pA2 value obtained in this study for atropine against ACh-induced relaxations of 
the rat aorta is consistent with an interaction with muscarinic receptors and is similar to 
that reported for the action of atropine against endothelial dependent relaxations in 
other preparations such as the dog femoral artery, rabbit ear artery and rabbit aorta 
(Rubanyi et al., 1986; Hynes et al., 1986; Eglen and Whiting, 1985).
The affinity of pirenzepine obtained in this study is higher than that previously 
reported for M2 muscarinic receptors in gastrointestinal smooth muscle (Brown et al., 
1980; Barlow et al., 1981) and intermediate between the values reported by Eglen and 
Whiting (1985) and Choo et al., (1986). The reasons for this disparity are unclear but 
may be due to a combination of factors: (i) use of superfusion techniques (Eglen and 
Whiting, 1985) as opposed to ‘classical’ organ bath experiments, (e.g. this study; 
Rubanyi et al., 1986), (ii) differences in antagonist equilibration time, (e.g. 60 mins 
used in this study and 30 mins used by Hynes et al., 1986), (iii) species variation in 
the affinity of pirenzepine (Yamanaki et al., 1986). The use of superfusion techniques 
in classification of the muscarinic receptor mediating endothelium-dependent 
relaxations is further complicated by the observation that in the perfused dog femoral
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artery ACh induces biphasic release of EDRF with a differential potency of pirenzepine 
for the phases (Rubanyi et al., 1986) suggesting a possible heterogeneity in muscarinic 
receptors or the release of more than one EDRF. Although not completely eliminating 
any controversy concerning the affinity of pirenzepine at the muscarinic receptor 
mediating endothelial dependent relaxations, the affinity of pirenzepine obtained in this 
study is clearly distinct from that observed at Mi muscarinic receptors (Brown et al., 
1980). Thus, the muscarinic receptor mediating ACh-induced relaxations of the rat 
aorta is of the M2 type cholinoceptor similar to that found in gastrointestinal smooth 
muscle.
Whilst neither atropine nor pirenzepine discriminates between subtypes (atrial and 
ileal) of M2 muscarinic receptors (Mitchelson, 1984) the antagonist 4DAMP exhibits a 
10 fold selectivity for the ileal muscarinic receptor (Brown et al., 1980). In addition, 
himbacine and methoctramine show 10 and 270 fold selectivity for the atrial muscarinic 
receptor (Gilani and Cobbin, 1986; Melchiorre et al.,1987). Therefore, 4DAMP, 
himbacine and methoctramine provide tools for the definitive classification of the 
muscarinic receptor subtype mediating ACh-induced relaxation of the rat aorta.
As can be seen in Figure 4.16, the pA2 value obtained using 4 DAMP was similar to 
that reported for the muscarinic M2 receptors in smooth muscle (9.0) but different from 
that reported for these receptors in the atria (7.9; Eglen and Whiting, 1986). The 
similarity to the smooth muscle M2 muscarinic receptor is supported by the values 
obtained using methoctramine and himbacine, which were dissimilar to those observed 
at atrial muscarinic receptors (8 . 0  and 8 . 2  respectively) but similar to those observed at 
smooth muscle receptors (5.9 and 7.1 respectively, Melchiorre et al., 1987; Gilani and 
Cobbin, 1986). Thus, on the basis of selective antagonist studies the muscarinic 
receptor mediating endothelium-dependent relaxations of the rat aorta is similar to M2 
receptors in non-vascular smooth muscle but dissimilar to M2 receptors in the atria.
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F igure  4.16
Summary of pA 2 values for muscarinic antagonists inhibiting acetylcholine- 
induced relaxations of rat aortic rings.
I'.'.'......... 1 Indicates mean pA 2 (midpoint) with 95% confidence intervals
(limits of box) for data obtained in this study.
Data from other studies (see Eglen and Whiting, 1986):
▼ & V  Indicate affinity for pirenzepine at,Y - Mi and,V - M2 receptors.
O  Indicates pAi for antagonists at atrial receptors.
A  Indicates pA2 for antagonists at smooth muscle receptors.
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Lithium has been shown to inhibit myo-inositol-l-phosphate phosphatase activity and 
thereby decrease receptor-mediated inositol phospholipid hydrolysis (Allison and 
Stewart, 1971; Sherman et al., 1986; see Chapter One). Eglen et al., (1987), 
demonstrated that pretreatment of animals with lithium selectively inhibited muscarinic 
receptor function in the ileum (M2) from the guinea-pig. Therefore, if this subtype of 
M2 muscarinic receptor is universally coupled to inositol phospholipid hydrolysis and 
muscarinic receptors can be practically defined according to their effector systems 
(Harden et al., 1986) then the ACh-induced, M2 receptor mediated relaxations of rat 
aortic rings would be selectively attenuated by pre-treatment with lithium.
In their study, Eglen et al., (1987), could not show an effect of lithium on the 
sensitivity or maximum response of carbachol-induced contractions in the guinea-pig 
ileum (mediated by M2 muscarinic receptors) despite a significant attenuation of the 
effect of bethanecol and pilocarpine. This could indicate that carbachol activates 
different receptors than bethanecol and pilocarpine or it may indicate that whilst the 
agonists bind to the same receptor, carbachol, through an unknown mechanism, 
produces contraction via activation of a different second messenger system than 
bethanecol and pilocarpine. Alternatively, carbachol may have such a high relative 
efficacy that lithium pre-treatment has no apparent effect whilst the responses to the 
agonists with lower relative efficacy are markedly attenuated. Preliminary experiments 
suggested that lithium pre-treatment had little if any effect on ACh-induced relaxations 
of the rat aorta. I therefore decided to examine the effect of lithium pretreatment on 
ACh-, bethanecol- and pilocarpine-induced relaxations of rat aortic rings, i.e. 
relaxations induced by agonists which have been shown to be ‘full’ and ‘partial’ 
(Furchgott and Cherry, 1984).
For this part of the study the preparations were pre-contracted with U46619 since 
lithium treatment significantly attenuated contractions to PhE (see Chapter One). There 
was no significant difference in the potency of ACh to relax U46619-induced 
contractions compared to PhE-induced contractions. This was somewhat surprising
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since work earned out previously (Templeton, PhD thesis 1988) indicated that ACh- 
induced relaxations of U46619-induced tone in the rat aorta were smaller than 
relaxations of PhE-induced tone. However, the results from the work carried out by 
Templeton may be atypical since the pA2 for atropine indicated a non-competitive 
interaction with the muscarinic receptor mediating endothelium-dependent relaxation 
(slope of Schild plot = 0.6) and an unusually high pA2 (9.6) . Lithium also depresses 
the contractile response to U46619 (data not shown) and therefore care was taken to 
try to ensure that equieffective concentrations of U46619 were used: differences in 
activation of the rat aorta can produce changes in the sensitivity of the preparations to 
ACh-induced relaxations (see Chapter Two).
In this study bethanecol and pilocarpine were shown to be partial agonists since both 
agonists exhibited a lower intrinsic activity than ACh in paired preparations (i.e., the 
maximum relaxant response obtained to these agonists was significantly smaller than 
that obtained for ACh). Bethanecol and pilocarpine were found to be partial agonists 
in both control and treated preparations. Antagonist studies were not performed to 
demonstrate conclusively that ACh, bethanecol and pilocarpine all act at the same 
receptor to cause relaxation. However, lOjiM ACh added in the presence of maximal 
relaxation to bethanecol and pilocarpine did not induce further, substantial relaxations 
of the preparation despite the maximum response to the test agonist being significantly 
less than that for ACh in the paired preparation. This provides indirect evidence that 
bethanecol and pilocarpine are acting at the same receptor as ACh: bethanecol and 
pilocarpine would act as antagonists of the action of a full agonist at high 
concentrations and therefore if ACh were to act through different receptors then it 
would be expected to induce further relaxations of the rat aorta.
At high concentrations agonist-induced relaxations of U46619-induced tone (in terms 
of the percentage reduction of that tone) by ACh, bethanecol and pilocarpine were 
significantly smaller in the lithium pre-treated preparations compared to the control 
preparations. However, there were no significant differences in the potencies (pIC50)
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of the agonists between control and treated preparations. Furthermore, the lithium- 
induced depression of maximum relaxant response of the partial agonists was not 
significantly greater than that for ACh. Therefore it would appear that whilst lithium 
appears to attenuate muscarinic receptor mediated relaxations of the rat aorta, this effect 
is not preferentially greater for agonists of lower intrinsic activiy. The lack of 
difference in potency of the agonists between control and treated preparations is 
surprising particularly since this treatment did produce a depression of the maximum 
relaxation. This would suggest that in contrast to the response of the guinea-pig ileum 
(Eglen and Whiting, 1987) which is mediated by muscarinic M 2 receptors the M2 
receptor mediating relaxation of rat aortic rings is not selectively inhibited by lithium.
The apparent depression by lithium of agonist-induced relaxation may at least partly 
be explained by differences in the degree of U46619-induced activation of the smooth 
muscle. Although care was taken to try to ensure that the concentration of U46619 
used to induce tone was equieffective in treated and control preparations, when the 
effects of ACh, bethanecol and pilocapine were expressed as absolute tension (mg. 
wt.) the tone induced in the treated preparation was consistently greater than in the 
control preparations. Increases in the degree of activation used to examine 
endothelium-dependent relaxations can result in attenuation of the size of relaxation 
without a concomitent decrease in potency of the relaxant agonist (see Chapter Two). 
Whilst the relaxant responses to the higher concentrations of ACh, bethanecol and 
pilocarpine were significantly greater in control compared to lithium pre-treated 
preparations, the difference in the absolute size of induced tone between control and 
treated tissues was not statistically significant. Therefore it is unlikely that the apparent 
depression of maximum response to the muscarinic agonists is due wholly to 
differences in induced tone. A significant reduction in maximum relaxation without a 
change in sensitivity to the relaxing agent can also be observed when the resting 
tension of the preparation is varied (see Chapter Two). In this study the resting 
tension in control and treated preparations was equal. However, treatment with lithium
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may have had some effect on the rat aorta such that the optimum degree of stretch for 
demonstration of endothelium-dependent relaxations is different in both preparations 
and this may play a major role in the differences in the maximum relaxant response to 
muscarinic receptor activation seen in the present study between treated and control 
preparations.
Although removal of the vascular endothelium leads to loss of in vitro vasodilatation 
to ACh (Furchgott and Zawadzki, 1980), and thereby implies the presence of 
cholinoceptors on the endothelium mediating these relaxant responses, this has not 
been definitively shown. The published evidence appears to indicate that the 
muscarinic receptor is not located on the endothelium. Studies using cultured 
endothelial cells have failed to show a muscarinic-receptor mediated increase in 86Rb 
efflux or release of EDRF (Gordon and Martin, 1983; Loeb et al., 1985; Cocks et al., 
1985; Gryglewski et al., 1986). In addition, radioligand binding studies using 
[3H]QNB as the muscarinic receptor ligand have failed to detect binding in endothelial 
cell cultures (Peach et al., 1985). This may be attributed to the loss of muscarinic 
receptors on culturing (a phenomenon not seen with bradykinin receptors; Cocks et al.,
1985). The lack of functional responses to muscarinic receptor agonists in endothelial 
cell cultures may also be due to the highly unphysiological nature of the technique 
since there is evidence for differences in the response to agonists in cell culture and 
intact preparations (Chamley-Campbell et al., 1981) and also a decline in cultured 
endothelial cell responsiveness with time (Ager and Martin, 1983; Needham et al., 
1987). In addition, autoradiographic studies have shown that in a variety of arterial 
preparations from different species there is a high density of muscarinic receptors 
present in the adventitial layers of the vascular smooth muscle but not on the 
endothelium (Stephenson and Summers, 1987). This is somewhat surprising since in 
preparations such as the rat aorta, the functional response to ACh (particularly at low 
concentrations) appears to be mediated via an intact endothelium. Hynes et al., (1986) 
using organ bath and radioligand binding techniques demonstrated that pirenzepine had
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the same affinity at the receptors mediating ACh-induced relaxation of the rabbit ear 
artery and the underlying smooth muscle. Moreover, these workers showed that 
removal of the endothelium did not reduce the density of the muscarinic receptors in 
the preparation but rather increased it. This might suggest that muscarinic receptors 
were present only on the vascular smooth muscle and not on the endothelium.
Therefore the evidence to-date suggests that muscarinic receptors present on the 
smooth muscle of vascular preparations may release some unknown substance which 
induces or promotes the release of EDRF from the endothelium (Stephenson and 
Summers, 1987). This hypothesis is supported by the study of Loeb et al., (1985) 
who showed that an increase in cell cGMP content (a marker of EDRF-induced 
vasodilatation; Rapaport and Murad, 1983) could be produced by activation of 
muscarinic receptors in cultured endothelial cells only when the endothelial cells were 
co-cultured with smooth muscle cells: stimulation of single cell-type cultures of 
smooth muscle or endothelial cells with the muscarinic receptor agonist methacholine 
produced no release of relaxant substance(s). Since EDRF induces an increase in 
smooth muscle cGMP (Rapaport and Murad, 1983) then it is perhaps to be expected 
that single cultures of endothelial cells or smooth muscle cells would not show an 
increase in cGMP levels in response to muscarinic receptor stimulation. However, 
Martin et al., (1988) did show that levels of cGMP are increased in endothelial cell 
cultures by stimulation of EDRF production with agents such as A23187 and 
bradykinin but not ACh. Therefore if muscarinic receptors mediating EDRF release 
were present on the cultured endothelial cells and the smooth muscle cells play no part 
in ACh-induced release of EDRF then activation of muscarinic receptors in co-cultures 
of smooth muscle and endothelial cells (Loeb et al., 1985) would not be expected to 
induce an increase in levels of cGMP.
To conclude, whilst the present study does not investigate the intriguing question of 
the location of muscarinic receptors mediating endothelium-dependent relaxations of 
the rat aorta I have classified this receptor on the basis of differential antagonist
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affinities as being an M2 muscarinic receptor similar to that found in smooth muscle 
preparations such as the guinea-pig ileum and trachea. This M2 muscarinic receptor, in 
contrast to that found in the ileum, is insensitive to lithium pre-treatment of the donor 
animal and is therefore probably not coupled to inositol phospholipid hydrolysis. The 
location and coupling mechanism of the receptor remain to be evaluated.
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Chapter Five
The effect of palmitoyl carnitine on endothelium- 
dependent relaxations of the rat aorta.
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In tro d u c tio n
In myocardial cells, ischaemic conditions lead to the breakdown of mitochondrial [3- 
oxidation of fatty acids resulting in the accumulation of acyl-CoA in mitochondria and 
acyl carnitines in the cytosol (Liedtke et al., 1978; Neely and Feuvray, 1981; Knabb et 
al., 1986). Under these conditions the level of cytosolic acyl carnitines can reach 75- 
200|iM  (Corr et al., 1984) and it has been suggested that the accumulation of these 
lipid metabolites contributes to cellular damage and electrophysiological derangements 
associated with cardiac ischaemia (Neely and Feuvray, 1981; Knabb et al., 1986).
Palmitoyl carnitine is a long chain acyl carnitine which accumulates in ischaemic 
conditions, rapidly partitions into the sarcolemma and under prolonged ischaemic 
conditions can leak into the extra-cellular space (Shug et al., 1978; Knabb et al., 
1986). In cardiac myocytes, hypoxia causes a 70 fold increase in sarcolemmal acyl 
carnitines (Knabb et al., 1986). In myocardium palmitoyl carnitine may increase 
contractile force by increasing membrane permeability to calcium (Inoue and Pappano, 
1983) and can directly activate Ca2+ channels in smooth muscle (Mir and Spedding,
1986). Palmitoyl carnitine has been shown to resemble the dihydropyridine Ca2+ 
channel activator BAY K 8644 (Schramm et al., 1983) in a variety of interactions at 
voltage-operated Ca2+ channels and has been suggested to be an endogenous ligand at 
voltage operated calcium channels (Spedding and Mir, 1987).
Recent work in vascular smooth muscle has shown that hypoxia augments K+- 
induced contractility of rat portal vein and that this augmentation is attenuated by 
phenylalkyloxirane carboxylic acid (POCA), an inhibitor of carnitine acyltransferase 
(Fasehun et al., 1987). In addition, palmitoyl carnitine can increase K M nduced 
contractions in the rat tail artery by increasing sensitivity to Ca2+ (Ugwu et al., 1987). 
These experiments suggest that, as with cardiac muscle, acyl carnitine accumulates in 
vascular smooth muscle under ischaemic conditions and can act as an endogenous Ca2+ 
channel activator in the vascular smooth muscle. During ischaemia this would limit the
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blood supply further by potentiating the effect of any basal tone in the vascular smooth 
muscle due to circulating and neuronally released hormones or autocoids from 
aggregating platelets. This would then lead to further vasoconstriction and hence 
decreases in blood flow to the affected area possibly exacerbating the ischaemic 
damage.
Preliminary experiments have shown that BAY K 8644-induced contractions in ring 
preparations of rat aorta partially depolarised with 12mM KC1 are potentiated by 
disruption of the endothelial cell layer (Spedding et al., 1987). This was attributed to 
removal of the basal release of EDRF which directly opposed the contractile response 
to BAY K 8644. However, under similar conditions the contractions to cumulative 
addition of palmitoyl carnitine are unaffected by removal of the endothelium. Thus, 
contractions to palmitoyl carnitine are resistant to basal release of EDRF possibly 
indicating activation of layers of vascular smooth muscle or some contractile 
mechanism which is not activated by BAY K 8644 and which is resistant to EDRF. 
Alternatively, palmitoyl carnitine may inhibit the release or action of EDRF and 
therefore removal of the endothelium has no net effect on palmitoyl carnitine-induced 
contractions. In ring segments of rat aorta precontracted with ljiM  PhE, palmitoyl 
carnitine inhibits, and reverses, the endothelium-dependent relaxation to l|iM  
acetylcholine (Bigaud and Spedding, 1986). Therefore it would appear that palmitoyl 
carnitine inhibits the release or action of EDRF. This could be of some physiological 
significance since in ischaemic conditions when blood supply may be limited due to the 
Ca2+ channel activating action of palmitoyl carnitine this would limit the blood supply 
even further by removing the effect of basal release of EDRF which directly opposes 
the effect of contractile agents on the vascular smooth muscle (see Chapter Three for 
references).
In this study I have further investigated the inhibition of endothelium-dependent 
relaxations by palmitoyl carnitine in this tissue and made a comparison with the effect 
of BAY K 8644 on endothelium-dependent and independent relaxations.
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Methods
Male Wistar rats (250-300g) were killed by stunning followed by exsanguination. 
Ring segments of descending thoracic aorta (2-3mm) were prepared as described in 
General Methods. When necessary, the endothelial cell layer was disrupted by gendy 
rubbing the intimal layer of the ring with curved forceps. When this procedure was 
not carried out care was taken to maintain an intact endothelium.
Agonist-Induced Relaxations
Ring segments were suspended between rigid wire tissue holders in 10ml isolated 
organ baths containing PSS maintained at 37°C for isometric tension recordings. The 
presence of an intact endothelium was demonstrated by the ability of lp.M ACh to relax 
l |iM  PhE-induced tone as described in General Methods. After this preliminary 
procedure the effect of palmitoyl carnitine (3-100jiM) on agonist-induced relaxations 
was examined.
Four endothelium-intact ring preparations from each rat were used. One ring was 
kept as control, i.e. unexposed to palmitoyl carnitine, and the other three used to 
examine the effect of various concentrations of palmitoyl carnitine on agonist induced 
relaxations of PhE-induced tone.
When required, one concentration of palmitoyl carnitine (3-100pM) was added to the 
organ baths 10 minutes prior to the addition of lpM  PhE. This concentration of PhE 
induces 90-95% maximum contraction (approx 1000 mg. wt.). When the contraction 
to PhE had reached a stable plateau, a CCRC for agonist-induced relaxations was 
obtained by addition of ACh (0.01-100p.M), ATP (10-lOOOjiM), the calcium 
ionophore A23187 (0.01-10|iM) or sodium nitroprusside (SNP; 0.001-3|iM) in 0.5 
log10 molar increments. Preliminary experiments had already shown that SNP caused 
endothelium-independent. The sensitivity of intact aortic rings to ACh-induced 
relaxations can vary with time (see Chapter Four). Therefore, in order to avoid any
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possible variation in tissue sensitivity with time only one CCRC for the agonist tested 
was obtained in each preparation.
The effect of repeated washing in palmitoyl carnitine-free saline on the relaxant 
response to ACh in preparations pre-contracted with PhE and previously exposed to 
palmitoyl carnitine was examined. In these experiments two endothelium-intact 
preparations from each rat were used: one preparation to be used as control (i.e. not 
exposed to palmitoyl carnitine) and the other preparation to be treated with palmitoyl 
carnitine. After the preparations were set up and the presence of a functional 
endothelium had been demonstrated as described previously, the preparations were pre­
contracted with lpM  PhE. A relaxant response to a maximal concentration of ACh 
(10|iM ) was obtained. The preparations were washed as described in General 
Methods and allowed to equilibrate for 30 mins. Palmitoyl carnitine (30|iM) was 
added to the organ bath of one ring segment 1 0  minutes prior to inducing tone with 
ljiM  PhE. The other ring segment was used as a vehicle control: 10 fil 20% ethanol. 
When the contractions to PhE had reached a stable plateau in both preparations, ACh 
(IOjiM) was added to both organ baths and any relaxation observed. When relaxation 
had reached a plateau the preparations were washed according to the schedule 
described in General Methods with palmitoyl carnitine-free saline and left for 30 
minutes before once more obtaining 10|iM ACh-induced relaxation of ljiM  PhE- 
induced tone in the absence of palmitoyl carnitine. This procedure was repeated four 
times. Relaxations in the preparation exposed to palmitoyl carnitine were compared to 
those in the control preparation which showed any deviation in ACh-induced 
relaxations due to time.
Comparative Effect o f BAY K 8644
The effect of BAY K 8644 and palmitoyl carnitine on PhE-induced tone and ACh- 
induced relaxation of that tone was examined. Paired ring preparations with an intact 
and disrupted endothelium were used. In preparations pre-contracted with l|iM  PhE
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the effect of cumulative addition of palmitoyl carnitine (0.01-100|iM) or BAY K8644 
(0.001-3jiM) in 0.5 log10 molar increments was examined. In some intact preparations 
tone was induced by addition of lp.M PhE 10 minutes after addition of palmitoyl 
carnitine (30|iM) or BAY K 8644 (3|iM). The effect of this pre-treatment on ACh- 
induced relaxations was then examined by cumulative addition of ACh after the PhE- 
induced contraction had reached a plateau. In addition the effect of palmitoyl carnitine 
(30|iM) or BAY K 8644 (3|iM) on an established relaxation of l|iM  PhE-induced tone 
by ljiM  ACh or 0.1 jiM SNP was examined.
Bioassay o f EDRF
The endothelium of some rings obtained in the manner described above was 
disrupted by gently rubbing the intimal layers with forceps. These rings were cut 
longitudinally to form strips to be used as ‘recipients’ for EDRF. Ring preparations 
with an intact endothelium were also cut longitudinally with care taken to minimise 
disruption of the endothelium. These were used as ‘donors’ of EDRF for superfused 
‘recipient’ aortic strips. Recipient aortic strips were suspended in a perspex gutter for 
isometric tension recording of the circular smooth muscle (Figure 5.1). A ‘donor’ 
strip was placed over the ‘recipient’ strip such that the circular smooth muscle of the 
‘donor’ and ‘recipient’ strips were at right angles in order to prevent mechanical 
interference from agonist-induced contraction of the ‘donor’ strip. This arrangement 
was then superfused with PS S at a rate of 6  ml min'1.
After 45 minutes equilibration, the strips were superfused with 0.1 jiM PhE in order 
to contract the rubbed ‘recipient’ strip. When the recorded tension in the ‘recipient’ 
strip had reached a plateau the strips were superfused with 10qM carbachol and any 
relaxations of the ‘recipient’ strip recorded. The effect of palmitoyl carnitine on 
carbachol-induced relaxations was examined by 2 0  minutes pre-incubation of the 
‘donor’ or the ‘recipient’ preparation with 30(iM palmitoyl carnitine prior to 
superfusion with carbachol.
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Figure 5.1
Diagram of apparatus used for bioassay of EDRF. An endothelium-disrupted 
(‘recipient’) strip of rat aorta is suspended in a channel in a perspex block between a 
fixed wire support and an isometric tension transducer. The strip is superfused 
with PSS (6 ml min'1) and an endothelium intact ring, cut to form a strip, placed 
over the ‘recipient’ with its intimal layer in contact with the smooth muscle of the 
‘recipient’ to act as a ‘donor’ of EDRF.
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All agonist-induced relaxation responses were expressed as a percentage of the 
induced tone. When necessary statistical analysis was carried out using Student’s 
unpaired t test. The potency for the inhibitory action of palmitoyl carnitine against 
agonist-induced relaxation of PhE-induced tone was estimated as the molar 
concentration of palmitoyl carnitine required to inhibit the maximum relaxation by 50% 
(IC50) and expressed as the negative log10(IC50), i.e. the pIC50.
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Results
Agonist-Induced Relaxations
In ring preparations of rat aorta with an intact endothelium, ACh, ATP and A23187 
induced concentration-dependent relaxations of ljiM  PhE-induced tone (Figure 5.2a). 
The order of potency for agonist-induced relaxations was ACh = A23187 > A TP 
(Figure 5.2b). The maximum relaxation (as a percentage of induced tone) to ACh, 
ATP and A23187 was 62.0 ± 6.7, 47.2 ± 5.2 and 34.4 ± 7.2 respectively (Figure 
5.2a). In addition to these endothelium-dependent relaxations, SNP induced 
concentration-dependent relaxations of pre-contracted preparations with a maximum 
relaxation of 97.3 ±7.1 % of the induced tone (Figure 5.3).
At concentrations greater than lfiM, A23187 produced contraction of the ring 
preparation which directly opposed its relaxant effect (Figure 5.2b). When added prior 
to inducing tone with PhE, palmitoyl carnitine (3-100fiM) had no effect on the resting 
tension of the ring preparations. Palmitoyl carnitine (3-30|iM) had little effect on the 
contraction produced by l|iM  PhE when compared to the contraction in the control 
preparation (i.e. in the absence of palmitoyl carnitine). However, at a higher 
concentration (100)iM), palmitoyl carnitine caused a slight depression in the PhE- 
induced contraction compared to that in the control preparation (Figure 5.4). In ring 
segments pre-contracted with lfiM  PhE, palmitoyl carnitine caused concentration- 
dependent inhibition of the ACh- and ATP-induced relaxations (Figures 5.5 and 5.6). 
A23187-induced relaxations were not inhibited by concentrations of palmitoyl carnitine 
< 30fiM but were completely abolished by 30|iM palmitoyl carnitine. However, 
contractions induced by high concentrations of A23187 were augmented by palmitoyl 
carnitine in a concentration-dependent manner (Figure 5.7). Examination of the effect 
of palmitoyl carnitine on relaxation to a single, submaximal concentration of ACh 
(3fiM), ATP (100|lM) or A23187 (l^iM) clearly illustrates the concentration-dependent 
inhibition of agonist induced relaxation (Figure 5.8). The potencies (pIC50) for the
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Figure 5.2
Relaxations of lfiM  PhE-induced tone in intact rat aortic rings to cumulative 
addition of ACh (O ), A23187 (# ) ,  and ATP (A). Data shown represents 
relaxations expressed as (a) the percentage reduction of induced tone and (b) the 
percentage maximum relaxation to that agonist.
Points shown are mean ± s.e.m. (n=4-6).
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Figure 5.3
The effect of palmitoyl-camitine on SNP-induced relaxations of rat aortic rings pre­
contracted with ljiM  PhE. SNP-induced relaxations are expressed as a percentage 
of the induced tone in the absence (O) and presence of 30fiM palmitoyl-camitine.
Points shown are mean ± s.e.m. (n=6 ).
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Figure 5.4
Response of the rat aorta to repeated administration of ljiM  PhE (A ) in 
preparations with an intact endothelium. Responses shown are (a) time control 
and (b) the response before and after incubation with 100|iM palmitoyl carnitine 
10 minutes before addition of PhE.
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The effect of palmitoyl-camitine on ACh-induced relaxations of rat aortic rings pre­
contracted with lpM  PhE. ACh-induced relaxations are expressed as a percentage 
of the induced tone in the absence (O) and presence of 10|iM (# ) , 30|iM (A) and 
100|iM (A) palmitoyl-camitine.
Points shown are mean ± s.e.m. (n=4-6).
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The effect of palmitoyl-camitine on ATP-induced relaxations of rat aortic rings pre­
contracted with lf±M PhE. ATP-induced relaxations are expressed as a percentage 
of the induced tone in the absence (O) anti presence of 3|iM (# ) , 10}iM (A) anti 
30fiM (A) palmitoyl-camitine.
Points shown are mean ± s.e.m. (n=4-6).
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Figure 5.7
The effect of palmitoyl-camitine on A23187-induced relaxations of rat aortic rings 
pre-contracted with ljiM  PhE. A23187-induced relaxations are expressed as a 
percentage of the induced tone in the absence (O) and presence of 3|iM (# ) , 10|iM 
(A) and 30|iM (A) palmitoyl-camitine.
Points shown are mean ± s.e.m. (n=4-6).
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Figure 5.8
The effect of palmitoyl carnitine on relaxation of PhE-induced tone by a) 3|iM ACh, 
b) lOOfiM ATP and c) ljiM  A23187. Data shown is mean percentage reduction of 
induced tone ± s.e.m. (n=4-6) in the presence of palmitoyl carnitine (# ) .
Please note: O  represents the mean response in the absence of palmitoyl carnitine.
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inhibitory action of palmitoyl carnitine against ACh-, ATP- and A23187-induced 
relaxation of PhE-induced tone were estimated as 5.12, 4.90 and 4.83 respectively, 
palmitoyl carnitine, at a concentration which markedly inhibited ACh-induced 
relaxations (30}iM) had no significant effect on the endothelium-independent relaxation 
induced by SNP (Figure 5.3).
In ring segments with an intact endothelium lOfiM ACh induced a rapid, well 
maintained relaxation of tone induced by l|iM  PhE which was markedly attenuated by 
incubation with 30|iM  palmitoyl carnitine. The relaxation to 10|iM ACh in the 
preparation previously exposed to palmitoyl carnitine was restored to levels 
comparable to those seen in the paired control preparation after four wash cycles 
(Figure 5.9). Histological examination of the intima by electron microscopy showed 
that pre-incubation with 30|iM  palmitoyl carnitine had no visible effect on the 
endothelial cell layer compared to control preparations (Figure 5.10).
Comparative Effect o f BAY K 8644
In paired preparations of rat aorta pre-contracted with ljiM  PhE, cumulative addition 
of palmitoyl carnitine or BAY K8644 had no significant relaxant effect in either the 
presence or absence of an intact endothelium. BAY K 8644 but not palmitoyl carnitine 
caused further contraction of the preparations (Figure 5.11). In endothelium-intact 
preparations, incubation with palmitoyl carnitine (30|iM) or BAY K 8644 (3fiM) 10 
minutes before addition of l|iM  PhE attenuated subsequent ACh-induced relaxations. 
However, BAY K 8644 caused a marked potentiation of the contraction to PhE; this 
phenomenon was not seen with palmitoyl carnitine (Figure 5.12).
Palmitoyl carnitine (30|iM) or BAY K 8644 (3|iM) caused reversal (contraction) of 
l |iM  ACh-induced relaxation in preparations with an intact endothelium which had 
been pre-contracted with PhE. The magnitude of the contraction due to reversal of 
relaxation (contraction) by BAY K 8644 was greater than would be expected in the 
absence of ACh-induced relaxation. However, the magnitude of the contraction
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Figure 5.10
Scanning electron micrograph of rat aortic ring with an intact endothelium after 
incubation for 20 minutes with 100|iM palmitoyl carnitine. Upper and lower 
panels show the intimal surface of the aortic ring at magnifications of x500 and 
x2 0 0  respectively.
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resulting from the reversal of relaxation (contraction) by palmitoyl carnitine was 
comparable to that which would be expected in the absence of ACh-induced relaxation 
(Figure 5.13). Similarly, BAY K 8644 (3|iM) caused reversal (contraction) of 
0.1 fiM SNP-induced relaxation in preparations with an intact endothelium which had 
been pre-contracted with PhE: this contraction, as seen with reversal of ACh-induced 
relaxations was greater than would be expected in the absence of SNP-induced 
relaxation. In contrast palmitoyl carnitine (30|iM) had no effect on relaxations induced 
by 0.1 |iM  SNP (Figure 5.14).
Bio as say o f ED RF
In superfused recipient strips of rat aorta with a disrupted endothelium PhE produced 
a well maintained contraction. Superfusion with 10|iM carbachol caused a rapid well 
maintained relaxation of this PhE-induced tone (35.7 ± 5.3, n=4, percentage reduction 
of induced tone) only when ‘donor’ strips with an intact endothelium were placed over 
them. When the ‘donor’ segment was removed from the superfusion gutter the 
carbachol-induced relaxation in the ‘recipient’ strip was rapidly reversed and the PhE- 
induced tone returned to a level which would be expected in the absence of carbachol- 
induced relaxation (Figure 5.15).
The relaxation, by carbachol, in the presence of an intact ‘donor’ ring, was 
significantly reduced (P<0.05; Student’s unpaired t test to 11.7 ± 2.9, n=4, percentage 
reduction of induced tone) if the ‘donor’ ring was pre-incubated with palmitoyl 
carnitine. No significant change in response to carbachol was observed if the recipient 
strip alone was pre-incubated with palmitoyl carnitine (35.3 ± 8.7 percentage 
reduction of induced tone; Figure 5.16).
205
-wv'Sui 0001
T f
in
0)u
3
0 £
Z
206
Re
ve
rs
al
 o
f 
the
 
re
la
xa
tio
n 
of 
to 
O.
ljiM
 
SN
P 
(▼
) 
in 
rat
 a
or
tic
 
rin
gs
 p
re
-c
on
tra
ct
ed
 
wi
th 
lpM
 
Ph
E-
in
du
ce
d 
ton
e 
(A
) 
by 
ad
di
tio
n 
of 
(a)
 B
AY
 
K 
86
44
 
and
 
(b)
 p
al
m
ito
yl
-c
am
iti
ne
. 
•
IT)
in
CJ
s
2 ?Z
ion
R
el
ax
at
io
n,
 in
 
the
 
pr
es
en
ce
 
of 
a 
‘d
on
or
’ t
iss
ue
, 
by 
su
pe
rfu
sio
n 
wi
th 
lOp
M 
ca
rb
ac
ho
l, 
of 
a 
rat
 a
or
tic
 
str
ip 
wi
th 
di
sru
pt
ed
 
en
do
th
el
iu
m
. 
To
ne
 
w
as
 
ind
uc
ed
 
by 
su
pe
rfu
sio
n 
wi
th 
O.
lpM
 
ph
en
yl
ep
hr
in
e.
 
Re
m
ov
al
 o
f 
the
 
‘d
on
or
’ t
iss
ue
 
rap
idl
y 
re
ve
rse
d 
the
 
ca
rb
ac
ho
l-i
nd
uc
ed
 
re
lax
ati
on
 
of 
the
 
‘re
ci
pi
en
t’ 
tis
su
e.
5 0 “
0)
|  40-  
■oD O
-§ 30-
I.-o3 
T3
£  1 0 - 
0 -
Figure 5.16
Relaxation of PhE-induced tone (expressed as a percentage reduction of the induced 
tone) in superfused ‘recipient’ aortic strips with a disrupted endothelium. 
Relaxations are due to carbachol-induced release of EDRF from a ‘donor’ 
preparation placed over the ‘recipient’.
Data shown represents mean relaxations ± s.e.m. (n=4) in control preparations 
(open bar), after incubation with palmitoyl-camitine (30fiM) of ‘recipient’ strips 
alone (filled bar) and after incubation with palmitoyl-camitine of ‘donor’ strips alone 
(hatched bar). Statistically significant difference from control preparations using 
unpaired Student’s t test; ** P<0.005.
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Discussion
The contractile effects of the dihydropyridine Ca2+ channel activator, BAY K 8644, 
in partially depolarised rat aorta are reduced in the presence of the endothelium by a 
tonic release of EDRF (Spedding et al., 1987). However, the contractile effects of the 
lipid metabolite palmitoyl carnitine (Corr et al., 1984) which also acts as a Ca2+ channel 
activator (Spedding and Mir, 1987) under similar conditions of partial depolarisation 
were unaffected by the presence of a functional endothelium (Bigaud and Spedding,
1986). This suggested that palmitoyl carnitine, unlike BAY K 8644, depressed the 
tonic release or action of EDRF such that palmitoyl carnitine-induced contractions were 
unaffected by the endothelium. Evidence for the blocking action of palmitoyl carnitine 
on the release or effect of EDRF was provided by the observation that palmitoyl 
carnitine (10-100p.M) but not BAY K 8644 (lfiM ) attenuated and reversed ACh- 
induced relaxations of pre-contracted rat aortic rings.
The results of the present study confirm the inhibitory effect of palmitoyl carnitine on 
ACh-induced relaxations of the rat aorta (Bigaud and Spedding, 1986). A possible 
interaction of palmitoyl carnitine with the muscarinic receptor mediating endothelium- 
dependent relaxations has been excluded since relaxations to both ATP and the calcium 
ionophore A23187 (Pressman, 1976) were also inhibited by palmitoyl carnitine. The 
inhibitory action of palmitoyl carnitine is exclusive to endothelium-dependent 
relaxations since endothelium-independent relaxations to sodium nitroprusside were 
unaffected by a high concentration of palmitoyl carnitine which markedly inhibited the 
relaxations to ACh. Therefore, palmitoyl carnitine appears to block the release or 
effects of EDRF and this would explain the lack of effect of removal of the 
endothelium on palmitoyl carnitine-induced contractions of the rat aorta.
W hilst relaxations to ACh and ATP were inhibited in a concentration-dependent 
manner the relaxations to A23187 were blocked only by 30}iM palmitoyl carnitine. 
This might have indicated a preferential blockade by palmitoyl carnitine of ACh- and
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ATP-induced relaxations over relaxations induced by A23187. A similar preferential 
effect has been observed for the phospholipase A2 inhibitor monoalide (Long et al.,
1987). Thus, A23187 could release EDRF via a different cellular mechanism or 
release a different EDRF since there is evidence for species differences in EDRF or its 
metabolism (Forstermann et al., 1985) and there is now strong evidence for the 
existence of more than one endothelium-dependent relaxing factor (Vanhoutte, 1987; 
Komori and Suzuki, 1987; Feletou and Vanhoutte, 1988; Taylor et al., 1988). A 
simpler, and perhaps more likely, explanation is that A23187, at concentrations greater 
than ljiM , induced a contraction which masked the stimulated release of EDRF. This 
hypothesis is supported by the fact that the estimated potency for palmitoyl carnitine 
inhibition of A23187-induced relaxation was not markedly different from that for ATP 
and ACh. In addition, palmitoyl carnitine induced a concentration-dependent 
augmentation of the A23187-induced contractions: an observation consistent with 
inhibition of the A23187 mediated release of EDRF which in the absence of palmitoyl 
carnitine would attenuate its contractile effects.
In the study of Bigaud and Spedding, (1986), BAY K 8644 (l|iM ) had no inhibitory 
action against ACh-induced relaxations of the rat aorta. In contrast, the results of the 
present study indicate an inhibitory effect of BAY K 8644 (3|iM). This difference in 
the observed effects of BAY K 8644 is difficult to explain but may be partly due to the 
different concentrations of BAY K 8644 used. However, this cannot be the full 
explanation since in two experiments using the lower concentration of BAY K 8644 
(data not shown) I have observed marked attenuation of the relaxation to ACh though 
less than that seen with the higher concentration used in this study (3|iM). Thus, both 
BAY K 8644 and palmitoyl carnitine inhibit endothelium dependent relaxations.
The inhibitory action of BAY K 8644 is perhaps surprising since it has been shown 
that in dog femoral arteries Ca2+ channel activators stimulate the release and augment 
the action of EDRF by activation of voltage operated Ca2+ channels (Rubanyi et al., 
1985) though this effect may be species or tissue dependent since in the rat aorta, BAY
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K 8644 does not increase the release of EDRF (Spedding et al., 1987). The 
explanation of this discrepancy is probably that the concentration range for BAY K 
8644 used in the present study (0.001-3fiM) is such that the facilitation of contractility 
caused by the activator masks any stimulated release of EDRF (seen also in the study 
of Rubanyi et al.). Since increasing the degree of activation of vascular smooth muscle 
attenuates subsequent endothelium-dependent relaxations (see Chapter Two) the 
inhibitory action of BAY K 8644 may not be due to a specific interaction with EDRF 
but secondary to its smooth muscle activation. This suggestion is supported by the 
observation that when added cumulatively to a pre-contracted preparation BAY K 8644 
did not induce any measurable relaxation in rubbed or unrubbed preparations indicating 
no release of EDRF. Moreover, the apparent reversal (contraction) of an established 
ACh-induced relaxation by BAY K 8644 produced a final tone which was greater than 
would be expected in the absence of ACh-induced relaxation and BAY K 8644. In a 
similar manner, BAY K 8644 reverses the endothelium-independent relaxation to SNP 
to a similar extent probably indicating that the inhibition of relaxation by BAY K 8644 
is due to activation of the vascular smooth muscle and not to an interaction with the 
mediators of endothelium-dependent relaxation. This is consistent with the 
observation that removal of the basal release of EDRF potentiates BAY K 8644- 
induced contractions (Spedding et aL, 1987)
A comparison between the effects of palmitoyl carnitine and BAY K 8644 indicates 
that their actions differ. Although both are Ca2+ channel activators in smooth muscle 
(Spedding and Mir, 1987) the action of palmitoyl carnitine in contrast to that of BAY K 
8644 is not due to augmentation of smooth muscle tone. In contrast to BAY K 8644, 
concentrations of palmitoyl carnitine which inhibited endothelium-dependent 
relaxations did not potentiate the tone induced by PhE whether added before or after 
establishment of the PhE-induced contraction. In addition, in the presence of an 
established ACh-induced relaxation, palmitoyl carnitine caused a contraction which 
could be accounted for wholly by reversal of the relaxation to ACh. Moreover, in
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contrast to BAY K 8644, palmitoyl carnitine had no effect on an established 
endothelium-independent relaxation to SNP. Thus palmitoyl carnitine inhibits the 
relaxations of the rat aorta only by agents whose action is mediated by release of 
endothelium dependent relaxing factor and this effect is not simply due to augmentation 
of smooth muscle tone.
The presence of extracellular calcium is a pre-requisite for the production of 
endothelium-dependent relaxations since exclusion of Ca2+0 attenuates endothelium- 
dependent relaxations (Singer and Peach, 1982; Long and Stone, 1985; Winquist et 
al., 1985) although the precise involvement of Ca2+ channels is still under question 
since some studies have reported a lack of effect of calcium antagonists (Winquist et 
al., 1985; Jayakody et al., 1987). Thus activation of Ca2+ channels of the endothelium 
by palmitoyl carnitine might be expected to induce the release of EDRF in a manner 
similar to that seen by Rubanyi et al., (1985). Indeed, Criddle et al., (1987) have 
reported endothelium-dependent relaxations of pre-contracted rat aortic rings by 
palmitoyl carnitine. If this activation resulted in a maximal release of EDRF then this 
would obviously inhibit any further stimulated (or basal) release of EDRF. This is 
unlikely to be the mechanism of the inhibitory action of palmitoyl carnitine in the 
present study since addition of palmitoyl carnitine to a pre-contracted ring preparation 
did not produce relaxations in the presence or absence of functional endothelium. 
Moreover, palmitoyl carnitine reversed relaxations induced by a near maximal 
concentration of ACh, an effect which would not be seen if palmitoyl carnitine also 
stimulated the release of EDRF at the concentration used.
The discrepancy in the effects of palmitoyl carnitine on pre-contracted tissues 
between this study and that of Criddle et al., (1987) is difficult to explain since the 
same preparation was used and the concentration ranges overlap. The influence of the 
basal release of EDRF in the rat aorta has been shown to be particularly marked 
(Collins et al., 1986). One explanation of the effects reported by Criddle et al., (1987) 
could be that palmitoyl carnitine at the concentrations used did not induce the release of
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EDRF but rather potentiated the effect of EDRF released under basal conditions. The 
tonic and stimulated release of EDRF activates guanylate cyclase elevating cytosolic 
cGMP levels (Rapaport and Murad, 1983; Griffiths et al., 1985). This leads to 
lowering of the cytosolic concentration of Ca2+ (Kobayashi et al., 1985) due to 
stimulation of the plasmalemmal Ca2+-extrusion ATPase (Popescu et al., 1985) and 
sequestration of Ca2+ into the sarcoplasmic reticulum (Twort and van Breemen, 1988). 
Low concentrations of palmitoyl carnitine can stimulate Ca2+ ATPase and sequestration 
of Ca2+ into the sarcoplasmic reticulum (Adams et al., 1979) and it is possible that this 
might potentiate the effects of tonicly released EDRF and may produce an apparently 
endothelium-dependent relaxation. This effect, therefore might explain the results 
obtained with low concentrations of palmitoyl carnitine by Criddle et al., (1987).
Using a simple bioassay technique we have demonstrated that carbachol can induce 
relaxations of an endothelium denuded ‘recipient’ strip of aortic smooth muscle only 
when an endothelium intact ‘donor’ strip is placed on the recipient such that the intima 
of the donor is in contact with the smooth muscle of the ’recipient’. This clearly 
demonstrates the diffusion of EDRF from ‘donor’ to ‘recipient’ (Furchgott & 
Zawadzki, 1980). The relaxation of endothelium denuded ‘recipient’ strips by EDRF 
released from intact ‘donor’ rings was inhibited if the ‘donor’ strip was pre-incubated 
with palmitoyl carnitine but not if the assay strip itself was pre-incubated with 
palmitoyl carnitine. This suggests that the inhibitory effect is not due to an inhibitory 
action of palmitoyl carnitine at the smooth muscle and is unlikely to be due to 
‘deactivation’ of EDRF. Thus the inhibitory action of palmitoyl carnitine is likely to be 
on the endothelium to inhibit release or synthesis of EDRF, and not on the vascular 
smooth muscle itself.
The present study provides evidence for the site of action of palmitoyl carnitine for 
inhibition of stimulated and basal release of EDRF. The precise mechanism of this 
effect has not been found though an action at Ca2+ channels to facilitate contraction and 
hence attenuate relaxation has been excluded. In addition to being a possible
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endogenous Ca2+ channel activator (Spedding and Mir, 1987), palmitoyl carnitine also 
acts as a detergent at relatively high concentrations (Idell-Wenger et al., 1978; Neely 
and Feuvray, 1981; Spedding and Mir, 1987) and this could have accounted for the 
loss of endothelium-dependent relaxation due to removal or irreversible damage of the 
endothelial cell layer. This is probably not the case however, since histological 
examination of ring preparations incubated in 30pM palmitoyl carnitine showed the 
presence of an intact endothelial cell layer. Moreover, in preparations where the 
relaxant response to ACh had been abolished by pre-treatment with 30[iM palmitoyl 
carnitine, repeated washes in palmitoyl carnitine-free PSS resulted in almost complete 
restoration of the relaxant response to ACh. Thus, whilst the effect of palmitoyl 
carnitine was somewhat difficult to ‘wash out’, the eventual restoration of most of the 
relaxant response to ACh indicates that palmitoyl carnitine does not irreversibly 
damage the endothelium suggesting that the detergent properties of palmitoyl carnitine 
are not the major factor in its inhibitory action on EDRF.
Hypoxia, and incubation with low concentrations of palmitoyl carnitine (lpM ) for 10 
minutes, leads to an increase in the number of a!-adrenoceptors in dog myocytes 
(Heathers et al., 1987). An increase in the number of ai-adrenoceptors would 
presumably lead to a greater degree of activation by a submaximal concentration of 
PhE and therefore would cause attenuation of the effects of agonist-induced release of 
EDRF (see Chapter Two). In a similar manner to the Ca2+-channel activating action of 
palmitoyl carnitine, this effect cannot explain the inhibition of endothelium-dependent 
relaxations since there is no palmitoyl carnitine-induced increase in the contraction to 
PhE.
In addition to the actions described above, palmitoyl carnitine can also cause 
inhibition of Na+/K+-ATPase (McMillan-Wood et al., 1977; Lamers and Hulsmann, 
1977; Adams et al. 1979). Recent studies have indicated that some agents that produce 
endothelium -dependent relaxations also generate endothelium -dependent 
hyperpolarisations (Bolton and Clapp, 1986; Beny et al., 1986). This transient
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hyperpolarisation is independent of the stimulation of guanylate cyclase by EDRF and 
appears to be due to activation of smooth muscle N a7K +-ATPase or K+ channels 
(Feletou and Vanhoutte, 1988; Taylor et al., 1988) by a substance other than nitric 
oxide (Vanhoutte, 1987). One substance which has been shown to activate K+ 
channels has been termed endothelium-dependent hyperpolarising factor (EDHF; 
Taylor and Weston, 1988). The significance of EDHF(s) is dependent upon the 
species and preparation used (Taylor and Weston, 1988) but the action of palmitoyl 
carnitine on Na+/K+-ATPase may play an important role in its inhibition of endothelium- 
dependent relaxations. However, if this inhibition of Na+/K+- ATPase is to account for 
the inhibition of endothelium-dependent relaxations by palmitoyl carnitine then the 
action must be at the endothelial Na+/K+-ATPase since there is no inhibitory action of 
palmitoyl carnitine at the smooth muscle. This is consistent with the observation by 
Feletou and Vanhoutte (1988) that the relaxations and membrane hyperpolarisation of 
‘recipient’ dog coronary artery by ACh-induced release of EDRF(s) from ‘donor’ dog 
femoral artery was abolished by ouabain. Although these workers suggested that this 
effect may be due to a pharmacological action of ouabain not involving Na7K+-ATPase 
this may give an indication of the mechanism of action of palmitoyl carnitine in 
inhibiting endothelium-dependent relaxations of the rat aorta.
To conclude: we have provided evidence for the inhibition of endothelium- 
dependent relaxation of the rat aorta by a lipid metabolite that accumulates under 
ischaemic conditions: palmitoyl carnitine. The mechanism of action of the inhibition is 
unknown but it appears not to be associated with the Ca2+ channel activating action of 
palm itoyl carnitine since the inhibition is dissim ilar to that seen with the 
dihydropyridine Ca2+ channel activator, BAY K 8644. The site of action of palmitoyl 
carnitine appears to be at the endothelium but is unlikely to be due to a detergent action 
of palmitoyl carnitine on the endothelial cell layer. Further work is required to 
determine ( 1 ) the precise mechanism of action of palmitoyl carnitine in inhibiting 
endothelium-dependent relaxation, (2 ) any possible involvement of palmitoyl carnitine
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in anoxic augmentation and hypoxic contraction and (3) whether the build up of 
palmitoyl carnitine during ischaemia and possible blockade of release of EDRF occurs 
and is of pathological significance.
216
General Discussion
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Using the descending thoracic aorta of the rat, I have examined several aspects of the 
influence of the vascular endothelium on the effect of stimulation of a-adrenoceptors, 
5-HT receptors and muscarinic receptors in a vascular smooth muscle preparation. 
The basal release of EDRF may modulate agonist activity by affecting Ca2+ fluxes of 
the smooth muscle cells. In order to rule out the possibility that any differential effect 
of removal of the endothelium on the responses to a-adrenoceptor and 5-HT receptor 
activation may have been due to differences in their Ca2+ dependency I first examined 
the responses to agonists at these receptors. This part of the study revealed an 
interesting phenomenon in that whilst contractions induced by ‘PhE/Ca2+-re-addition’ 
were comparable with PhE-induced contractions in ‘fixed’ [Ca2+]0, ‘5-HT/Ca2+-re- 
addition’ produced unexpectedly smaller contractions than those seen with addition of 
5-HT in ‘fixed’ [Ca2+]0. No definitive explanation of this was discovered but 
differential activation of VOCs by the agonists was ruled out. However, a possible 
differential effect of the agonists on phosphotidyl-inositide hydrolysis was indicated by 
the differential effect of LiCl pre-treatment on contractions to PhE and 5-HT. Despite 
this marked difference between the Ca2+ re-addition response in the presence of 5-HT 
and PhE, removal of the endothelium (and therefore the basal release of EDRF) 
potentiated the responses to both agonists to a similar degree suggesting that, in this 
case, the depressant effect of the endothelium on the agonist-induced contractions was 
not mediated by an effect on Ca2+ fluxes.
Since the first reports concerning EDRF there has been a great deal of work carried 
out to characterise the nature and action of the factor(s). It is noticeable that the reports 
of the effects of both the basal and stimulated release of EDRF can vary markedly 
between laboratories and/or workers. In addition to the usual factors affecting 
experimental results (PSS composition, temperature etc) I decided (as a joint study 
with Alison Templeton) to investigate the possibility that the tissue resting tension and 
degree of agonist-induced tone used to examine the effects of EDRF might contribute 
to the variation seen in the published data. The results of the study show that when the
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initial resting tension of paired rubbed/unrubbed rat aortic rings is the same then the 
degree of stretch in both tissues is comparable. Thus, there can be no contribution 
from different degrees of stretch of the muscle to the differences seen between the 
tissues. However, the optimum degree of stretch for demonstration of contraction of 
the tissue per se was, in most cases, different from the optimum for demonstration of 
the basal or stimulated release of EDRF. Therefore, suspending a smooth muscle 
preparation at the optimum tension for contraction (as is often the case in published 
studies) might mask the effect of EDRF which is being examined leading to errors in 
interpretation of experimental data. This is important in comparing preparations of 
different vessels or from vessels in different pathological states where the relationship 
between stretch and the optima for different responses may be different.
In addition to the influence of resting tension, the degree of agonist induced tone was 
found to affect the sensitivity to endothelium-dependent relaxations such that increases 
in tone produced decreases in the sensitivity of the preparation. This decrease in 
sensitivity to endothelium-dependent relaxations did however reach a point beyond 
which further increases in tone had no further effect on the tissue sensitivity. Thus the 
conditions under which the effect of basal and stimulated release of EDRF are 
examined can markedly alter the observed effects and this must be taken into 
consideration when designing experiments and interpreting experimental results. For 
the remainder of the study, standard conditions of resting tension and agonist-induced 
tone (when examining stimulated release of EDRF) were used.
The potentiation of agonist-induced contractions (in particular those mediated by a- 
adrenoceptors) by removal of the endothelium has been characterised by a number of 
researchers. The apparently greater degree of potentiation of responses to a 2- 
adrenoceptor agonists compared to those of a r adrenoceptor agonists was first 
attributed to removal of a concomitant c^-adrenoceptor mediated stimulation of EDRF 
release which directly opposed the contractile effects of the agonists. The effect was 
later shown to be mainly due to the low efficacy of the ‘a 2-adrenoceptor’ agonists at
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ccradrenocepttors through which they cause contraction (the basal release of EDRF 
having a greater depressant effect on the contractions to ‘partial’ rather than ‘full’ 
agonists). Since the earlier work in the present study indicated that, in addition to the 
depression of a-adrenoceptor mediated contractions, responses to 5-HT in the rat aorta 
were also depressed I decided to examine if 5- HT receptor agonists of lower efficacy 
(i.e. N-MeT, 5-MeT and 5-CT) would be depressed to a greater degree than the ‘full’ 
agonist (5-HT). The study indicated that this was indeed the case. Despite the fact that 
in a number of preparations 5-HT and its analogues have been shown to induce 
endothelium-dependent relaxations, in the rat aorta no evidence for such an effect could 
be obtained. Thus in this preparation, the potentiation of 5-HT-induced contractions 
seen on disruption of the endothelium is wholly attributable to removal of a basal and 
not a stimulated release of EDRF.
Having assessed the influence of the basal release of EDRF on agonist-induced 
contraction I decided to examine the stimulated release of EDRF. Two aspects of the 
stimulated release of EDRF were examined. The first aspect was the classification of 
the muscarinic receptor mediating the endothelium-dependent relaxations of the 
preparation. There has been some debate as to the precise subtype of muscarinic 
receptor mediating endothelium-dependent relaxations. Using selective antagonists I 
have now characterised this receptor as being of the M2 subtype. Interestingly, 
although the antagonists studied indicate that the receptor is similar to that found in non 
vascular smooth muscle preparations such as the guinea-pig ileum and trachea, the 
receptor would appear to be linked to a different second messenger system. This is 
indicated by the observation that chronic pre-treatment with LiCl (a treatment 
attenuating the responses to muscarinic agonists in the ileum) had no effect on the 
sensitivity to several muscarinic agonists of various efficacies. Further work is needed 
to characterise the second messenger system of this receptor population since pertussis 
toxin (a substance which inactivates the atrial type M2 receptor) has no effect on ACh- 
induced relaxations in this preparation (R.M. Eglen, personal communication).
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The second and final aspect of the stimulated release of EDRF examined was the 
effect of a lipid metabolite of ischaemia (palmitoyl carnitine) on endothelium-dependent 
relaxations. This substance may have a modulatory role on the effect of the 
endothelium in ischaemic conditions. I found that palmitoyl carnitine caused a 
concentration-dependent inhibition of endothelium-dependent relaxations to a number 
of agonists without affecting endothelium-independent relaxations to sodium 
nitroprusside. This inhibition did not appear to be related to the Ca2+ channel 
facilitation that occurs with this substance since the inhibition of endothelium- 
dependent relaxations by BAY K 8644 was qualitatively different. Whilst the site of 
action of palmitoyl carnitine appears to be at the endothelium the precise mechanism of 
action was not determined. However, since the extent to which palmitoyl carnitine 
plays a role in the damage found in ischaemic tissues and the role of EDRF under such 
conditions is largely unknown, further work in this area could lead to a therapeutically 
useful target for drug development.
In conclusion, using a readily available preparation I have carried out (in part in 
collaboration with colleagues) an extensive study into the effects of the endothelium on 
responsiveness of vascular smooth muscle. I have characterised the Ca2+ requirement 
for activation of the preparation by a-adrenoceptor and 5-HT receptor activation. The 
study has illustrated that varying the initial experimental conditions can, in some cases, 
influence the interpretation of the experimental data. I have confirmed and expanded 
observations made by others on the depression of contractile responses by the basal 
release of EDRF and have made a definitive classification of the muscarinic receptor 
subtype mediating endothelium-dependent relaxations. Finally, I have examined the 
effect of a possible mediator of ischaemic damage on the production and/or release of 
EDRF.
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W hilst the experim ental w ork which I have presented in this thesis has answ ered a 
num ber o f questions, the nature o f  pharm aco log ica l research  is such that m ore 
questions have been asked. In the future I hope to be able to answ er som e o f these 
questions.
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Appendix
Computerised system for 
acquisition and analysis of data.
Appendix
The analysis of experimental data by measuring traces recorded on chart recorders is 
often time consuming and tedious. This is particularly the case if a number of different 
parameters are to be measured from one trace e.g. tension at set times, tension at 
plateau of response, and time between events.
In order to reduce the time spent on this task, I designed a system for the BBC 
microcomputer which allows the direct sampling of data recorded on a Linseis chart 
recorder. As with the majority of serious software applications for the BBC 
microcomputer, the system is ‘soft key driven’ i.e. it utilises the programmable ‘soft 
keys’ of the computer, and is therefore simple to use. The sampled data (or data 
entered independently of the chart sampling facility) is stored and can then be retrieved 
repeatedly for analysis by a variety of methods.
With maximum flexibility of the system in mind, in addition to the data collection, 
storage, retrieval, and analysis functions of the system, it is also possible to ‘program’ 
a series of instructions for the recorder to follow. For example the recorder can be 
switched on and off and the speed can be altered at set times for various lengths of 
time. This is particularly useful when physiological responses change slowly over a 
long period and there is a need to examine more closely the response at set intervals 
(by speeding up the trace) e.g. twitch response of vas deferens.
In the following pages is a description of this data retrieval and storage system which 
I have called DATAFILE.
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DATAFILE has been designed as a simple to use, ‘user-friendly’, menu driven, data 
storage system principally for the storage and analysis of concentration-response 
curves and can be used by people with a minimum of ‘computer know-how’. Within 
DATAFILE there is a limited scope for analysis of the stored data e.g. expression of 
the tissue response as; a percentage of its own maximum or another entered value, 
actual changes in tension, absolute tension. DATAFILE can be used to plot stored data 
using an Epson printer. Stored data can also be converted to a ‘BEEMAC’ format 
which may be transferred to an Apple Macintosh Microcomputer, a powerful facility 
which allows further, more sophisticated data analysis and plotting and gives an 
indirect method of transferring data to an IBM PC.
DATAFILE was designed to have several advantages over ‘manual’ data storage 
systems:
i) standardised print-out of data thus making reading of the data much easier and 
avoiding complications of individual handwriting.
ii) storage of raw data thus enabling greater ease of varied analysis at a later date.
iii) rapid effortless plotting of data gives a very quick indication of the results of the 
current experiment.
iv) disc storage (in particular of more than one copy kept in different locations) offers 
greater security against loss of valuable experimental data.
DATAFILE was written primarily on and for the BBC model B microcomputer but 
will function equally as well with a BBC B+ and/or in conjunction with a second 
processor. Use of a BBC Master 128K microcomputer allows data captured from a 
Linseis chart recorder to be analysed practically. In these systems with expanded 
capacity the programs run faster and it is possible to enter a greater number of data 
items, e.g. curves, preparations, concentrations.
A (iii) Appendix
Disc and Disc Drive
DATAFILE cannot be used with a single-sided, single disc drive. The minimum 
requirement for the system is a single sided, double disc drive. However, due to the 
limitations of the BBC disc filing system (i.e. a maximum of 31 files per side of 
diskette) a double sided, double disc drive is preferable thus reducing the number of 
data discs necessary. Although it is possible to store files on side 2 of the program 
discs this is not advisable since it necessitates a comprehensive knowledge of the 
DATAFILE programs, an error in which may result in the loss of data which has taken 
some time to enter.
The Datafile System
The program disc has been designed with an ‘AUTO BOOT’ and therefore after 
placing the program disc into drive 0, pressing <SHIFT-BREAK> will give access to 
the system.
DATAFILE is a menu-driven system and thus once within it the user may move 
within the system via certain menus.
In order to maximise the speed of operation and the amount of data that can be 
entered DATAFILE utilises the ‘shadow’ memory of the BBC (see User Manual). If 
the user’s computer does not support shadow memory DATAFILE will compensate 
for this and prevent a system crash. After a brief title page the system then displays the 
first menu, i.e. MAIN MENU.
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MAIN MENU
A FOR DATA INPUT Entering of data for future analysis
B TO PROCESS FILE Manipulation of stored files and further analysis
C LINCHART Allows data collection from Linseis chart recorder.
D FORVOLADD Volume of liquid needed to give a concentration
E FORAMMADD Amount of solid needed to give a set concentration
F SCHILD ANALYSIS Allows Schild Analysis on entered log10 (CR-1) or EC50
values.
G KERMIT Allows access to communications program (if Kermit 
ROM is installed in the BBC micro) for transfer of data to 
the Macintosh.
A FOR DATA INPUT
Within this option various ‘screens’ are used to input data. Errors made whilst 
entering data can be rectified at the time of entering or at a later date using the EDIT 
facility available in option B. Below is a brief summary of option A.
Enter a) date of experiment, b) preparation, c) agonist, d) antagonist, and e) 
conditions used e.g.
14/2/86,
RAT A RINGS,
5-HT,
RITANSERIN,
KREBS’ 5/95% CARBOGEN 37’C pH 7.4
Enter Number of concentrations used, number of preparations used, number of 
curves generated
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Enter Concentrations used - entries made in exponential format, i.e. IE - 6  = l(iM, 
1x10-6 M. The red function keys are programmed to aid concentration entry, 
i.e. fl = 1E-, f2 = 2E-, f3 = 3E- etc.
Enter Baseline tensions - important if there is a need to know the absolute tension 
(response + resting tension) of the tissue.
Enter Treatment - of each preparation for each curve, e.g. 5HT. This is printed when 
a printout of a file is obtained.
Enter Response - to each concentration of each preparation for each curve 
constructed. It is recommended that these values be entered as mg.wt. rather 
than g.wt. for reasons of formatting.
Enter Comments - the comments are (if necessary) entered as two entries each of 238 
characters.
After entry of any relevant comments (which should include any observations made 
throughout the experiment) DATAFILE asks the user to declare the drive containing 
the data disc followed by a suitable filename. The user is not allowed to store the data 
that has been entered using the name of a file which already exists on the declared 
drive since this will erase that file. When DATAFILE saves a datafile it ‘locks’ the file 
thus preventing accidental erasure whilst outside the DATAFILE system. When files 
are converted by options in other menus (see later discussion) and again stored the 
datafile are again ‘locked’. DATAFILE unlocks and re-locks files automatically when 
necessary.
On completion of data input DATAFILE returns to MAIN MENU.
B TO PROCESS FILE
This option allows access to the PROCESS FILE menu which will be discussed 
later.
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C LINCHART
The method of capturing data from a Linseis chart recorder was developed as a 
separate function from the data-storage and retrieval function of DATAFILE and 
incorporated into the system at a later date. The LINCHART option gives access to 
both data capture from the Linseis chart recorder and also a means by which to 
‘program’ a series of instructions for the recorder to follow. For example the recorder 
can be switched on and off and the speed can be altered at set times for various lengths 
of time. This is particularly useful when physiological responses change slowly over a 
long period and there is a need to examine more closely the response at set intervals 
(by speeding up the trace) e.g. twitch response of vas deferens. LINCHART is 
operated using the red function keys of the BBC.
Sampling Data
Data sampling from the Linseis recorder is accomplished by continuous measurement 
of the position of the recorder pens. The user enters a conversion factor (which will 
be used to convert the captured data into a more useful format (e.g. mg.wt.). The 
maximum number of available data samples will depend on the number of channels 
being used for a particular set of curves. The number of samples required (in 
combination with the sampling interval) will limit the duration of sampling. The 
interval between sampling determines the resolution of the sampling. If the sampled 
responses are slowly developing, a five second sampling interval will be sufficient to 
give a clear resolution when later measuring the recorded data. The minimum 
sampling interval is 0.5 seconds.
The user uses the BBC’s red function keys to ‘mark’ an event e.g. the addition of a 
drug. Other function keys are used to begin, pause, and end continuous sampling after 
which the captured data is stored on disc. Individual files are created for the data 
obtained from all channels at a particular time. For example if three concentration 
response curves are obtained from six channels then three files, each containing the 
data from all six channels, will be created.
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Programming the Linseis Chart Recorder
Sequences of instructions may be entered and saved for the chart recorder to follow
at a later stage. The user enters a sequence of instructions that are to be followed,
again using function keys assigned a particular instruction.
Available Instructions:
Pen Up Lifts pens if pens already in the down position.
Pen Down Lowers pens if pens already in the raised position.
Start Chart Starts chart: this instruction is followed by a time parameter which is
the length of time (in seconds) that the chart is to run at the present 
speed and direction.
Stop Chart Stops chart: this instruction is followed by a time parameter which is
the length of time (in seconds) that the chart is to be stopped for. This 
can be used as a method of pausing the sequence of instructions.
Move Chart Moves the chart in a declared direction (forward or reverse) for a set
distance
MZK Sync This instruction has a variety of functions and is dependent on the
parameter which is entered. (For further details see DATAFILE 
manual).
D FORVOLADD
This option is a utility program which calculates the volume (in mis) of liquid that 
must be added to an entered weight (in mgs), of a compound of entered molecular 
weight (in grammes), to give an entered molar concentration.
E FOR AM ADD
Another utility program which calculates the amount (in mgs), of a compound of 
entered molecular weight (in grammes), to be added to an entered volume of liquid (in 
mis), to give an entered molar concentration.
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F SCHILD ANALYSIS
This option allows the calculation of pA2 values and slope of Schild plots (y = log10 
(Concentration ratio - 1); x = Antagonist Concentration) giving mean values ± standard 
deviation for both pA2 and slope. The Schild analysis can be plotted and the entered 
data saved.
PROCESS FILE MENU
This menu is accessed via option B of MAIN MENU and allows the manipulation of 
whole datafiles and to give access to further analysis of the data contained within.
A EDIT DATAFILE Editing of stored datafiles.
B PROCESS DATAFILE Manipulation and further analysis of stored data 
C RENAME DATAFILE Renaming of stored datafiles.
D DELETE DATAFILE Deletion of stored datafiles.
E CATALOGUE Catalogue of files stored on disc in declared drive.
A EDIT DATAFILE
Within this option the stored data can be edited or simply examined. Each of the 
‘input’ screens used in option A of the MAIN MENU are shown and any changes can 
be made. The edited file can be saved using the old filename, a new filename, or 
simply aborted.
B PROCESS DATAFILE 
This option allows access to the PROCESS DATAFILE menu discussed below.
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C RENAME DATAFILE
This option allows the re-naming of stored files. If the new filename already exists 
the computer will inform the user. Renaming of files to existing file names is not 
allowed.
D DELETE DATAFILE
This option gives the means by which datafiles can be deleted. Deletion then takes 
place following a prompt from the user.
E CATALOGUE 
This option provides a list of the files stored on the disc in a declared drive.
PROCESS DATAFILE MENU
This menu is accessed via option B of the PROCESS FILE menu. The menu allows 
manipulation and access to further analysis of the data contained within a stored 
datafile.
A PRINT DATAFILE Print-out of stored datafile using standard format.
B DATAFILE CALCS Manipulation of data contained in datafiles.
C PLOT DATAFILE Plots data from stored datafiles.
D BEEMAC FORMAT Converts stored datafile to BEEMAC usable format.
E LINCHART-DATFELE Conversion of data captured using LINCHART into a
datafile.
F CATALOGUE Catalogue of files stored on datadisc in declared drive.
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A PRINT DATAFILE
This option produces a print-out in standardised, easy-to-read format from a datafile 
stored on a declared disc drive. The print-out can be made as a ‘rough’ or a ‘store’ 
copy the latter having a superior presentation. This provides a ‘hard copy’ of the disc 
data.
B DATAFILE CALCS 
This option allows access to the DATAFILE CALCS menu discussed below.
C PLOT DATAFILE
This option allows the plotting of data (or transformed data) from stored datafiles via 
a screen dump facility. The quality of the plots are not of report standard but are 
intended to be used as a quick indication of the results obtained from an experiment 
and any simple analysis that has taken place. More sophisticated plotting can be made 
using the Macintosh via DATAFTLE’s BEEMAC option.
After certain preliminaries are completed DATAFILE produces a screen plot of the 
data which may then be screen dumped to an Epson printer with or without the 
addition of a key. The user can then replot data from the same file, another file, or 
return to the PROCESS DATAFILE menu.
D BEEMAC FORMAT
This option allows the conversion of stored files to a format which can be sent to a 
Macintosh microcomputer for more complicated statistical analysis or plotting.
Files are converted to a text format and stored on disc. The converted files can then 
be transferred, as the text file, to a Macintosh by use of the communications program 
KERMIT (available on ROM for the BBC and software for the Macintosh) or any 
communications package which allows transfer of text files. The transferred text file
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can be read using a word processor or read directly into the spreadsheet package 
EXCEL.
E LINCHART-DA TFILE
This option allows the measurement of data previously captured from a Linseis chart 
recorder using the LINCHART option of MAIN MENU. Data captured using 
LINCHART is stored as individual files. The user enters the number of files to be 
used (equivalent to the number of curves entered during manual data input), the 
treatments for each curve of each preparation and any comments. The filename of the 
LINCHART files to be analysed are then entered and each recalled to produce an on­
screen ‘plot’ of the data contained within it. The range of concentrations used is 
displayed at the top of the screen and the response for each measured using a 
horizontal measuring line (positioned at the point of measurement using the cursor 
keys. The values measured are converted to mg. wt. or any other unit (depending 
upon the scaling factor entered in the LINCHART option). When all of the desired 
LINCHART files has been measured it is saved on a declared drive as a DATAFILE 
file which can then be treated as any other datafile.
F CATALOGUE
This option has the same function as in other menus.
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DATAFILE CALCS MENU
This menu is accessed via option B of the PROCESS DATAFILE menu. The menu 
allows manipulation and analysis of the data contained within stored datafiles.
A CALC ABSOLUTES Calculates absolute size of stored responses.
B CALC PERCENTAGES Converts stored data into percentage values.
C CALC SUBTRACTS Subtracts an entered value from stored data.
D EC-Response Calculates ECResponse values.
E EC-Percentage Calculates ECPeicemage values.
F SCALING FACTOR Multiplies stored data by an entered factor.
A CALC ABSOLUTES
Sometimes it is useful to know the absolute tension of the tissue, i.e. baseline 
tension + change in tension due to treatment. For example the same concentration of a 
drug in two tissues may produce very different responses in terms of the changes in 
tension which the drug produces. This may be due to several things, one of them 
being that the resting tension in each tissue is different. Expression of the results in 
this manner will give some indication as to whether or not this plays a role in such 
differences in responses.
DATAFILE retains a note of the fact that a file has been transformed and this is noted 
on any printout (including printed plots) that might be obtained. This transformed data 
can be further manipulated or analysed in the usual manner via options contained 
within DATAFILE.
B CALC PERCENTAGES
This option allows the stored data of a datafile to be expressed in terms of 
percentages. The data for each individual curve in a datafile may be expressed 
automatically as a percentage of the maximum response of that particular curve.
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Alternatively a single value to be used as the 100% value for all the curves contained 
within the datafile or individual values for each curve separately may be entered. As 
with option A, this transformed data can be further manipulated or analysed in the 
usual manner via options contained within DATAFILE.
C CALC SUBTRACTS
This option allows the responses contained as data within a datafile to be subtracted 
from any value. In a similar manner to option B above the value used may be the 
maximum for each curve (automatically determined by DATAFILE) or a single entered 
value for all curves or individual values entered for each curve. This option is 
designed primarily for analysis of relaxation response curves where the response to 
increasing concentrations is a decrease in developed tension but it is desirable to 
express the observed response as an increase (in relaxation) with increasing drug 
concentration. This can be seen more clearly in Figure A. 1 below.
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Figure A .l: Use of the CALC SUBTRACTS option to ‘invert data’.
As with options A and B, this transformed data can be further manipulated or 
analysed in the usual manner via options contained within DATAFILE.
D EC-Response
This option is used to calculate multiple EC-response values i.e. the effective 
concentration of agonists inducing a particular response, e.g. 500 mg.wt. increase in 
tone ( E C 50o mg.wt.). EC-Response values are calculated by finding the responses 
above and below the entered value, ‘drawing’ a straight line between them and the
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extrapolating downwards to determine the actual concentration (see Figure A 2). In 
order-to determine IC-Responses for relaxation responses the data must be first 
‘inverted’ using the CALC SUBTRACTS option above. The calculated EC- Response 
values may also be expressed as -log10 EC- Response values i.e. pEC-Response. 
These EC-Response/pEC-Response values may be printed or saved on disc for direct 
incorporation into options such as SCHILD ANALYSIS and BEEMAC FORMAT.
E  EC-Percentage
This option is used to calculate multiple EC-Percentage values, i.e. the effective 
concentration of agonists inducing a particular percentage response e.g. 50%. increase 
in tone (EC50). Calculation of EC-Percentage values is similar to that for EC- 
Responses and is calculated by finding the percentage responses above and below the 
entered value, ‘drawing’ a straight line between them and extrapolating downwards to 
determine the actual concentration (see Figure A.2). To determine IC-Percentages for 
relaxation responses the data must be first ‘inverted’ using the CALC SUBTRACTS 
option above. The calculated EC-Percentage values may also be expressed as -log10 
EC-Percentage values i.e. p EC-Percentage. These EC-Response/pEC-Response 
values may be printed or saved on disc for direct incorporation into options such as 
SCHILD ANALYSIS and BEEMAC FORMAT.
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Figure A.2: Method of calculation of EC- values.
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F SCALING FACTOR
This option is designed to aid the user who is entering data into DATAFILE 
manually, i.e. not via the use of the LINCHART and LINCHART-DATFILE options. 
This simply allows data measured in arbitrary units, such as mm or cm, to be 
converted to more meaningful values (e.g. mg.wt.) by simply entering a conversion 
factor. The converted data may then be saved as a normal DATAFILE file.
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